Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
A4GALT	"A14GALT, Gb3S, P(k), P1"	ENSG00000128274	"Alpha 1,4-galactosyltransferase (P blood group)"	Q9NPC4	22	42692112-42721298	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Urothelial cells: 69.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"NK-cell: 1.4;plasmacytoid DC: 3.4"	"Group enriched"	"Detected in many"	13	"dendritic cells: 3.4;NK-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 21.9;ASC TERT1: 17.9;RPTEC TERT1: 14.8;TIME: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001141			Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA001141: AB_1078139"	"unprognostic (2.59e-2)"	"prognostic favorable (2.48e-4)"	"unprognostic (2.24e-2)"	"unprognostic (4.54e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.82e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.74e-1)"	22.7	5.9	3.5	8.2	3.7	3.8	15.3	1.4	3.8	21.2	12.0	2.3	32.6	4.8	13.0	16.9	15.0	11.7	11.0	26.8	2.3	1.3	30.0	4.4	14.0	6.4	2.9	3.0	11.8	3.4	1.4	7.7	12.6	2.9	15.4	2.1	9.9	15.4	39.8	12.5	8.7	7.0	18.6	5.3	11.4	11.3	6.7	2.4	1.3	10.7	13.0	10.1	16.1	25.6	0.1	3.4	0.0	0.0	1.4	0.0	0.0	0.6	7.4	0.0	0.0	21.9	17.9	11.2	2.9	3.2	0.6	1.1	2.3	1.2	7.2	5.2	5.2	3.8	0.7	7.1	3.5	0.1	0.0	1.4	0.1	11.8	0.2	6.6	0.0	0.5	10.5	1.0	3.1	0.5	1.0	2.6	0.0	0.0	0.0	2.8	10.1	0.0	0.0	0.9	0.5	1.8	0.0	1.7	0.7	14.8	12.7	0.1	0.0	9.1	0.2	0.0	1.4	5.8	0.8	15.7	0.0	1.4	13.4	3.8	1.5	6.8	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	3.4	0.0	0.0	3.5	3.7	1.4	3.8	2.3	1.3	2.9	3.0	2.9	2.4	0.0	0.3	1.4	28.5	8.1	0.0	14.6	2.5	2.7	9.1	17.4	0.0	36.7	11.6	18.0	0.4	40.9	0.0	23.3	1.0	26.1	24.9	31.4	1.1	0.2	4.8	0.0	0.0	22.1	1.8	1.5	42.8	5.4	6.8	52.3	0.0	0.5	3.7	0.0	28.3	45.6	0.4	38.8	39.6	0.4	0.4	7.8	7.9	1.0	0.0	69.8
A4GNT	alpha4GnT	ENSG00000118017	Alpha-1,4-N-acetylglucosaminyltransferase	Q9UNA3	3	138123718-138132387	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"gallbladder: 25.9;pancreas: 7.0;stomach 1: 25.0"	"Cell type enriched"	"Detected in single"	9	"Cholangiocytes: 2.5"	"Group enriched"	"Detected in some"	6	"pancreatic cancer: 2.5;stomach cancer: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.6;BJ: 3.7;hTERT-RPE1: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA008017	Enhanced				"Intracellular and membrane"	NA	NA					"HPA008017: AB_1078073"	"unprognostic (1.21e-1)"	"unprognostic (2.52e-1)"			"unprognostic (2.14e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.79e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.48e-3)"	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	2.5	0.1	0.1	0.1	0.1	25.9	0.1	0.1	0.1	1.5	0.4	0.3	0.1	0.1	0.1	0.2	7.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	25.0	0.1	0.1	0.1	0.3	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	2.6	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.6	0.0	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACER1	ASAH3	ENSG00000167769	"Alkaline ceramidase 1"	Q8TDN7	19	6306142-6333629	"Enzymes, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"esophagus: 14.3;skin 1: 38.2;tongue: 17.3"	"Cell type enhanced"	"Detected in some"	23	"Melanocytes: 1.7;Spermatocytes: 1.8;Suprabasal keratinocytes: 5.1"	"Group enriched"	"Detected in some"	7	"head and neck cancer: 1.0;melanoma: 2.2;prostate cancer: 0.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"MCF7: 2.2;T-47d: 8.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.13e-2)"	"unprognostic (2.87e-4)"		"unprognostic (5.04e-2)"	"unprognostic (6.18e-2)"	"unprognostic (8.16e-4)"	"unprognostic (7.27e-4)"	"unprognostic (2.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.02e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-5)"	"unprognostic (2.11e-1)"	"unprognostic (4.44e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.24e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	2.2	0.1	0.1	3.8	0.1	0.1	0.1	0.0	0.4	0.1	14.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.1	0.0	0.1	1.4	0.1	0.2	38.2	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	17.3	3.5	0.1	2.2	0.6	0.4	0.4	0.2	1.0	3.6	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	8.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.1	0.1	0.2	0.0	3.6	0.1	3.5	1.6	0.0	0.6	2.3	2.3	0.4	1.0	0.2	0.4	2.0	0.7	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	1.8	0.5	5.1	0.0	0.0	0.0	0.1
ACER2	"ALKCDase2, ASAH3L, FLJ41587"	ENSG00000177076	"Alkaline ceramidase 2"	Q5QJU3	9	19409059-19452020	"Enzymes, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"stomach 1: 41.0;urinary bladder: 31.3;vagina: 40.6"	"Cell type enhanced"	"Detected in some"	11	"Cone photoreceptor cells: 2.0;Early spermatids: 2.1;Ito cells: 1.8;Late spermatids: 1.8;Syncytiotrophoblasts: 3.3"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 15.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"BEWO: 16.7;RT4: 41.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.94e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.46e-3)"	17.4	1.7	3.1	0.7	5.9	0.4	20.7	2.3	6.8	1.4	3.5	0.9	5.3	3.0	1.3	3.0	1.8	2.8	1.3	3.2	3.0	1.9	1.6	2.6	1.5	0.6	4.4	0.3	1.3	4.7	2.7	1.6	20.0	4.5	9.4	3.1	1.4	1.8	6.8	2.1	4.0	1.7	2.1	2.9	1.2	41.0	1.3	4.7	0.4	1.8	1.0	0.8	31.3	40.6	1.0	1.2	0.0	3.1	0.0	1.0	0.5	0.6	1.3	2.1	1.1	3.5	0.2	16.7	1.1	0.8	0.5	0.5	0.3	1.0	0.7	0.4	0.1	0.2	2.5	0.5	3.3	0.9	1.4	0.6	1.1	1.0	1.5	0.7	0.2	1.1	1.1	3.1	1.3	1.4	0.3	3.5	1.2	1.7	2.1	1.2	1.0	1.9	0.9	1.6	6.0	0.5	1.7	0.6	0.4	0.3	41.0	3.9	0.9	0.2	1.1	0.2	5.6	1.4	1.4	1.7	0.3	0.8	0.3	0.5	0.7	0.9	0.8	0.3	0.8	0.7	0.0	0.1	0.0	0.8	3.1	0.2	1.0	0.3	0.3	0.3	0.4	1.0	0.2	0.0	0.0	0.0	1.2	0.3	0.5	3.1	5.9	2.3	6.8	3.0	1.9	4.4	0.3	4.5	4.7	0.0	0.0	0.0	0.2	0.2	0.6	0.1	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.1	2.1	0.3	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.8	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.5	0.0	3.3	0.0	0.0	0.5
ACER3	"APHC, FLJ11238, PHCA"	ENSG00000078124	"Alkaline ceramidase 3"	Q9NUN7	11	76860867-77026797	"Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA070087	Approved					NA	NA					"HPA070087: AB_2732147"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.54e-3)"	"unprognostic (1.37e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (7.13e-2)"	"unprognostic (2.35e-3)"	"unprognostic (8.45e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.68e-3)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (5.24e-2)"	"unprognostic (3.37e-1)"	"unprognostic (9.88e-2)"	"unprognostic (7.97e-2)"	18.3	5.9	11.8	8.6	19.8	7.1	7.8	7.9	15.2	10.5	10.8	29.5	1.5	12.0	7.0	7.1	9.8	5.4	6.3	5.3	14.7	11.0	9.1	4.9	11.3	8.2	27.3	7.2	4.0	4.6	8.3	3.6	31.6	21.8	8.3	10.0	6.0	6.3	5.0	2.7	6.1	8.1	7.2	22.0	8.7	7.2	9.3	24.6	1.3	6.0	6.5	6.7	5.4	6.5	1.6	4.7	3.9	5.0	0.6	2.2	1.4	4.9	5.9	4.9	5.9	22.0	10.5	3.2	7.3	7.5	6.2	6.7	4.1	5.5	4.6	5.3	5.6	7.1	8.8	6.6	7.8	7.5	5.6	2.2	7.2	4.0	2.8	6.1	6.5	12.5	5.3	3.9	7.3	8.2	3.6	10.5	4.0	4.0	2.3	6.9	4.7	0.5	5.0	2.5	14.0	5.8	2.9	16.5	3.1	5.2	5.2	1.7	4.3	8.6	10.0	2.7	3.5	7.2	3.9	13.7	6.1	4.6	18.4	5.9	2.0	4.2	6.4	3.9	3.7	7.2	0.6	5.0	3.9	1.2	4.5	1.4	1.6	0.9	1.5	4.7	1.0	0.7	1.0	1.8	0.6	2.8	2.5	2.2	1.4	11.8	19.8	7.9	14.4	14.7	11.0	27.3	7.2	21.8	24.6	38.7	44.4	9.7	19.0	28.3	17.8	6.0	10.2	16.0	36.4	8.7	9.8	10.6	6.6	13.8	46.3	25.2	28.7	0.0	15.4	6.2	15.6	13.3	79.9	8.6	38.9	41.3	2.4	30.1	55.7	26.2	18.7	52.0	16.9	19.8	22.5	12.0	14.1	31.5	24.4	11.0	9.4	6.5	21.7	73.8	17.9	14.6	22.4	10.7	16.2	19.2
ALG1L	ALG1L1	ENSG00000189366	"ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase like"	Q6GMV1	3	125929275-125937039	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 11.4;urinary bladder: 12.5"	"Cell type enriched"	"Detected in many"	5	"Ciliated cells: 30.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 11.0;CAPAN-2: 10.0;HaCaT: 10.7;MCF7: 20.7;OE19: 13.1;T-47d: 13.9"									HPA036108	Uncertain					NA	NA					"HPA036108: AB_10673344"	"unprognostic (7.06e-3)"	"unprognostic (1.50e-3)"	"unprognostic (1.47e-1)"	"unprognostic (4.14e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.37e-2)"	"unprognostic (5.79e-2)"	"unprognostic (4.50e-6)"	"unprognostic (1.35e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.57e-2)"	"prognostic favorable (6.24e-4)"	0.0	0.5	2.3	0.8	1.6	0.0	1.1	0.3	1.8	0.8	0.9			0.0	0.9	11.4	1.3	2.0	0.4	0.1	1.6	2.0	1.0	1.0	0.7	0.0	2.2		1.7	0.7	0.0	1.2	1.2		1.2	0.6		1.6	0.6	5.9	5.5	0.1	0.2	1.0	0.0	1.1	0.5			1.0		2.3	12.5	0.9	3.1	2.4	4.8	0.2	5.3	5.0	2.1	0.7	0.6	0.3	0.0	0.0	0.2	1.3	0.0	0.0	0.1	0.3	11.0	10.0	3.0	4.9	0.0	0.2	10.7	0.3	0.0	0.6	0.4	2.5	0.5	1.7	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	2.9	0.8	1.0	0.0	20.7	0.6	0.2	4.5	13.1	2.6	0.1	0.0	5.0	0.0	0.6	1.7	0.7	0.4	0.1	0.5	2.4	13.9	0.2	0.2	0.1	1.7	0.1	0.0	7.8	1.1	4.0	0.1	0.0	0.7	4.8	0.1	0.2	3.9	0.2	2.1	3.1	2.1	4.2	0.0	1.9	2.3	1.6	0.8	5.3	0.0	2.4	5.0	2.1											0.0	0.3	0.8	1.6	3.0	0.2	0.0	0.0	30.8	3.4	1.8	0.0	2.8	1.7	0.3	1.5	0.0	0.0	0.0	0.3	1.8	1.5	0.6	1.1	0.0	0.2	0.0	1.7	0.0	0.0	1.5	1.7	0.0	1.7	0.0	0.0	0.6	0.4	0.8	2.8	0.7	0.0	0.0	1.2	1.7	1.6	4.4	1.1	0.0	0.2	6.4
ALG1L2		ENSG00000251287	"ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase like 2"	C9J202	3	130081831-130113227	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 4.0;lymphoid tissue: 3.5"	"Cell type enhanced"	"Detected in some"	5	"Basal glandular cells: 4.9;Cone photoreceptor cells: 3.9;Horizontal cells: 4.8;Muller glia cells: 4.8"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	4	"plasmacytoid DC: 4.0"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 4.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.6;HDLM-2: 1.9;HEL: 1.8;Karpas-707: 1.4;REH: 2.9"									HPA060392	Uncertain		Uncertain	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA060392: AB_2684273"	"unprognostic (1.05e-1)"	"unprognostic (5.13e-2)"	"unprognostic (5.44e-3)"	"unprognostic (8.15e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.38e-1)"	"unprognostic (3.91e-1)"	"prognostic favorable (7.75e-4)"	"unprognostic (4.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.93e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.28e-3)"	0.0	0.0		0.8		1.2	0.0		0.0	0.0	0.0			0.8	0.0	0.0	0.3	0.3	0.0	0.0			0.0	0.0	0.0	0.0			0.2	0.0	0.0		0.0		0.0	0.0		0.2	0.0	0.0	0.9	0.0	0.0		3.5	0.3	0.0			0.0		0.0	0.1		0.7	4.0	0.0	0.3	0.0	0.9	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	1.4	0.0	0.0	0.0	0.5	0.1	0.9	0.0	2.9	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.4	0.6	0.3	0.3	0.4	0.1	0.0	0.0	0.0	4.0	0.9	0.1											0.0	1.6	0.8	4.9	0.0	1.9	0.2	0.0	1.4	1.2	1.8	3.9	0.2	1.7	0.0	0.4	0.0	0.9	0.0	0.0	0.2	0.6	1.8	0.0	0.2	0.2	4.8	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.6	4.8	0.0	0.0	2.5	0.3	3.0	0.0	0.1	0.5	0.1	0.0	0.0	0.5	0.6	1.4
ARSA		ENSG00000100299	"Arylsulfatase A"	P15289	22	50622754-50628173	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 87.0;Late spermatids: 100.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005554, CAB025183"	Enhanced		Uncertain	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		4500000	"Golgi apparatus"	Cytosol	"CAB025183: , HPA005554: AB_1078220"	"unprognostic (1.55e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.07e-2)"	"prognostic favorable (2.96e-5)"	"unprognostic (4.66e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.73e-3)"	19.0	15.2	14.0	15.2	15.7	16.6	15.2	11.9	17.9	12.0	20.3	21.4	26.4	30.2	13.3	21.4	15.6	18.5	23.3	18.8	13.4	8.8	17.5	24.1	15.7	16.8	19.1	10.3	9.3	45.4	13.1	20.4	18.5	17.3	15.8	8.8	14.0	36.8	21.9	6.3	11.1	23.4	8.7	13.2	25.6	23.6	27.2	17.9	10.6	18.7	7.5	16.5	14.8	13.3	5.6	15.7	30.1	19.8	3.9	8.9	7.7	4.1	5.8	2.8	5.4	20.9	11.4	7.0	6.7	8.2	2.9	5.0	1.6	6.4	2.8	4.1	11.0	5.4	6.4	0.6	6.2	0.4	1.2	4.4	1.6	6.5	5.8	14.5	2.4	17.1	13.5	12.1	4.8	3.1	9.9	6.6	5.8	1.7	39.3	5.9	4.7	2.2	2.8	0.8	4.3	5.8	2.0	0.2	12.9	4.9	6.4	1.3	4.3	9.5	8.5	4.8	2.6	3.8	3.0	11.6	2.1	8.0	7.5	1.9	9.3	0.8	2.1	6.1	2.2	6.9	4.3	13.7	17.1	8.9	16.0	7.9	5.6	6.5	7.3	11.2	5.6	3.9	5.3	30.1	3.9	19.8	15.7	8.5	7.7	14.0	15.7	11.9	17.9	13.4	8.8	19.1	10.3	17.3	17.9	6.0	11.7	17.5	11.1	4.1	4.9	6.5	30.6	13.4	4.5	12.2	3.9	10.2	1.7	28.6	51.1	7.9	87.0	23.3	18.7	18.1	13.0	12.6	5.8	27.6	33.4	6.4	35.3	9.2	28.5	100.4	10.0	17.4	16.9	37.9	23.2	9.3	25.7	35.9	5.6	20.6	6.2	0.0	4.7	43.1	3.1	4.8	11.1	10.5	19.0	14.9
ASAH1	"AC, ACDase, ASAH, FLJ21558, PHP32"	ENSG00000104763	"N-acylsphingosine amidohydrolase 1"	Q13510	8	18055992-18084998	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase	"Disease mutation, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Hofbauer cells: 805.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 27.0;classical monocyte: 53.6;eosinophil: 36.5;intermediate monocyte: 77.9;myeloid DC: 20.8;neutrophil: 73.8;non-classical monocyte: 80.5"	"Group enriched"	"Detected in all"	6	"dendritic cells: 20.8;granulocytes: 73.8;monocytes: 80.5"	"Cell line enhanced"	"Detected in all"		"ASC diff: 72.7;SK-MEL-30: 103.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005468	Supported				"Intracellular and membrane"	NA	NA		410000			"HPA005468: AB_1845062"	"unprognostic (1.99e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.15e-3)"	"unprognostic (9.23e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.29e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.03e-2)"	"prognostic favorable (3.08e-8)"	"unprognostic (1.95e-1)"	"unprognostic (3.91e-2)"	"unprognostic (6.54e-3)"	"unprognostic (7.36e-3)"	41.9	16.8	18.5	11.2	20.7	20.7	44.2	17.6	19.1	23.9	18.5	15.4	31.5	11.9	17.6	30.6	19.8	16.2	22.3	120.4	17.5	19.2	45.0	13.2	57.2	40.2	27.0	16.7	13.0	16.5	18.0	28.2	36.5	29.8	19.5	19.7	33.3	20.4	39.4	18.2	16.4	16.4	19.5	40.9	25.9	12.9	8.2	15.9	4.5	73.4	15.1	12.3	31.4	16.0	9.8	20.8	73.8	80.5	6.7	6.0	38.7	8.4	11.7	4.6	11.4	72.7	8.6	7.1	8.6	12.3	4.2	7.5	6.2	11.7	5.2	11.0	9.5	28.9	11.1	2.8	4.5	5.2	4.0	6.8	23.3	8.8	16.8	19.9	4.7	26.1	18.5	15.6	6.1	4.2	9.7	1.1	9.0	4.1	11.1	12.1	8.5	2.6	8.4	5.4	18.3	7.2	3.3	4.6	7.0	20.1	48.1	7.6	10.1	8.0	26.4	103.3	6.7	8.6	5.4	7.5	5.5	7.9	10.0	4.1	13.7	30.8	3.8	16.3	10.7	4.4	27.0	53.6	36.5	6.0	77.9	5.4	9.8	4.5	4.5	20.8	7.7	5.3	4.8	73.8	6.7	80.5	3.9	4.9	38.7	18.5	20.7	17.6	19.1	17.5	19.2	27.0	16.7	29.8	15.9	294.8	337.4	90.6	70.3	52.1	87.7	644.7	119.8	140.5	197.9	427.5	43.2	150.6	51.4	112.4	1.9	67.4	63.2	140.2	91.9	53.3	103.9	123.4	247.5	40.0	805.1	73.1	94.1	132.6	474.5	1.9	82.0	445.8	301.9	103.6	90.2	564.6	58.0	94.7	99.3	242.2	72.1	174.6	116.2	11.2	53.7	56.1	123.9	47.3	78.2	113.1
ASAH2		ENSG00000188611	"N-acylsphingosine amidohydrolase 2"	Q9NR71	10	50182778-50248610	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"intestine: 43.9"	"Cell type enhanced"	"Detected in many"	9	"Late spermatids: 6.0;Muller glia cells: 10.2;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											HPA061171	Supported		Approved	"Focal adhesion sites"	"Intracellular and membrane"	NA	NA		1200000	"Focal adhesion sites"		"HPA061171: AB_2684442"	"unprognostic (3.59e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.66e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.02e-3)"	0.3	1.1	0.6	0.2	0.9	0.0	0.5	0.5	1.3	1.7	0.5			43.9	0.7	0.3	0.7	0.5	0.2	0.9	0.5	1.4	0.6	1.6	0.4	0.2	1.2		1.4	1.5	0.3	1.0	0.4		0.5	0.3		0.9	0.2	0.8	0.7	33.4	0.7	0.6	0.2	2.5	1.1			0.6		0.1	1.0	0.5	0.9	0.9	0.0	0.0	0.0	2.2	0.1	1.8	1.4	1.6	2.2	2.9	1.1	2.0	2.0	1.3	3.8	3.5	1.0	4.6	0.0	2.2	2.7	3.1	1.7	2.1	0.7	4.7	2.3	3.8	1.3	3.8	2.9	1.8	0.4	0.2	0.4	2.6	6.6	7.5	0.5	0.8	0.0	2.5	1.2	2.5	1.5	1.4	0.1	4.8	0.0	4.1	0.0	6.4	1.6	2.1	0.3	2.7	7.3	2.5	1.8	3.3	3.9	1.5	1.0	2.0	1.9	4.4	4.7	6.1	1.9	0.2	0.0	5.5	0.0	1.7	0.0	0.0	0.0	0.7	0.0	2.2	0.9	0.4	1.7	0.0	0.1	1.4	2.1	0.0	0.0	0.0	0.9	0.6	0.1											0.0	0.0	0.0	0.2	0.3	1.8	3.0	0.0	0.0	1.2	0.0	2.0	0.3	0.0	1.1	4.1	0.1	1.3	0.0	1.3	0.2	0.4	0.2	0.0	1.8	0.2	1.6	0.0	0.6	0.0	6.0	1.1	0.0	0.0	0.0	1.2	10.2	1.4	0.0	1.4	0.6	1.8	6.5	0.9	0.9	0.8	0.1	0.2	0.0	0.6	0.1
B3GALNT1	"B3GALT3, beta3Gal-T3, galT3, GLOB, P1"	ENSG00000169255	"Beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)"	O75752	3	161083883-161105384	"Blood group antigen proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 36.8"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 52.9;Cardiomyocytes: 51.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 4.9;NK-cell: 16.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 4.9;NK-cells: 16.7"	"Cell line enhanced"	"Detected in many"		"PC-3: 17.2;RT4: 52.6"	"Low region specificity"	"Detected in all"							HPA041204			Approved	Vesicles		NA	NA		290000	Vesicles		"HPA041204: AB_10795585"	"unprognostic (3.85e-2)"	"unprognostic (5.11e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.06e-2)"	"unprognostic (7.83e-2)"	"unprognostic (4.07e-2)"	"unprognostic (9.26e-5)"	"unprognostic (1.49e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.19e-3)"	3.8	5.4	14.0	3.0	24.5	3.1	7.4	17.2	24.7	15.5	2.3	5.5	2.6	1.5	8.3	6.9	5.4	10.4	7.1	36.8	15.4	21.6	14.3	1.0	10.8	3.5	11.3	16.2	13.8	7.8	6.5	8.5	10.0	17.7	8.9	2.0	7.5	14.8	6.7	1.1	2.2	1.9	7.2	7.6	4.2	7.5	6.2	5.0	1.1	19.5	2.3	3.9	10.5	4.7	1.4	1.4	4.9	0.2	16.7	0.7	0.5	6.7	0.2	3.1	0.1	0.3	1.0	0.1	3.7	3.3	8.2	2.8	4.4	5.1	0.0	15.1	3.1	4.9	1.5	0.0	6.6	2.7	0.1	0.0	3.7	2.8	0.0	4.8	0.1	0.1	10.1	2.0	2.2	0.5	6.4	12.1	0.0	0.0	0.0	3.3	10.9	0.0	0.0	7.5	0.1	17.2	0.1	0.0	0.1	3.9	52.6	6.3	0.0	9.5	3.5	2.7	1.4	14.5	5.5	0.0	0.1	6.6	0.2	0.1	1.5	0.0	0.0	5.8	0.0	0.0	4.9	0.2	0.0	0.4	0.1	0.4	1.4	0.2	0.4	1.4	0.3	0.5	0.7	0.4	16.7	0.0	1.0	0.0	0.5	14.0	24.5	17.2	24.7	15.4	21.6	11.3	16.2	17.7	5.0	17.9	2.1	3.4	4.2	4.4	52.9	51.9	0.0	2.7	10.3	14.0	11.8	18.5	10.0	3.0	0.6	6.8	0.0	0.0	7.4	10.2	16.9	4.9	10.3	0.0	8.4	6.4	1.7	6.7	1.3	1.7	6.6	4.6	10.1	7.2	0.0	10.8	7.2	0.0	4.9	13.6	7.2	0.0	13.3	3.7	16.8	2.3	4.2	1.8	0.4	4.1
B3GALNT2	MGC39558	ENSG00000162885	"Beta-1,3-N-acetylgalactosaminyltransferase 2"	Q8NCR0	1	235449923-235504481	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 35.7"	"Cell type enriched"	"Detected in many"	7	"Cone photoreceptor cells: 237.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012502, HPA050662"	Approved		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA012502: AB_1845228, HPA050662: AB_2681209"	"unprognostic (5.50e-2)"	"unprognostic (3.16e-3)"	"unprognostic (6.60e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.59e-3)"	"unprognostic (1.96e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.19e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.53e-3)"	"unprognostic (8.34e-3)"	5.0	6.3	3.9	4.3	5.1	1.3	8.4	4.7	4.5	5.4	7.6	3.5	5.1	3.3	8.0	8.7	10.3	6.1	9.7	7.9	2.8	2.9	3.7	4.6	3.7	3.1	3.0	3.2	5.9	35.7	9.8	8.9	4.5	4.7	8.3	5.8	8.5	8.7	7.3	21.6	6.1	6.9	16.9	2.5	3.3	9.2	5.8	3.9	4.7	7.1	7.0	5.0	9.7	5.9	1.5	5.7	2.4	2.7	1.9	1.9	1.3	9.9	6.5	7.2	10.7	11.7	9.9	17.4	8.7	7.9	6.6	6.1	5.0	8.9	5.2	11.5	9.9	4.3	12.6	14.0	10.2	8.2	10.2	9.7	3.3	8.3	5.7	7.4	10.7	3.7	7.1	6.6	6.8	16.5	5.0	10.1	14.1	8.0	7.0	6.2	4.7	6.7	3.9	10.3	6.3	3.7	7.4	12.0	13.2	4.2	11.8	9.3	11.9	15.1	5.7	7.5	3.1	11.0	10.9	9.9	5.8	9.6	9.8	11.6	10.2	8.4	3.2	3.8	7.7	13.4	2.4	2.3	1.1	1.1	2.7	1.7	1.5	0.8	1.9	5.7	1.1	1.0	1.3	0.2	1.9	2.5	3.1	0.5	1.3	3.9	5.1	4.7	4.5	2.8	2.9	3.0	3.2	4.7	3.9	8.9	5.3	6.4	25.1	27.7	18.9	5.4	2.5	5.3	4.5	5.2	237.6	17.0	0.0	5.8	13.0	6.7	7.3	0.0	6.1	5.6	8.1	23.5	5.7	4.4	3.5	27.0	8.6	4.3	3.1	4.5	9.8	7.9	1.7	9.0	4.6	7.8	7.6	4.3	15.2	0.8	17.3	0.0	14.4	16.6	34.1	26.0	18.8	5.3	5.2	31.0
B3GALT1	beta3Gal-T1	ENSG00000172318	"Beta-1,3-galactosyltransferase 1"	Q9Y5Z6	2	167868948-167874041	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 2.4;brain: 5.1;intestine: 5.8;skeletal muscle: 7.1"	"Cell type enhanced"	"Detected in some"	9	"Enterocytes: 3.1;Mucus-secreting cells: 4.2;Undifferentiated cells: 5.2"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	8	"AN3-CA: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.98e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.23e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.94e-2)"	"unprognostic (8.72e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.30e-3)"	"unprognostic (8.34e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.79e-1)"	0.1	0.6	0.5	0.0	1.6	0.0	0.3	0.9	5.1	0.2	5.6			0.0	0.2	0.3	0.0	0.8	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.3		0.1	0.2	0.0	0.8	0.0		0.1	5.8		0.1	0.9	7.1	0.0	0.1	0.0	0.1	0.0	0.0	0.5			0.1		0.0	0.0	0.1	1.4	0.8	2.0	0.5	1.0	2.4	0.4	0.0	0.0	2.2	28.6	0.2	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	1.1	0.1	0.0	0.0	0.0	0.0	3.7	0.0	1.0	0.0	0.1	0.0	0.4	0.0	1.9	0.3	0.0	0.0	0.5	1.4	0.0	0.0	0.0	0.2	0.1	0.3	0.3	0.0	0.6	0.0	0.5	0.0	2.6	2.0	0.5	0.3	0.6	0.3	0.7	1.1	0.7	0.7	0.2	1.4	2.4	1.3	1.5	1.0	0.3	0.8	0.6	0.4											0.0	2.2	0.0	0.0	0.1	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	3.1	0.0	0.2	0.0	0.2	0.1	1.1	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.6	0.0	1.7	0.0	4.2	1.9	0.0	0.0	1.4	0.2	1.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	5.2	0.0
B3GALT2	beta3Gal-T2	ENSG00000162630	"Beta-1,3-galactosyltransferase 2"	O43825	1	193179045-193186654	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 32.9;gallbladder: 19.0;heart muscle: 25.1"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 47.7;Cardiomyocytes: 27.8;Cholangiocytes: 15.3;Leydig cells: 29.4;Peritubular cells: 19.8"	"Cancer enhanced"	"Detected in some"		"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"MAIT T-cell: 11.9"	"Lineage enriched"	"Detected in single"	57	"T-cells: 11.9"	"Group enriched"	"Detected in some"	4	"AF22: 16.4;ASC TERT1: 7.5;LHCN-M2: 11.1;WM-115: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078659			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA078659: AB_2686887"	"unprognostic (1.83e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.34e-3)"	"unprognostic (2.43e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.14e-4)"	"unprognostic (4.41e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.56e-3)"	0.7	2.0	11.3	1.3	8.9	0.7	0.9	1.4	32.9	0.8	1.7	1.2	0.9	1.6	0.6	1.8	1.2	0.7	19.0	25.1	10.1	7.9	1.7	0.8	2.6	0.7	5.7	19.1	13.8	0.8	0.4	0.9	0.9	5.0	6.5	2.0	0.3	0.5	7.1	0.6	0.7	4.1	0.8	6.5	1.4	2.1	1.4	4.7	0.0	1.8	0.0	1.6	2.0	0.7	0.0	0.2	0.1	0.0	0.0	11.9	0.3	0.0	0.0	16.4	0.0	0.4	7.5	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	1.4	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.2	0.0	11.9	0.0	2.7	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	2.3	0.3	11.3	8.9	1.4	32.9	10.1	7.9	5.7	19.1	5.0	4.7	0.0	0.3	0.0	0.0	0.2	47.7	27.8	15.3	4.0	0.0	1.8	3.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.3	2.3	0.0	0.2	7.9	2.9	1.3	0.3	0.0	29.4	0.1	0.0	0.0	0.3	1.7	0.4	0.0	19.8	0.0	5.8	0.0	0.4	0.0	0.0	0.3	0.0	5.1	0.4	0.0
B3GALT4	"beta3Gal-T4, GalT4"	ENSG00000235863	"Beta-1,3-galactosyltransferase 4"	O96024	6	33277132-33284832	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 54.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.1;SCLC-21H: 3.2;SK-BR-3: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043001	Approved					NA	NA					"HPA043001: AB_2678265"	"unprognostic (3.71e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.66e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.17e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.75e-2)"	7.0	6.9	3.0	9.8	4.0	3.0	6.7	5.3	6.3	7.6	9.0	6.2	13.1	8.0	6.2	7.0	14.0	6.1	9.4	5.7	3.6	3.4	7.1	1.7	6.7	11.9	3.7	3.0	3.1	3.1	5.3	4.4	7.4	4.0	6.5	4.9	6.7	9.1	15.9	2.7	10.9	12.5	4.3	4.6	11.1	7.7	19.0	2.5	14.7	5.6	5.3	9.8	8.6	7.9	7.3	4.1	12.4	8.4	6.3	9.5	5.2	0.0	0.3	0.6	0.2	0.9	1.6	0.8	0.3	0.4	0.0	0.1	0.0	5.1	0.0	0.0	0.7	1.2	2.6	0.0	0.2	0.0	2.8	0.3	0.9	0.4	0.0	1.0	0.0	2.7	2.1	1.3	0.1	0.1	0.0	0.7	2.4	0.0	0.3	0.0	0.1	1.3	1.2	0.2	1.9	0.3	0.2	0.0	0.0	0.0	0.8	3.2	0.4	0.1	5.2	0.4	0.6	0.0	1.4	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.7	12.4	6.9	10.0	9.5	6.7	7.4	6.0	5.9	8.0	4.1	7.3	5.7	5.1	7.3	6.3	8.4	3.3	6.3	5.2	3.0	4.0	5.3	6.3	3.6	3.4	3.7	3.0	4.0	2.5	11.9	4.5	10.4	5.9	2.9	13.7	3.3	17.8	14.7	7.9	14.0	3.9	15.4	5.0	12.9	25.9	9.8	29.5	0.0	16.5	9.9	5.2	9.6	10.3	0.5	18.3	11.1	12.1	11.1	23.0	54.2	7.2	12.7	8.5	30.7	15.3	11.8	14.7	25.9	5.6	5.3	13.9	6.5	3.8	28.9	3.0	4.3	26.8	14.9	10.1	14.6
B3GALT5	"B3GalT-V, B3T5, beta3Gal-T5, GLCT5"	ENSG00000183778	"Beta-1,3-galactosyltransferase 5"	Q9Y2C3	21	39556442-39673137	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.8;intestine: 27.1;lymphoid tissue: 14.8"	"Group enriched"	"Detected in many"	5	"Enterocytes: 85.3;Intestinal endocrine cells: 27.7;Mucus-secreting cells: 45.4;Paneth cells: 85.2;Undifferentiated cells: 35.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"basal ganglia: 15.8"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 18.6;RPTEC TERT1: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054092, HPA054684"	Approved				"Intracellular and membrane"	NA	NA					"HPA054092: AB_2682375, HPA054684: AB_2682573"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (6.36e-4)"	"unprognostic (9.23e-2)"	"unprognostic (4.62e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (7.86e-3)"	"unprognostic (1.67e-1)"	"unprognostic (6.09e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.55e-3)"	0.1	0.3	0.5	3.1	15.8	0.1	1.8	0.3	1.5	3.0	16.2	0.6	0.0	19.4	1.4	1.6	2.3	1.0	12.9	0.2	1.3	1.5	0.6	0.3	0.2	0.1	0.7	0.1	0.7	6.2	0.1	7.9	0.7	2.2	1.0	27.1	2.2	5.5	0.1	0.2	1.1	23.4	0.7	2.0	0.2	3.8	0.6	3.6	1.8	1.1	0.8	14.8	1.1	5.9	0.2	0.2	1.0	0.2	0.3	0.2	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	18.6	0.0	0.2	0.1	1.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	5.0	0.1	0.5	0.0	2.1	0.1	22.0	1.4	3.7	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.6	0.1	0.8	0.0	0.0	0.0	1.0	0.0	0.3	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.0	0.3	0.0	0.2	0.0	0.0	0.5	15.8	0.3	1.5	1.3	1.5	0.7	0.1	2.2	3.6	0.0	0.0	0.0	0.2	0.0	6.7	1.7	10.2	1.4	7.9	5.2	0.0	0.0	0.0	6.5	0.3	0.0	85.3	0.0	4.1	0.0	0.0	0.4	4.6	0.0	0.0	0.0	27.7	0.0	0.0	0.6	0.6	0.0	0.0	0.0	45.4	1.4	6.0	85.2	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	35.9	6.7
B3GLCT	"B3GALTL, B3Glc-T, B3GTL"	ENSG00000187676	"Beta 3-glucosyltransferase"	Q6Y288	13	31199936-31332276	"Disease related genes, Predicted intracellular proteins"	"Carbohydrate metabolism, Fucose metabolism"	"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 21.8;Cone photoreceptor cells: 15.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 34.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA						"unprognostic (3.31e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.71e-2)"	"unprognostic (6.17e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.91e-1)"	"unprognostic (3.28e-3)"	"unprognostic (6.74e-2)"	"unprognostic (5.51e-3)"	"unprognostic (2.26e-1)"	"unprognostic (5.70e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.51e-1)"	6.7	3.4	8.6	5.1	18.3	4.4	14.0	2.0	10.8	4.6	4.2	8.9	3.8	3.8	17.2	10.1	4.4	8.6	4.8	23.2	6.5	5.8	9.0	4.6	4.9	4.7	4.3	8.8	7.9	7.5	7.5	4.8	9.1	8.3	5.0	4.7	7.2	5.9	8.8	5.6	4.6	4.0	17.1	4.9	4.5	5.1	4.9	7.7	5.6	6.6	2.7	7.1	3.7	6.0	2.5	0.8	3.1	0.8	2.6	6.9	2.6	2.7	3.9	16.1	2.9	3.1	3.1	2.6	6.8	7.7	8.3	5.9	2.0	7.8	11.2	5.0	7.9	15.7	4.6	3.6	4.3	7.8	34.1	6.9	0.7	3.7	2.9	1.9	4.4	6.0	3.6	5.0	4.7	4.1	8.5	7.3	5.6	1.9	1.8	6.5	3.5	6.5	1.3	4.7	4.0	2.4	5.9	5.2	0.4	3.6	3.9	1.5	6.6	5.8	2.8	7.6	4.0	1.3	5.1	10.3	8.4	5.7	3.8	6.7	1.4	3.1	4.3	2.7	3.4	11.1	3.1	0.8	2.4	4.8	0.8	6.9	2.5	3.0	5.3	0.8	1.3	2.5	3.3	0.3	2.6	0.7	0.7	1.6	2.6	8.6	18.3	2.0	10.8	6.5	5.8	4.3	8.8	8.3	7.7	0.0	1.9	1.4	3.2	0.0	5.7	21.8	2.5	2.7	1.2	8.7	15.7	0.3	1.7	4.2	10.1	3.7	0.5	0.0	4.0	1.9	3.1	1.9	0.0	5.3	3.1	0.0	1.2	9.2	3.2	1.9	1.4	1.7	0.0	0.0	1.9	5.6	4.4	2.8	3.2	2.2	4.0	12.9	3.4	1.1	11.8	0.0	0.2	3.2	1.7	1.4
B3GNT2	"B3GN-T1, B3GN-T2, B3GNT-2, B3GNT1, BETA3GNT"	ENSG00000170340	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2"	Q9NY97	2	62196113-62224731	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005997	Approved		Approved	Vesicles		NA	NA		43000000	Vesicles		"HPA005997: AB_1845234"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.63e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.25e-1)"	18.9	14.3	8.6	10.8	23.0	41.6	17.5	3.1	14.1	18.4	17.9	7.4	5.6	17.9	19.8	8.0	24.5	8.7	18.1	20.9	7.6	11.5	24.4	14.2	23.9	13.9	9.7	7.1	9.0	43.2	5.4	25.9	22.8	9.5	7.5	16.3	14.4	17.2	6.0	5.2	13.0	21.7	16.3	7.6	14.6	12.0	7.0	10.6	27.0	15.6	8.5	18.5	11.8	14.7	8.4	6.8	28.3	5.6	20.3	19.3	8.2	7.8	5.4	8.2	3.6	9.0	4.1	23.7	7.6	8.5	6.1	8.2	11.1	12.6	8.5	7.0	7.1	8.6	7.5	5.2	6.4	10.6	17.6	4.2	20.8	2.6	6.5	6.8	12.4	9.4	4.9	12.1	11.7	4.2	4.3	9.1	5.9	11.3	5.3	7.3	5.9	23.6	18.6	7.8	14.2	2.2	43.4	5.7	4.6	11.6	7.7	8.0	5.9	5.4	11.7	8.7	13.8	3.3	14.7	10.3	7.4	6.5	12.5	7.5	15.1	5.3	36.5	5.8	21.6	7.1	7.2	4.5	28.3	11.0	4.4	15.6	7.6	8.2	19.3	5.5	8.4	9.9	14.4	11.3	20.3	5.6	6.8	13.2	8.2	8.6	23.0	3.1	14.1	7.6	11.5	9.7	7.1	9.5	10.6	59.6	9.8	25.1	27.0	63.4	16.0	8.7	17.8	5.3	3.4	17.4	0.0	31.1	19.9	20.8	0.1	21.0	17.3	46.7	50.7	30.1	35.3	23.6	3.5	15.5	51.9	0.0	9.1	37.4	22.7	0.2	2.3	20.4	33.7	24.4	19.1	8.1	37.8	21.8	2.1	18.9	2.4	64.7	52.3	0.2	1.5	56.7	54.6	17.5	11.9	34.6
B3GNT3	"B3GN-T3, B3GNT-3, beta3Gn-T3, HP10328, TMEM3"	ENSG00000179913	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3"	Q9Y2A9	19	17794828-17813082	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 69.9;intestine: 61.6;placenta: 56.0"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 53.5;Cytotrophoblasts: 51.9;Enterocytes: 58.5;Mucus-secreting cells: 40.2;Paneth cells: 42.5;Syncytiotrophoblasts: 57.1;Urothelial cells: 43.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"memory CD4 T-cell: 2.7;memory CD8 T-cell: 1.1;naive CD4 T-cell: 3.2"	"Lineage enriched"	"Detected in single"	32	"T-cells: 3.2"	"Cell line enhanced"	"Detected in some"		"A-431: 16.5;BEWO: 16.3;CAPAN-2: 44.2;OE19: 40.5;RT4: 15.8;SK-BR-3: 15.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA024298	Enhanced				"Intracellular and membrane"	NA	NA					"HPA024298: AB_1845236"	"unprognostic (1.10e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.84e-3)"		"unprognostic (1.10e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (3.26e-1)"	"unprognostic (4.64e-2)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.44e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.57e-2)"	0.4	0.2	0.2	8.7	0.3	0.0	1.8	0.2	0.3	3.5	25.3	0.0	12.0	16.6	0.4	1.2	15.1	0.6	69.9	0.5	0.2	0.3	11.4	2.5	1.0	1.2	0.2	0.0	0.3	9.1	0.0	0.3	56.0	0.0	4.4	22.4	0.3	24.4	12.8	0.3	2.0	61.6	1.9	0.2	0.3	21.8	0.3	0.0	0.3	0.4	2.6	18.3	10.2	5.4	0.0	0.0	0.0	0.0	0.0	3.2	0.6	16.5	4.4	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.2	44.2	0.0	11.3	0.0	0.0	1.6	0.0	5.3	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.1	40.5	7.1	0.0	0.0	0.4	9.8	15.8	0.0	0.0	0.0	15.0	0.0	0.0	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.1	0.0	0.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.2	0.3	0.2	0.3	0.2	0.0	0.0	0.0	0.0	2.9	0.5	1.3	0.1	0.0	0.4	53.5	0.0	6.8	15.7	0.0	51.9	1.7	15.2	0.0	0.5	58.5	0.0	24.8	5.9	0.7	7.2	5.7	0.0	5.1	0.0	15.6	0.6	0.0	0.0	0.0	0.0	0.0	1.0	40.2	0.0	23.5	42.5	0.0	1.8	0.0	0.0	0.0	0.0	0.4	0.0	57.1	0.0	20.6	43.1
B3GNT4	"B3GN-T4, beta3Gn-T4"	ENSG00000176383	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4"	Q9C0J1	12	122203543-122208952	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 16.3;skin 1: 8.5"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 2: 2.6;Proximal tubular cells: 6.1;Spermatogonia: 2.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.2;hTCEpi: 9.9;T-47d: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055261	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA055261: AB_2682765"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (3.52e-6)"	"unprognostic (1.24e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.97e-2)"	"unprognostic (9.47e-2)"	0.7	3.2	7.3	0.8	6.8	4.6	0.8	16.3	9.1	0.5	0.7	0.5	0.0	1.0	0.6	0.7	1.8	1.1	1.1	0.8	4.9	4.0	6.1	0.6	1.1	0.9	1.5	7.3	0.8	0.8	0.8	1.9	0.8	4.0	0.7	0.6	1.0	1.7	0.7	1.1	8.5	1.0	0.6	0.6	1.0	0.7	2.0	0.3	0.0	0.8	0.3	0.8	0.6	0.5	0.8	1.0	0.8	1.7	0.4	1.9	0.4	5.5	1.0	0.4	2.2	0.2	0.1	1.0	0.1	0.0	0.3	0.7	3.5	0.5	0.5	1.0	0.0	0.4	2.0	2.7	2.2	0.2	8.2	2.8	0.2	1.5	0.3	0.6	0.7	1.1	0.7	9.9	0.1	0.5	0.8	0.0	2.0	1.6	0.7	0.2	4.9	0.0	0.7	0.6	0.2	2.0	0.4	0.6	1.0	1.4	0.6	1.4	1.8	1.6	1.0	0.5	0.9	7.6	0.1	0.1	0.5	2.8	0.5	0.3	0.6	5.0	1.2	0.5	0.8	0.3	0.8	0.4	0.2	0.8	0.1	0.4	0.8	1.3	0.2	0.2	0.5	1.9	0.2	0.5	0.4	1.7	1.0	0.6	0.4	7.3	6.8	16.3	8.1	4.9	4.0	1.5	7.3	4.0	0.3	0.0	2.6	0.0	0.7	1.1	0.1	0.4	0.0	1.4	1.2	0.0	0.0	0.4	1.7	1.0	0.2	0.0	0.0	0.0	0.2	0.4	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.6	0.6	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.4	0.6	0.0	6.1	0.1	0.0	0.2	0.5	2.6	1.3	0.5	0.5	0.3	0.4
B3GNT5	"B3GN-T5, beta3Gn-T5"	ENSG00000176597	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5"	Q9BYG0	3	183253244-183298504	"Enzymes, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 80.2"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 101.7;Syncytiotrophoblasts: 132.0;Urothelial cells: 125.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 9.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"GAMG: 30.4;HBEC3-KT: 25.2;hTCEpi: 30.7"	"Region enriched"	"Detected in single"	12	"cerebellum: 16.5"	"Low region specificity"	"Detected in all"			HPA017292	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA017292: AB_1845237"	"unprognostic (2.17e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (5.09e-4)"	"unprognostic (7.10e-3)"	"unprognostic (7.78e-2)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (7.23e-6)"	"unprognostic (4.20e-1)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.18e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.53e-2)"	"unprognostic (8.10e-3)"	8.6	1.4	2.2	6.1	2.3	31.6	4.3	1.2	2.5	6.4	29.8	5.4	2.1	17.5	3.2	5.4	23.5	5.4	10.1	3.3	3.0	2.9	3.5	3.0	11.2	5.1	4.0	0.7	4.2	3.5	1.8	5.1	19.8	4.5	3.9	9.2	3.2	8.7	2.5	6.6	8.0	80.2	2.9	6.3	2.3	5.1	2.9	2.3	1.0	4.6	18.9	8.9	5.0	10.6	0.1	1.1	9.0	1.5	0.0	0.3	0.4	16.1	1.5	8.7	5.3	7.3	21.6	7.9	0.2	0.4	1.7	1.4	3.2	8.5	0.0	1.0	0.0	30.4	7.4	8.9	25.2	1.4	0.0	5.5	0.8	0.7	0.0	9.3	8.1	4.0	10.1	30.7	1.3	23.0	2.3	15.7	0.0	9.2	0.0	13.8	0.0	0.0	2.6	3.6	9.5	14.0	2.5	4.4	0.0	5.3	4.5	0.4	8.3	4.5	0.0	1.9	4.1	0.0	9.9	23.1	0.4	3.4	0.5	3.9	0.0	0.0	0.0	3.3	19.2	8.6	0.0	1.5	1.5	0.0	0.3	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.3	0.4	2.2	2.3	1.2	2.5	3.0	2.9	4.0	0.7	4.5	2.3	6.0	17.4	0.0	55.5	57.9	7.1	2.0	12.7	101.7	27.3	5.2	21.6	24.4	1.7	15.7	9.9	10.0	77.7	0.0	10.5	9.4	7.4	42.6	13.9	0.4	25.3	3.2	36.7	3.1	9.7	19.2	1.4	50.1	11.8	11.8	73.1	3.2	25.3	42.1	0.4	4.3	12.7	0.0	3.4	0.9	0.4	74.2	132.0	0.7	26.9	125.2
B3GNT6	B3Gn-T6	ENSG00000198488	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6"	Q6ZMB0	11	77034398-77041973	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 15.8;lymphoid tissue: 17.5;stomach 1: 17.9"	"Cell type enriched"	"Detected in some"	38	"Mucus-secreting cells: 60.5"	"Group enriched"	"Detected in some"	14	"colorectal cancer: 6.3;lung cancer: 3.9;pancreatic cancer: 5.1;prostate cancer: 5.0;stomach cancer: 4.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.3;neutrophil: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.0;RPMI-8226: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039805	Enhanced				"Intracellular and membrane"	NA	NA					"HPA039805: AB_2676690"		"unprognostic (1.71e-1)"	"prognostic favorable (2.31e-4)"	"unprognostic (4.79e-2)"	"unprognostic (5.42e-2)"	"unprognostic (7.64e-2)"		"unprognostic (1.95e-1)"		"unprognostic (2.72e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.77e-2)"		"unprognostic (2.19e-1)"		"unprognostic (9.30e-2)"	"unprognostic (1.71e-1)"	0.2	0.2	0.3	6.6	0.4	0.0	0.2	0.3	0.4	0.5	15.8	0.0	0.0	3.7	0.2	0.0	2.5	0.2	0.9	0.2	0.3	0.3	0.2	0.2	1.4	0.0	0.3	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.3	12.4	0.0	1.6	0.0	0.2	0.2	9.4	0.0	0.2	0.2	17.9	0.6	0.0	0.0	0.2	3.4	17.5	0.2	0.3	0.4	0.3	2.3	0.2	0.8	0.5	0.2	0.1	0.0	0.5	0.5	0.0	0.2	0.2	0.1	0.2	0.5	0.1	1.2	0.2	0.7	0.3	0.0	0.5	0.0	0.1	0.6	0.1	0.4	0.2	0.2	0.1	0.2	0.0	0.6	0.2	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	2.0	0.2	0.5	0.7	0.0	0.0	0.0	0.1	1.5	0.0	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.1	0.3	0.4	0.5	0.3	0.1	0.2	0.2	2.3	0.2	0.3	0.4	0.2	0.5	0.2	0.2	0.2	0.0	0.4	0.3	0.3	2.2	0.8	0.0	0.3	0.1	0.2	0.3	0.4	0.3	0.4	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.5	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.8	0.1
B3GNT7	beta3GnT7	ENSG00000156966	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7"	Q8NFL0	2	231395543-231401164	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 93.7;intestine: 41.2"	"Cell type enhanced"	"Detected in many"	12	"Intestinal endocrine cells: 99.1;Mucus-secreting cells: 119.1;Undifferentiated cells: 275.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 19.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 15.0;HEL: 11.8;THP-1: 10.5;WM-115: 18.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA013881, HPA035625, HPA035626"	Enhanced		Approved	"Golgi apparatus,Mitotic spindle,Cytosol"	"Intracellular and membrane"	NA	NA		2100000	"Golgi apparatus"	"Mitotic spindle, Cytosol"	"HPA013881: , HPA035625: AB_10601118, HPA035626: AB_2674707"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.17e-2)"	"unprognostic (7.77e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.96e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (3.57e-1)"	3.0	10.3	5.3	2.3	4.9	5.5	1.9	0.9	3.2	1.2	28.0	3.8	0.8	12.2	1.6	3.5	1.9	3.6	93.7	26.8	4.2	4.4	1.4	1.3	17.7	1.8	4.0	2.0	13.0	18.9	6.7	8.9	10.7	3.2	1.6	35.5	2.0	4.0	2.3	0.4	2.4	41.2	1.1	1.9	6.7	17.1	1.6	2.2	1.2	4.2	1.7	3.9	1.2	0.6	7.1	4.2	0.4	0.3	19.9	2.0	0.5	0.5	2.1	0.2	0.4	0.1	0.2	0.8	0.2	0.8	0.1	0.1	1.0	15.0	1.7	4.6	0.2	0.1	3.9	0.2	0.0	0.1	0.2	0.4	11.8	0.3	0.7	0.1	0.1	0.6	0.1	1.1	0.1	0.2	0.8	0.2	0.3	0.3	0.3	0.1	0.6	0.1	0.5	4.9	5.8	2.6	0.2	0.0	0.2	0.5	1.3	0.4	0.6	0.2	1.3	0.5	5.7	0.5	10.5	0.2	0.3	0.3	0.2	0.1	1.8	0.6	0.5	0.3	0.1	18.2	0.3	0.0	0.4	2.0	0.3	0.4	7.1	0.0	0.2	4.2	5.1	0.1	0.5	0.1	19.9	0.3	2.1	0.1	0.5	5.3	4.9	0.9	3.2	4.2	4.4	4.0	2.0	3.2	2.2	38.7	24.6	2.2	1.2	2.1	0.2	0.8	84.1	75.0	33.0	1.8	2.0	0.4	0.0	13.5	0.3	0.7	75.7	0.0	73.7	52.0	2.2	11.2	9.2	0.0	9.0	0.0	99.1	3.7	7.0	0.9	1.4	13.6	3.3	4.6	119.1	0.5	58.2	46.0	7.8	0.1	1.6	0.0	1.4	0.7	1.3	2.4	1.7	6.9	275.6	13.2
B3GNT8	"B3GALT7, beta3Gn-T8, BGALT15"	ENSG00000177191	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8"	Q7Z7M8	19	41425359-41428730	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.3;esophagus: 21.5"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 39.9;Collecting duct cells: 22.7;Enterocytes: 42.4;Paneth cells: 46.0"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"eosinophil: 29.9;neutrophil: 43.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 43.3"	"Cell line enhanced"	"Detected in some"		"HMC-1: 10.0;HUVEC TERT2: 5.4;K-562: 4.4;THP-1: 5.0;U-937: 8.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA043669	Enhanced				"Intracellular and membrane"	NA	NA		43000000			"HPA043669: AB_2678608"	"unprognostic (6.89e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (6.44e-3)"	"unprognostic (6.51e-3)"	"unprognostic (1.84e-2)"	"unprognostic (9.92e-3)"	"unprognostic (7.30e-2)"	"unprognostic (2.56e-2)"	"prognostic favorable (9.31e-6)"	"unprognostic (5.04e-2)"	"unprognostic (2.62e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.46e-1)"	0.7	0.2	0.0	0.9	0.0	2.7	0.7	0.0	0.0	5.0	7.3			13.0	0.9	0.0	21.5	0.4	0.0	1.9	0.0	0.0	1.5	0.0	4.6	0.1	0.0		0.0	0.6	0.0	0.6	0.1		1.3	2.0		2.8	2.2	0.1	2.2	12.5	0.3	0.0	4.3	1.0	0.0			0.3		0.9	1.2	8.4	0.0	1.6	43.3	6.7	0.4	8.1	1.7	0.3	0.0	0.3	0.1	0.5	2.2	0.5	0.6	0.2	0.0	0.1	3.1	0.0	0.1	0.8	1.5	0.0	2.1	0.0	0.5	0.0	0.1	0.4	0.0	0.1	1.6	0.8	0.7	10.0	2.7	1.9	0.1	0.1	0.0	5.4	0.2	4.4	0.3	0.0	0.8	0.0	2.9	0.7	0.0	0.1	0.2	0.6	0.0	0.2	1.1	1.4	0.9	0.0	0.2	0.0	0.3	0.0	5.0	1.9	0.1	0.2	0.1	0.0	0.4	0.3	0.1	0.2	8.1	0.0	21.7	4.3	29.9	0.7	3.3	8.1	0.0	0.3	1.5	1.6	0.0	0.0	0.1	43.3	0.4	6.7	0.1	0.1	1.7											6.0	39.9	0.0	4.4	1.5	0.2	0.4	0.0	1.4	1.2	22.7	0.0	0.5	3.3	4.6	0.0	1.0	42.4	0.0	0.6	1.9	2.3	5.7	4.7	0.0	10.9	0.0	14.5	1.8	9.1	0.0	1.4	3.2	0.0	1.8	19.3	0.0	2.2	46.0	0.7	0.0	0.2	0.0	1.4	0.0	0.0	1.5	1.9	1.3	13.6	11.3
B3GNT9	MGC4655	ENSG00000237172	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9"	Q6UX72	16	67148105-67151214	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Leydig cells: 10.6;Peritubular cells: 12.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"dendritic cells: 1.5;T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"SiHa: 24.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA052743, HPA062734"	Approved		Approved	"Nucleoli fibrillar center,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"	"Nucleoli fibrillar center"	"HPA052743: AB_2681934, HPA062734: AB_2684854"	"unprognostic (2.56e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.28e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.96e-3)"	"unprognostic (7.56e-3)"	5.6	7.3	5.0	5.2	7.1	0.6	7.2	0.9	8.8	12.6	5.7	12.4	12.6	3.5	11.7	11.3	6.6	11.4	11.4	11.4	6.0	3.9	7.0	5.0	7.3	4.6	12.2	5.3	20.6	3.1	34.7	17.9	7.9	5.5	12.0	3.6	16.6	8.9	15.9	2.1	4.7	4.4	8.0	5.3	5.0	6.1	9.7	7.1	0.8	25.2	4.6	3.9	8.6	7.9	0.1	1.5	0.2	0.1	0.0	1.9	0.1	2.2	4.1	0.3	0.4	13.5	14.0	0.5	10.6	17.1	6.9	8.9	1.8	0.4	0.3	0.7	16.3	2.9	5.2	0.1	0.5	3.8	3.5	1.5	0.3	4.6	1.6	10.9	0.2	0.2	11.6	4.0	6.7	0.2	17.2	0.9	0.2	0.4	1.3	10.7	1.2	1.2	0.6	2.5	1.7	3.7	3.4	6.2	2.0	1.0	2.8	2.4	5.3	24.0	0.1	0.3	2.1	0.6	1.8	2.1	12.4	0.5	12.3	4.7	1.6	1.1	0.4	15.4	0.6	6.0	0.0	0.1	0.2	0.9	0.0	1.1	0.1	1.9	1.6	0.2	0.0	0.4	0.2	0.0	0.0	0.0	1.5	0.6	0.1	5.0	7.1	0.9	8.8	6.0	3.9	12.2	5.3	5.5	7.1	6.0	5.3	0.0	3.2	2.9	1.1	2.8	7.6	4.0	2.3	3.5	0.0	0.2	0.0	1.2	4.4	1.1	0.1	0.0	1.5	0.3	8.0	2.5	0.0	0.0	1.4	0.0	2.4	5.5	0.8	3.6	10.6	0.7	1.7	0.0	0.7	0.3	0.9	0.0	12.7	0.5	0.0	6.5	4.2	0.5	2.1	3.6	0.7	0.0	0.6	0.9
B3GNTL1	B3GNT8	ENSG00000175711	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1"	Q67FW5	17	82942155-83051810	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 17.4;Late spermatids: 15.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.9;HL-60: 18.6;THP-1: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023585, HPA024547"	Supported		Approved	"Nucleoli,Nucleoli fibrillar center,Vesicles"		NA	NA			"Nucleoli, Nucleoli fibrillar center"	Vesicles	"HPA023585: AB_2061075, HPA024547: AB_1845240"	"unprognostic (1.51e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.61e-7)"	"unprognostic (9.95e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.80e-2)"	"unprognostic (4.17e-9)"	"unprognostic (2.02e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.39e-3)"	3.7	4.3	6.5	7.2	13.9	17.7	4.0	6.4	10.7	4.7	3.6	4.2	1.7	4.7	6.3	6.1	3.7	8.3	3.9	6.2	6.9	4.7	2.9	3.4	4.4	5.6	3.8	7.1	6.6	7.6	1.7	6.1	3.9	7.1	4.6	2.8	3.7	5.6	4.5	5.0	4.4	3.3	5.1	4.4	6.6	4.9	4.0	3.7	6.9	4.4	4.8	3.3	4.3	3.8	3.7	8.8	16.9	5.7	2.4	11.2	3.3	8.2	5.5	0.1	2.7	1.5	4.9	3.4	3.0	2.7	3.5	2.7	3.3	17.9	4.0	5.9	3.7	8.5	1.6	1.4	0.0	3.0	6.2	3.6	8.5	8.2	11.0	5.6	18.6	0.3	1.8	1.5	2.1	3.5	1.7	4.2	6.4	3.7	3.9	2.8	1.8	5.2	7.1	1.3	5.6	4.0	6.8	0.7	0.3	2.0	1.8	1.7	0.6	2.5	1.9	2.5	2.6	0.0	17.9	6.9	6.8	4.6	1.0	5.3	0.8	1.9	3.0	7.5	2.4	0.9	2.6	5.7	0.9	2.7	5.0	4.1	2.8	4.3	3.0	8.8	3.7	3.8	4.6	16.9	2.4	2.5	3.5	11.2	3.3	6.5	13.9	6.4	10.7	6.9	4.7	3.8	7.1	7.1	3.7	3.0	5.0	1.3	1.7	0.9	3.9	1.7	2.5	17.4	6.8	5.2	3.9	5.1	1.7	1.6	11.7	1.5	0.3	0.0	0.8	2.1	3.0	1.5	6.9	1.0	7.2	3.2	1.2	1.8	8.1	15.2	2.8	6.7	1.7	3.6	1.2	1.1	1.9	2.9	4.6	2.2	3.4	0.0	1.2	0.7	4.3	1.5	1.6	6.4	2.7	2.0
B4GALNT1	"beta1-4GalNAc-T, GALGT, SPG26"	ENSG00000135454	"Beta-1,4-N-acetyl-galactosaminyltransferase 1"	Q00973	12	57623410-57633355	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.4"	"Cell type enhanced"	"Detected in some"	16	"Bipolar cells: 8.1;Horizontal cells: 20.6;Sertoli cells: 6.5;Smooth muscle cells: 6.6"	"Cancer enriched"	"Detected in many"	6	"glioma: 10.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.9"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 22.0;HDLM-2: 18.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008968	Enhanced				"Intracellular and membrane"	NA	NA		9500			"HPA008968: AB_1078253"	"unprognostic (3.18e-1)"	"unprognostic (8.34e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.70e-3)"	"unprognostic (3.73e-5)"	"unprognostic (1.26e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.18e-14)"	"unprognostic (2.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.92e-4)"	3.0	2.1	12.9	2.3	16.4	1.0	1.5	26.5	32.4	1.9	2.4	1.0	0.0	1.4	2.2	3.8	1.3	1.4	1.5	3.9	15.3	11.2	1.3	1.3	1.7	1.6	6.5	14.3	1.0	1.2	1.1	1.0	1.3	11.6	4.2	2.2	1.6	3.2	6.8	8.1	1.6	1.9	3.2	2.3	1.3	1.4	1.6	2.3	0.0	1.3	0.6	1.8	1.5	0.9	0.0	0.0	0.0	0.0	0.8	1.9	0.0	2.8	14.7	3.2	5.7	0.2	0.0	0.0	1.4	3.0	6.0	6.4	0.9	7.7	0.8	22.0	4.1	13.6	1.4	2.5	1.1	2.0	18.7	0.9	0.2	3.7	4.8	0.2	0.7	1.4	0.0	0.4	3.6	0.2	2.4	0.1	3.3	2.3	4.6	1.0	3.8	0.6	0.0	3.8	0.3	2.9	0.0	4.4	2.3	0.0	0.0	12.3	3.1	0.8	0.4	0.1	0.2	2.7	1.0	0.0	3.6	8.3	6.9	9.1	11.5	8.6	0.8	8.1	0.9	9.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	12.9	16.4	26.5	25.9	15.3	11.2	6.5	14.3	11.6	2.3	0.0	0.0	0.0	0.0	0.3	8.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.2	0.2	1.1	0.1	0.0	0.0	0.1	20.6	0.0	0.0	0.0	0.4	2.6	0.0	3.3	4.6	0.0	0.8	0.6	0.0	2.8	0.0	1.9	6.5	6.6	0.3	0.9	0.0	0.0	0.0	0.0	0.1
B4GALNT2	"Cad, GALGT2, Sda"	ENSG00000167080	"Beta-1,4-N-acetyl-galactosaminyltransferase 2"	Q8NHY0	17	49132460-49176840	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 19.6;lymphoid tissue: 30.9"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 5.2;Enterocytes: 5.1;Mucus-secreting cells: 13.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA015721	Approved					NA	NA					"HPA015721: AB_1845245"	"unprognostic (4.39e-4)"	"unprognostic (3.18e-1)"	"unprognostic (8.26e-3)"	"unprognostic (2.03e-4)"		"unprognostic (1.72e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.67e-2)"	"unprognostic (4.06e-1)"	"unprognostic (7.18e-3)"	"unprognostic (2.43e-1)"	"prognostic favorable (1.29e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.81e-3)"	"unprognostic (2.15e-1)"	0.3	0.8	0.4	30.9	0.5	2.2	0.4	0.3	0.5	0.3	19.6	0.3	0.3	0.7	0.3	0.3	0.5	0.4	4.0	0.3	0.3	0.3	8.3	0.3	1.1	0.8	0.3	0.3	0.3	0.5	0.0	0.4	0.7	0.6	0.3	7.9	0.4	1.7	0.3	0.3	1.8	11.9	1.3	1.1	0.8	5.3	0.7	0.3	0.3	10.3	0.3	0.8	0.3	1.4	2.0	1.2	2.3	0.6	0.6	1.6	0.2	1.5	3.0	2.9	5.2	0.1	0.1	1.5	2.2	1.6	0.1	0.2	6.1	2.4	3.6	3.6	0.1	1.1	1.7	1.1	0.1	0.4	3.1	3.2	3.9	7.3	3.6	0.1	1.9	6.2	0.3	2.1	0.6	0.3	1.3	0.0	2.8	2.2	5.9	0.1	1.8	2.5	2.7	3.6	0.5	1.5	4.2	1.3	1.1	8.4	2.4	2.7	2.6	1.0	1.4	1.2	3.2	3.2	2.6	1.2	3.7	2.3	2.4	1.2	4.5	1.4	3.8	1.3	2.6	1.6	2.3	0.6	0.9	1.1	0.5	0.6	1.3	1.2	0.8	0.5	2.0	1.6	1.5	1.2	0.6	0.3	1.2	0.6	0.2	0.4	0.5	0.3	0.3	0.3	0.3	0.3	0.3	0.6	0.3	0.0	1.0	0.0	0.0	0.3	0.0	0.4	0.0	1.4	1.2	5.2	0.0	0.0	1.7	0.4	0.5	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	13.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0
B4GALNT3	"B4GalNac-T3, FLJ16224, FLJ40362"	ENSG00000139044	"Beta-1,4-N-acetyl-galactosaminyltransferase 3"	Q6L9W6	12	460364-563509	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 43.1"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 46.6;Late spermatids: 64.3;Paneth cells: 36.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 26.2;HDLM-2: 9.2;HEK 293: 9.2;NTERA-2: 11.6;U-937: 11.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA011404	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"	Vesicles	"HPA011404: AB_1845242"	"unprognostic (2.38e-2)"	"unprognostic (9.59e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.69e-10)"	"unprognostic (4.22e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.46e-2)"	"unprognostic (9.53e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.46e-2)"	"unprognostic (9.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.98e-1)"	0.3	5.7	1.4	2.1	3.8	1.5	1.1	0.3	8.2	6.1	12.8	0.6	0.4	0.8	8.5	2.9	6.0	3.4	9.6	16.8	5.6	0.9	4.1	0.3	6.2	0.2	0.9	1.7	2.1	7.9	2.5	14.7	0.1	2.0	1.6	9.8	1.5	3.8	1.1	2.7	11.0	1.7	1.9	0.5	0.4	43.1	8.0	0.1	1.0	2.1	9.1	4.1	1.8	4.0	0.0	0.0	0.7	0.1	0.0	1.4	0.0	0.0	0.0	0.2	0.9	0.0	0.0	26.2	0.0	0.0	0.0	0.0	6.5	5.0	0.0	0.7	0.0	0.5	2.9	6.5	0.7	0.0	9.2	9.2	0.0	0.0	1.3	0.0	0.1	3.9	0.0	4.6	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	11.6	7.9	0.5	0.4	3.6	0.0	6.3	5.5	3.1	2.0	0.6	0.2	0.7	4.2	0.6	2.0	0.0	0.0	2.0	0.2	0.6	0.0	0.1	0.1	0.0	11.3	4.4	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.4	3.8	0.3	8.2	5.6	0.9	0.9	1.7	2.0	0.1	0.0	6.5	0.0	4.8	6.6	0.0	11.8	2.5	6.7	5.7	8.7	0.0	0.0	0.0	8.9	25.7	0.0	46.6	0.0	4.2	0.1	0.6	8.9	0.0	0.0	0.6	0.0	9.9	0.0	0.0	64.3	0.0	0.0	0.0	1.0	18.8	0.0	12.7	36.2	0.0	0.0	0.0	0.0	0.9	1.9	1.4	15.2	0.0	1.7	20.2	13.6
B4GALNT4	"FLJ25045, NGalNAc-T1"	ENSG00000182272	"Beta-1,4-N-acetyl-galactosaminyltransferase 4"	Q76KP1	11	369796-382116	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.1;ovary: 18.6"	"Cell type enhanced"	"Detected in some"	16	"Bipolar cells: 17.5;Cardiomyocytes: 11.2;Horizontal cells: 31.8;Muller glia cells: 40.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 20.2;NTERA-2: 18.0;SCLC-21H: 22.4;SH-SY5Y: 27.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043276, HPA053126"	Uncertain		Uncertain	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"	NA	No			"Nucleoplasm, Cytosol"	Vesicles	"HPA043276: , HPA053126: AB_2682049"	"unprognostic (6.11e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.92e-3)"	"unprognostic (5.36e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.99e-3)"	"unprognostic (1.52e-10)"	"unprognostic (9.01e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.92e-4)"	"unprognostic (1.25e-1)"	1.6	2.5	20.6	2.8	16.7	1.2	3.5	26.5	35.1	5.9	2.0	8.6	0.8	2.4	8.6	2.4	1.8	8.7	2.1	1.4	17.6	16.8	1.2	1.1	1.3	1.6	11.5	14.9	18.6	1.8	6.3	6.1	1.1	13.0	3.8	1.6	2.3	4.0	3.7	1.1	3.8	2.9	3.1	8.3	1.5	1.5	1.8	11.0	0.0	1.1	0.0	1.7	1.3	1.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.6	20.2	11.5	0.0	0.0	4.7	3.6	0.9	1.6	0.5	2.0	0.0	0.0	2.7	0.4	3.2	0.7	2.7	4.8	0.5	0.0	6.8	0.0	6.4	6.2	0.2	0.0	4.9	0.4	2.9	0.1	2.2	7.3	0.2	1.0	6.1	0.0	0.0	5.9	0.2	0.0	18.0	0.3	7.9	0.0	0.0	2.6	0.2	0.0	22.4	27.3	1.3	1.0	0.2	2.2	7.9	0.0	4.9	1.1	6.4	1.9	0.2	0.0	0.9	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	20.6	16.7	26.5	21.2	17.6	16.8	11.5	14.9	13.0	11.0	0.0	0.0	0.0	1.3	0.7	17.5	11.2	0.0	0.0	0.0	1.8	3.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.2	31.8	1.7	0.0	0.0	0.0	2.8	0.0	3.3	0.0	0.0	40.9	0.3	0.0	1.1	0.0	8.1	0.0	0.2	0.0	0.2	0.3	0.2	0.0	0.0	0.4
B4GALT1	"beta4Gal-T1, GGTB2"	ENSG00000086062	"Beta-1,4-galactosyltransferase 1"	P15291	9	33104082-33167356	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 56.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 56.9;SiHa: 107.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA010806, HPA010807"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		98000000	"Golgi apparatus"		"HPA010806: AB_1078255, HPA010807: AB_1078254"	"unprognostic (7.57e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (6.85e-7)"	"unprognostic (1.83e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.93e-3)"	"unprognostic (4.98e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.46e-2)"	32.0	19.5	4.5	22.5	4.5	22.1	35.1	5.9	3.5	25.4	20.4	6.4	29.1	6.5	19.5	34.1	24.7	26.3	24.2	33.1	3.2	2.5	31.7	91.2	34.9	44.9	5.8	2.2	56.8	20.1	30.2	11.9	79.0	5.9	22.6	11.1	32.1	39.1	42.7	15.0	17.6	18.9	17.7	6.4	38.5	19.9	37.6	3.6	23.1	39.3	16.9	41.0	26.4	21.6	24.8	56.4	24.9	9.1	18.2	16.5	5.4	16.2	12.0	2.2	3.1	11.4	20.2	40.7	17.0	21.3	10.3	10.2	7.3	19.0	6.2	10.8	24.7	13.3	8.8	2.3	21.0	10.3	56.9	2.3	3.5	50.2	5.6	22.5	2.9	6.0	22.5	37.7	11.7	14.3	22.2	10.9	1.9	4.0	7.8	9.7	14.2	2.6	5.8	1.3	9.0	3.7	3.4	2.1	4.1	30.7	14.2	1.7	2.1	107.2	20.9	4.2	7.3	26.4	5.3	10.0	7.3	8.7	23.5	6.6	1.3	2.8	3.9	22.8	4.0	2.7	6.2	9.1	5.0	13.0	7.8	16.5	24.8	8.7	11.4	6.1	20.7	5.3	6.7	24.9	18.2	6.0	56.4	5.7	5.4	4.5	4.5	5.9	3.5	3.2	2.5	5.8	2.2	5.9	3.6	80.4	65.7	101.3	48.3	125.9	1.4	29.7	86.6	26.8	59.1	158.7	19.6	74.7	13.3	63.1	9.2	49.6	45.8	23.3	110.1	134.4	71.0	89.2	36.8	170.8	48.5	0.0	8.1	90.9	71.6	5.1	46.9	58.9	91.1	22.6	42.2	7.2	120.8	32.3	41.8	46.1	39.5	51.8	65.3	4.8	13.4	94.7	145.4	44.5	21.7	74.5
B4GALT2	beta4Gal-T2	ENSG00000117411	"Beta-1,4-galactosyltransferase 2"	O60909	1	43978943-43991170	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007620, HPA047739"	Supported		Supported	"Golgi apparatus,Vesicles"		NA	NA		12000	"Golgi apparatus, Vesicles"		"HPA007620: AB_2667879, HPA047739: AB_2680141"	"unprognostic (1.11e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (2.96e-5)"	"unprognostic (1.12e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.23e-3)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (3.62e-5)"	"unprognostic (6.54e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.12e-3)"	18.6	8.6	34.5	10.1	22.4	4.6	15.6	8.1	35.7	18.4	16.1	16.1	10.7	9.4	13.3	8.5	20.2	11.4	11.9	23.3	25.3	18.9	8.4	24.2	7.7	4.4	18.9	15.6	15.3	39.5	9.9	10.6	9.9	12.7	13.5	10.4	8.7	21.4	21.5	41.0	19.5	9.4	21.3	16.1	5.2	11.2	11.4	11.3	1.9	9.0	12.1	10.1	16.5	11.7	1.7	0.4	0.1	0.6	0.2	2.6	0.7	20.1	14.7	15.3	26.1	20.9	18.7	15.4	22.8	18.8	18.2	16.7	9.7	17.7	13.2	11.7	36.4	16.7	14.0	13.7	23.3	8.5	13.3	26.0	8.8	10.2	22.1	16.9	8.4	0.3	16.3	27.3	13.0	26.7	19.2	21.0	5.3	16.6	8.6	14.2	14.5	4.4	8.4	21.4	14.4	18.4	15.7	20.6	20.7	12.9	9.4	27.9	23.2	10.0	31.6	15.3	8.0	13.7	10.0	16.5	31.7	40.6	21.9	25.4	3.1	6.0	5.6	14.2	6.4	21.1	0.0	0.2	0.0	2.6	0.6	2.4	1.7	1.2	2.2	0.4	0.5	0.0	2.0	0.1	0.2	0.1	0.2	1.1	0.7	34.5	22.4	8.1	35.7	25.3	18.9	18.9	15.6	12.7	11.3	0.0	12.0	0.8	8.4	6.9	13.5	12.2	7.6	2.7	4.5	14.0	3.9	1.6	1.7	12.6	14.0	7.4	5.8	0.0	17.4	6.6	10.6	10.5	0.0	17.8	2.1	17.5	15.6	4.3	0.6	5.4	15.3	1.8	3.3	2.8	19.7	7.5	21.8	7.0	11.7	8.6	12.0	6.5	6.1	3.5	13.0	11.0	0.5	1.3	13.3	14.9
B4GALT3	beta4Gal-T3	ENSG00000158850	"Beta-1,4-galactosyltransferase 3"	O60512	1	161171310-161177968	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 95.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 74.9"	"Low region specificity"	"Detected in all"							HPA010793	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA		74000	"Golgi apparatus"	Cytosol	"HPA010793: AB_1078256"	"unprognostic (5.67e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.20e-2)"	"unprognostic (8.15e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (5.87e-5)"	"unprognostic (3.11e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (7.12e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-1)"	20.7	18.7	16.5	17.2	22.1	17.3	33.4	20.1	23.2	15.0	19.0	12.4	22.2	18.4	13.6	21.0	20.4	17.2	17.5	17.2	13.4	14.7	22.5	21.7	20.8	21.6	16.4	13.4	25.4	37.5	15.8	29.1	41.0	16.6	18.5	19.3	14.8	33.0	27.8	19.5	20.2	15.1	11.7	14.1	26.6	21.5	28.4	16.4	14.8	28.2	10.7	21.4	20.6	22.9	16.7	22.6	7.1	12.6	15.1	25.5	11.9	9.9	6.6	9.8	12.9	14.6	7.5	15.7	5.7	10.2	11.8	10.9	13.0	20.4	9.2	16.3	6.4	11.3	10.2	10.3	6.3	7.0	9.6	12.6	5.3	4.4	10.4	10.5	10.3	14.8	10.4	9.4	10.9	11.9	14.2	13.4	12.1	17.0	20.8	9.6	10.3	6.7	9.9	12.3	20.1	14.1	8.2	5.5	22.7	10.1	6.2	14.0	16.6	5.7	15.1	11.9	13.9	15.1	18.9	5.6	5.9	10.7	6.7	16.6	74.9	40.4	12.3	8.8	8.9	9.4	5.1	8.9	7.1	17.6	10.1	15.7	16.7	16.7	16.8	10.8	13.5	16.4	15.4	5.9	15.1	12.6	22.6	25.5	11.9	16.5	22.1	20.1	23.2	13.4	14.7	16.4	13.4	16.6	16.4	17.9	18.3	36.5	26.3	34.2	12.6	9.5	7.6	10.7	6.8	24.4	2.0	38.4	5.0	25.4	7.0	20.2	14.7	0.0	19.9	75.2	19.5	33.5	9.2	11.6	25.2	25.4	27.6	26.4	16.8	4.0	8.9	13.8	21.9	6.4	22.4	7.4	28.1	14.4	6.7	17.3	6.3	25.8	34.6	9.8	42.9	36.6	95.5	34.6	21.7	45.5
B4GALT4	beta4Gal-T4	ENSG00000121578	"Beta-1,4-galactosyltransferase 4"	O60513	3	119211732-119241103	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 111.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 38.8"	"Low region specificity"	"Detected in all"							"HPA046819, HPA063546"	Approved		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA046819: AB_2679824, HPA063546: AB_2685036"	"unprognostic (4.07e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.59e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (6.30e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.58e-1)"	"unprognostic (6.10e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.11e-1)"	9.6	7.7	7.0	8.6	8.5	11.6	8.8	5.3	6.6	10.1	20.8	8.2	12.6	14.6	15.1	43.4	13.2	12.6	21.3	11.1	6.0	6.2	15.0	11.8	8.9	8.0	7.7	7.3	13.5	20.8	8.5	16.2	23.7	9.1	9.4	17.9	10.2	10.1	16.1	4.8	10.9	40.4	11.3	9.3	8.2	16.8	5.8	6.5	8.5	10.8	6.5	11.4	13.0	8.7	3.7	4.7	11.2	4.6	11.7	12.2	4.8	17.6	34.3	4.0	2.8	12.5	10.4	20.4	38.8	17.2	18.1	18.2	20.2	5.7	3.8	8.1	20.3	10.9	24.3	6.8	5.2	18.3	7.5	2.3	5.2	5.8	10.7	8.6	3.1	4.7	7.5	7.3	7.7	6.2	6.9	1.7	2.8	3.6	4.0	7.4	6.7	1.4	2.7	5.2	10.2	9.3	1.4	3.7	1.5	9.9	19.4	3.5	8.2	9.3	4.1	8.4	9.0	8.9	1.4	1.2	8.6	7.9	4.3	4.3	8.9	7.0	5.0	7.2	2.9	7.1	11.2	3.7	6.8	12.2	4.6	6.9	3.7	6.0	6.4	4.7	2.9	11.3	6.8	2.2	11.7	4.0	3.1	2.3	4.8	7.0	8.5	5.3	6.6	6.0	6.2	7.7	7.3	9.1	6.5	0.0	6.5	17.8	18.3	9.5	10.5	7.7	40.8	30.8	18.2	7.0	3.9	30.1	1.7	26.8	0.9	8.3	39.8	0.0	29.7	111.2	24.4	21.4	12.7	9.0	12.7	17.5	13.3	4.3	7.5	1.7	13.8	10.8	13.5	13.6	76.6	21.5	28.0	42.1	26.5	21.6	9.4	19.4	12.7	1.6	10.5	9.3	43.7	14.6	21.7	68.6
B4GALT5	beta4GalT-V	ENSG00000158470	"Beta-1,4-galactosyltransferase 5"	O43286	20	49632945-49713878	"Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Urothelial cells: 107.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.2"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 10.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA						"unprognostic (7.98e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.41e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.69e-2)"	20.0	37.2	16.2	13.8	15.8	53.3	15.7	22.6	19.0	15.5	16.4	8.5	10.6	16.5	17.2	7.5	27.4	14.6	21.1	32.7	12.4	12.6	16.8	17.3	20.1	7.7	10.4	9.9	19.5	11.7	7.0	14.1	17.8	17.3	12.4	16.1	15.3	15.7	15.7	46.9	6.4	15.5	24.7	13.5	22.6	16.9	16.6	9.3	3.9	9.5	8.0	13.7	19.2	16.0	0.4	1.1	10.2	1.6	1.7	2.4	0.6	15.8	18.3	24.4	10.3	25.5	17.4	21.4	7.8	14.7	36.0	17.3	23.5	19.8	4.8	33.7	13.0	34.1	25.4	15.3	11.7	21.2	14.9	4.2	12.9	10.0	14.0	8.0	16.7	25.3	26.0	11.0	15.6	7.5	33.3	21.8	8.7	20.8	3.0	10.4	7.9	1.0	15.4	12.7	15.7	11.9	8.7	21.1	7.0	17.3	11.3	29.2	14.8	28.0	35.9	15.7	18.8	8.1	23.1	16.7	21.7	17.5	11.5	16.4	3.7	3.2	11.8	11.3	16.1	13.7	1.3	1.6	3.7	2.2	1.6	2.4	0.3	1.0	2.1	1.1	0.4	0.2	1.5	10.2	1.7	1.6	0.9	1.3	0.6	16.2	15.8	22.6	19.0	12.4	12.6	10.4	9.9	17.3	9.3	14.9	45.0	3.2	24.2	16.8	6.2	15.3	30.6	24.1	35.2	34.9	9.8	19.4	1.7	27.9	4.5	43.9	21.4	23.3	17.1	21.5	24.3	41.5	84.0	20.2	21.9	11.1	33.0	47.3	27.6	5.3	18.4	28.0	20.3	9.0	23.7	5.2	29.8	28.6	30.8	31.6	4.8	25.8	26.8	7.5	17.7	15.3	4.7	15.2	16.4	107.6
B4GALT6	beta4GalT-VI	ENSG00000118276	"Beta-1,4-galactosyltransferase 6"	Q9UBX8	18	31622247-31685836	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.3"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 67.0;Cone photoreceptor cells: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 3.8"	"Group enriched"	"Detected in many"	5	"NK-cells: 3.8;T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"WM-115: 51.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020701, HPA058284"	Approved				"Intracellular and membrane"	NA	NA					"CAB020701: , HPA058284: AB_2683668"	"unprognostic (3.79e-1)"	"unprognostic (4.52e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.23e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.50e-2)"	"unprognostic (5.18e-1)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.65e-4)"	"unprognostic (2.77e-1)"	"prognostic favorable (6.40e-5)"	"unprognostic (5.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.00e-1)"	3.6	13.8	7.8	2.8	16.0	4.4	2.1	20.6	22.3	2.2	3.5	2.6	0.0	7.7	2.5	2.2	4.8	2.5	7.2	3.8	10.7	7.9	3.7	2.7	1.8	1.2	6.1	10.0	4.3	2.1	7.3	14.8	2.7	16.3	5.8	3.6	13.2	4.6	4.4	3.3	2.2	9.7	1.7	3.1	1.5	3.4	5.4	2.3	5.0	2.1	1.5	1.0	3.6	2.1	0.0	0.5	0.0	0.4	3.8	1.1	0.3	2.3	5.4	9.7	5.4	0.1	0.2	3.6	0.7	0.0	0.1	0.0	10.0	2.0	3.7	4.5	0.9	11.7	0.9	5.1	4.3	0.6	14.5	4.5	4.8	0.5	0.2	1.1	8.8	0.8	1.0	0.9	1.4	3.1	4.9	5.3	8.8	0.7	0.0	0.0	1.4	9.8	0.6	4.2	2.8	2.9	18.4	1.7	0.0	1.1	4.9	5.1	8.1	3.5	0.6	6.3	8.2	0.6	2.7	5.3	11.0	2.3	0.0	5.9	3.6	0.2	7.6	4.5	8.0	51.0	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.1	0.9	0.5	0.0	0.0	1.1	0.0	3.8	0.4	0.0	0.0	0.3	7.8	16.0	20.6	22.3	10.7	7.9	6.1	10.0	16.3	2.3	0.0	0.3	0.0	0.7	4.8	67.0	6.7	0.0	0.0	1.2	1.8	37.3	0.4	3.3	1.3	3.6	2.3	3.1	0.0	1.0	0.2	1.7	1.5	0.0	1.7	0.6	12.7	2.9	3.7	0.8	3.3	1.1	0.0	0.0	0.0	2.6	3.3	1.7	2.5	2.5	1.1	4.7	0.0	0.9	0.5	10.2	1.5	0.2	0.5	2.9	0.6
B4GALT7	"beta4Gal-T7, XGALT-1"	ENSG00000027847	"Beta-1,4-galactosyltransferase 7"	Q9UBV7	5	177600100-177610347	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, Dwarfism, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Extravillous trophoblasts: 110.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042330	Supported					NA	NA					"HPA042330: AB_10796576"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.97e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (9.53e-2)"	"unprognostic (4.19e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.00e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.00e-2)"	13.8	33.0	16.0	20.4	14.3	20.7	19.1	10.6	19.6	13.3	12.4	14.9	20.4	16.1	15.5	15.9	11.7	13.3	20.3	17.3	13.7	18.0	16.2	21.3	12.0	21.5	15.1	17.9	16.9	37.0	15.5	23.9	15.3	14.3	16.4	11.7	14.7	22.4	20.9	14.4	12.9	13.7	12.2	10.8	16.3	16.2	16.1	11.7	10.4	16.7	9.8	18.6	13.0	10.2	15.8	16.3	11.2	16.1	8.5	12.5	9.0	8.5	15.2	6.4	16.0	12.8	9.6	28.9	13.4	14.2	12.2	14.0	14.3	13.7	11.1	24.7	13.6	21.4	10.2	4.4	28.6	5.3	36.9	11.6	5.8	11.9	10.0	18.6	6.0	10.2	14.7	10.2	13.1	10.7	11.2	13.5	7.5	5.0	10.7	12.3	20.0	5.1	7.4	6.2	7.7	22.4	10.4	4.6	12.1	9.2	13.1	5.7	6.5	6.6	13.5	11.7	5.3	8.7	7.1	10.4	15.6	9.0	10.2	13.2	13.4	6.2	7.8	13.2	14.5	14.1	11.2	14.6	7.8	12.5	16.1	11.3	12.8	11.6	11.0	16.3	15.8	10.5	10.3	1.0	8.5	15.3	12.8	7.5	9.0	16.0	14.3	10.6	19.6	13.7	18.0	15.1	17.9	14.3	11.7	3.0	6.4	14.9	14.1	6.0	11.8	5.9	10.2	5.3	10.3	15.7	3.9	37.3	6.6	28.8	12.3	11.3	13.7	0.0	34.1	110.0	18.1	23.5	10.3	13.9	28.4	11.1	13.9	10.4	8.8	7.8	13.0	10.6	20.3	33.3	19.6	12.2	26.0	10.5	17.3	15.8	15.1	0.0	11.4	13.0	12.4	7.8	36.7	10.1	20.9	13.9
CERK	"dA59H18.2, dA59H18.3, DKFZp434E0211, FLJ21430, FLJ23239, hCERK, KIAA1646, LK4"	ENSG00000100422	"Ceramide kinase"	Q8TCT0	22	46684411-46738261	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064699			Approved	Vesicles		NA	NA			Vesicles		"HPA064699: AB_2685327"	"unprognostic (2.93e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.55e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.35e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.58e-4)"	10.6	15.5	10.6	16.7	10.8	14.5	12.9	29.3	21.7	10.8	14.6	9.8	15.8	24.9	14.1	7.5	10.0	15.3	18.9	36.5	11.4	16.8	15.2	12.1	10.6	19.1	21.7	13.1	22.7	23.2	7.2	33.3	7.9	23.9	8.2	12.2	12.3	11.8	11.6	12.8	11.9	25.1	12.5	10.2	14.5	14.0	6.0	6.5	39.2	16.1	8.7	19.5	10.7	17.4	2.0	4.9	3.6	6.9	2.0	16.4	3.6	9.4	5.7	27.8	8.7	16.0	12.1	2.6	16.6	13.0	9.5	6.7	8.3	3.2	13.2	7.8	17.7	5.8	6.2	11.7	7.5	9.8	4.6	12.6	5.9	14.4	10.8	11.1	18.4	1.5	10.1	9.7	10.4	3.6	15.4	28.2	14.2	4.4	17.1	17.4	0.7	12.4	9.2	12.5	3.8	6.3	23.3	31.5	15.0	5.7	0.1	25.9	23.6	8.1	3.9	17.5	6.7	4.3	14.1	25.6	19.7	10.5	14.5	24.0	17.8	21.5	8.3	21.0	10.5	16.0	0.6	2.6	3.0	9.4	6.0	16.4	1.8	9.9	9.0	4.5	2.0	5.8	5.4	3.6	2.0	6.9	4.9	8.6	3.6	10.6	10.8	29.3	21.7	11.4	16.8	21.7	13.1	23.9	6.5	8.9	20.5	11.9	5.1	3.1	21.3	35.3	5.1	0.0	15.9	1.8	5.9	1.9	13.3	11.3	5.0	14.8	26.5	0.0	10.3	1.3	7.3	1.3	9.3	19.8	9.7	25.4	13.8	28.8	27.0	9.4	8.9	13.6	3.3	5.4	2.7	19.0	8.9	15.0	14.2	13.0	10.1	0.0	12.0	0.9	1.6	3.9	1.5	20.8	15.1	0.9
CERS1	"LAG1, LASS1, UOG1"	ENSG00000223802	"Ceramide synthase 1"	P27544	19	18868545-18896727	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 86.3"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 85.2"	"Cancer enhanced"	"Detected in many"		"glioma: 13.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.7;EFO-21: 13.0;HEK 293: 18.1;NB-4: 19.4;NTERA-2: 13.3"									HPA045724	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA045724: AB_10969762"	"unprognostic (8.25e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.59e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.02e-1)"	"unprognostic (7.04e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.92e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.15e-2)"	"unprognostic (3.49e-1)"	2.4	4.7	28.9	2.3	32.9	1.7	1.7	12.5	86.3	2.2	2.1	40.5	0.0	1.6	2.0	2.1	2.5	2.1	3.9	3.4	29.5	23.2	1.6	1.6	1.9	1.6	31.9	20.5	4.3	2.4	1.7	3.2	1.9	33.8	2.0	1.8	1.8	2.3	2.1	17.8	2.0	1.9	3.0	37.8	1.7	1.8	15.7	22.2	0.0	2.4	0.0	1.6	2.6	0.4	0.0	0.0	1.7	0.1	0.0	0.1	0.0	0.1	1.8	10.9	17.7	0.6	0.2	0.3	1.2	0.1	3.1	2.2	8.7	0.6	0.0	13.0	0.8	2.5	0.1	8.0	0.3	1.2	0.0	18.1	0.1	0.4	6.5	1.4	1.8	0.2	0.6	0.1	1.0	0.3	3.5	0.7	0.1	1.1	0.1	2.1	4.5	0.1	19.4	13.3	0.0	0.3	0.0	0.3	0.3	2.4	0.0	9.3	9.3	0.4	0.0	7.9	3.7	3.0	10.8	0.3	0.0	2.5	1.7	2.5	0.3	0.2	0.0	0.0	0.6	6.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	28.9	32.9	12.5	35.7	29.5	23.2	31.9	20.5	33.8	22.2	0.0	0.0	0.0	0.1	0.5	2.0	0.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	18.9	0.4	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	85.2	1.1	0.0	1.7	0.0	0.0	9.2	0.0	0.0	1.1	0.0	1.2	0.0	0.3	0.9	2.7	0.4	0.2	0.0	0.0	0.0
CERS2	"FLJ10243, LASS2, SP260"	ENSG00000143418	"Ceramide synthase 2"	Q96G23	1	150960583-150975004	"Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 142.3"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 187.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027262, HPA078737"	Approved		Supported	"Nuclear membrane,Endoplasmic reticulum"		NA	NA		24000	"Nuclear membrane, Endoplasmic reticulum"		"HPA027262: AB_1852717, HPA078737: "	"unprognostic (1.01e-1)"	"unprognostic (2.70e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.29e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.03e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.05e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.85e-1)"	19.4	65.5	17.0	10.5	36.1	13.9	22.6	9.6	21.3	19.8	21.1	59.3	22.1	19.6	16.9	19.0	12.5	21.1	21.6	14.4	23.0	16.1	60.9	142.3	28.6	14.0	50.1	14.5	21.8	29.7	28.7	17.6	24.0	25.5	18.5	18.8	16.5	12.3	19.2	7.1	9.1	33.3	21.2	63.7	13.2	23.4	10.2	38.7	10.2	35.5	8.8	14.0	17.5	25.6	12.3	23.5	56.6	27.0	19.3	33.6	26.2	25.5	28.0	23.6	50.6	70.5	43.3	17.7	26.1	38.4	49.9	34.3	29.3	45.3	22.5	43.7	41.1	31.2	29.2	32.7	27.9	41.0	30.5	26.7	31.0	19.6	35.4	51.0	35.2	38.4	39.4	36.0	44.0	54.9	60.5	31.1	32.5	33.2	51.5	62.2	38.5	23.0	20.3	36.1	85.2	50.0	26.3	16.0	35.8	54.0	21.7	21.8	34.0	28.8	51.3	29.9	30.7	61.0	53.4	24.1	36.1	16.3	32.6	46.0	33.4	37.5	141.2	40.6	15.1	36.6	56.6	27.0	44.0	28.0	14.6	33.6	12.3	25.7	28.4	23.4	11.4	22.9	22.2	29.2	19.3	10.2	23.5	28.8	26.2	17.0	36.1	9.6	21.3	23.0	16.1	50.1	14.5	25.5	38.7	62.5	51.6	17.2	31.4	21.4	7.0	2.2	101.9	21.4	14.8	50.6	3.9	65.8	11.6	88.6	6.4	42.6	55.1	0.0	80.3	35.9	56.4	34.0	35.8	187.2	49.9	3.2	23.6	32.5	43.8	3.8	52.0	30.4	35.4	20.8	32.1	25.3	90.5	30.8	37.8	65.4	8.2	38.8	25.5	11.8	5.2	13.7	45.3	37.6	28.9	27.6
CERS3	"LASS3, MGC27091"	ENSG00000154227	"Ceramide synthase 3"	Q8IU89	15	100400395-100544995	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 25.6;skin 1: 29.0;testis: 37.9"	"Cell type enhanced"	"Detected in some"	16	"Basal keratinocytes: 16.8;Early spermatids: 19.4;Late spermatids: 12.5;Spermatocytes: 33.6;Suprabasal keratinocytes: 43.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 14.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"hTCEpi: 38.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006092, HPA024356"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006092: AB_1079236, HPA024356: AB_1852721"	"unprognostic (5.01e-3)"	"unprognostic (3.43e-2)"	"unprognostic (6.47e-4)"	"unprognostic (2.35e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.84e-3)"	"unprognostic (3.23e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.31e-5)"	"unprognostic (2.65e-1)"	"unprognostic (4.74e-4)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.05e-3)"	0.4	0.0	0.4	0.4	0.4	0.0	1.9	0.4	0.4	6.0	0.4	0.4	0.4	0.0	0.4	0.4	25.6	0.3	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.0	0.4	3.6	0.4	0.4	29.0	0.4	0.4	0.4	0.4	0.0	37.9	0.4	0.4	0.4	0.4	8.5	0.4	11.2	0.0	0.0	1.5	0.6	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.1	0.2	0.2	0.0	0.7	0.3	0.0	0.0	3.3	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.0	0.0	0.0	3.6	16.8	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.5	0.6	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	33.6	0.4	43.8	0.0	0.0	0.0	7.4
CERS4	"FLJ12089, LASS4, Trh1"	ENSG00000090661	"Ceramide synthase 4"	Q9HA82	19	8206736-8262421	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 63.6;Muller glia cells: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 21.6;NB-4: 39.0;U-937: 24.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033734, HPA054729"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB033734: AB_2132977, HPA054729: "	"unprognostic (5.96e-2)"	"prognostic favorable (2.71e-4)"	"unprognostic (2.46e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (7.83e-4)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.45e-5)"	"unprognostic (1.48e-2)"	"unprognostic (3.32e-1)"	"prognostic favorable (8.05e-4)"	"unprognostic (1.77e-1)"	"prognostic favorable (9.63e-5)"	"unprognostic (6.08e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.08e-3)"	6.2	6.7	17.5	10.5	22.9	2.5	21.6	14.5	19.3	13.2	6.8	24.3	7.8	4.6	9.9	41.8	26.4	11.9	7.7	9.7	16.1	10.8	16.5	32.4	12.9	12.2	26.9	13.3	13.8	56.7	11.6	10.1	2.2	16.8	22.4	3.2	26.2	34.8	12.8	2.1	20.9	6.1	8.5	20.3	8.6	9.9	8.4	29.0	6.4	38.1	9.5	15.9	9.3	13.2	13.3	2.7	16.9	4.4	13.5	5.2	3.5	0.1	0.9	0.9	10.2	0.3	0.0	0.7	1.3	3.4	1.5	0.7	7.6	0.8	15.9	11.3	0.0	4.0	5.5	6.6	0.1	0.7	14.0	5.2	3.1	0.1	21.6	13.2	0.0	8.7	5.1	8.5	3.6	7.8	4.3	0.1	7.3	2.2	0.5	0.0	0.3	1.2	39.0	10.4	0.0	3.8	19.2	0.2	1.2	2.5	0.0	3.9	5.2	1.7	0.3	5.5	7.2	7.5	3.6	0.0	1.2	3.3	7.6	0.0	10.0	8.0	12.2	0.0	24.4	1.1	5.9	4.4	16.9	5.2	2.3	3.9	13.3	3.0	3.1	2.7	12.1	2.8	2.6	14.0	13.5	1.5	2.6	3.5	3.5	17.5	22.9	14.5	19.3	16.1	10.8	26.9	13.3	16.8	29.0	6.0	12.5	16.4	11.3	16.0	23.7	3.0	12.7	16.0	15.9	1.8	17.7	2.2	6.6	15.6	1.1	6.0	0.0	0.0	26.2	0.4	11.8	36.8	12.7	63.6	12.8	11.1	23.0	6.7	9.8	4.6	13.3	5.6	25.3	29.7	0.2	146.0	15.3	0.0	15.2	35.3	25.4	6.5	10.3	0.7	1.7	22.6	2.4	17.5	0.6	9.8
CERS5	"FLJ25304, LASS5, MGC45411, Trh4"	ENSG00000139624	"Ceramide synthase 5"	Q8N5B7	12	50129306-50167533	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026589	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA026589: AB_1852727"	"unprognostic (1.59e-2)"	"unprognostic (9.83e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.49e-3)"	"prognostic unfavorable (4.63e-5)"	"unprognostic (5.56e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.88e-3)"	"unprognostic (5.67e-2)"	"prognostic unfavorable (9.33e-11)"	"unprognostic (8.37e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (5.76e-5)"	"unprognostic (3.26e-1)"	18.0	13.2	18.3	13.3	21.6	10.9	18.0	38.3	19.6	21.1	15.0	17.5	8.9	6.3	22.6	20.9	14.1	17.7	14.9	9.9	16.7	11.6	16.0	7.8	14.7	15.1	13.9	19.1	22.5	13.8	23.9	22.4	19.7	14.3	15.6	11.5	14.9	14.6	16.2	5.0	21.5	12.2	21.8	10.3	15.7	13.3	11.6	14.4	12.7	15.5	7.0	14.9	18.4	18.3	21.0	26.1	33.5	35.1	29.0	26.3	22.3	9.2	10.4	23.0	6.5	12.8	10.8	19.5	20.5	17.7	19.7	18.7	24.5	14.7	14.0	17.2	29.0	10.3	8.7	10.0	7.9	19.6	22.1	10.2	11.7	8.8	14.8	25.6	11.9	16.0	18.5	12.0	16.2	15.1	25.9	17.9	12.3	8.8	13.0	24.7	16.2	10.3	32.4	14.7	5.2	10.1	13.5	15.0	10.0	25.6	12.0	7.0	11.4	17.4	8.2	27.5	15.8	11.2	13.7	17.1	17.0	11.4	12.7	8.9	12.7	12.1	11.3	13.4	8.3	7.8	24.8	19.0	28.1	26.0	25.5	22.9	17.9	22.9	22.4	18.2	21.0	17.9	24.3	33.5	29.0	35.1	26.1	26.3	22.3	18.3	21.6	38.3	19.6	16.7	11.6	13.9	19.1	14.3	14.4	17.9	17.3	12.1	17.3	15.3	41.7	5.6	15.3	9.4	14.8	14.0	19.6	27.6	6.6	19.6	0.6	14.9	9.1	0.0	12.2	48.5	20.0	10.2	15.0	3.8	17.4	30.2	15.0	15.4	17.0	1.1	15.5	16.5	11.8	30.7	7.0	21.7	14.2	7.0	16.3	6.8	36.1	32.3	17.6	8.1	7.5	12.5	28.1	20.0	6.0	11.3
CERS6	LASS6	ENSG00000172292	"Ceramide synthase 6"	Q6ZMG9	2	168455862-168775137	"Predicted membrane proteins"	"Inflammatory response, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 9.0"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 9.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044683, HPA063527"	Approved		Uncertain	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA044683: AB_10965059, HPA063527: AB_2685030"	"unprognostic (2.17e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.92e-3)"	"prognostic unfavorable (7.31e-4)"	"unprognostic (3.24e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.80e-2)"	12.3	13.5	17.7	12.2	17.5	9.6	14.2	28.0	23.2	12.3	24.4	6.5	19.8	22.4	17.4	17.0	12.7	9.8	9.7	26.9	14.5	15.9	12.1	11.7	9.4	12.5	11.0	15.9	15.6	7.3	15.8	14.6	8.3	9.2	12.2	27.1	13.4	6.9	17.1	9.4	20.0	28.3	11.0	8.5	6.9	21.0	11.0	8.1	25.1	24.1	7.4	7.5	11.8	30.5	0.8	9.0	0.7	1.7	1.1	1.7	0.5	5.9	5.3	9.5	10.9	23.6	17.6	0.0	6.0	6.1	6.4	8.7	8.4	13.2	0.0	8.7	5.4	9.1	11.3	12.2	13.9	10.8	0.0	8.4	10.9	5.7	6.0	20.7	22.9	5.3	19.5	40.1	13.5	10.6	6.4	3.2	16.3	5.8	0.0	13.3	6.5	20.1	6.4	8.8	12.8	7.8	15.6	18.0	10.3	6.1	17.9	13.2	15.9	5.8	15.0	3.1	8.2	13.3	13.1	1.8	16.5	6.9	4.5	10.3	0.1	0.0	0.0	10.8	12.2	11.0	0.7	1.7	0.0	0.3	1.2	0.6	0.2	0.6	0.3	1.3	0.8	1.7	1.3	0.2	1.1	1.0	9.0	0.0	0.5	17.7	17.5	28.0	23.2	14.5	15.9	11.0	15.9	9.2	8.1	6.0	10.1	10.9	40.4	96.7	20.6	40.6	30.6	25.4	18.2	10.4	0.0	0.5	0.0	12.6	4.2	12.7	42.8	0.0	20.1	0.8	10.8	29.9	10.3	41.4	21.3	35.0	99.7	14.7	43.8	2.7	18.4	31.6	10.1	96.4	94.8	31.2	14.0	35.1	37.4	8.4	2.3	64.7	18.6	3.9	3.0	81.1	0.5	8.6	107.7	39.9
CTSA	"GSL, PPGB"	ENSG00000064601	"Cathepsin A"	P10619	20	45890144-45898820	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 125.7"	"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 279.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 113.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024930, HPA031068, HPA072487"	Enhanced		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		18000000	Vesicles		"CAB024930: , HPA031068: AB_10601205, HPA072487: "	"unprognostic (8.61e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (6.33e-2)"	"unprognostic (9.53e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.40e-2)"	29.0	125.7	12.0	22.8	19.5	22.1	35.3	11.4	30.0	14.1	50.6	17.4	16.2	29.4	18.2	19.3	20.7	12.7	28.0	32.6	11.5	11.6	88.2	43.8	28.4	38.9	12.3	16.1	23.9	19.2	28.3	16.5	47.7	15.7	18.2	50.5	30.1	20.5	15.1	19.3	28.2	40.6	19.6	11.9	38.8	19.7	14.3	11.2	8.0	18.1	24.9	22.4	23.3	18.7	7.0	16.6	81.1	46.1	12.0	31.2	50.0	14.1	14.5	2.7	12.4	113.6	58.9	6.3	20.3	54.2	22.3	29.1	27.3	38.1	3.0	23.6	38.1	84.2	22.6	7.3	13.7	14.0	5.9	6.8	8.0	10.2	47.5	25.3	12.7	33.2	46.7	16.5	14.4	3.2	55.8	24.2	3.9	7.9	46.7	24.1	29.1	3.2	11.8	2.8	21.6	34.6	5.1	14.1	16.8	17.8	12.5	5.5	5.2	33.9	59.3	56.7	7.3	14.5	18.3	22.3	44.8	10.5	25.3	15.9	23.1	29.1	2.1	80.6	16.9	18.4	60.6	46.1	81.1	7.5	26.6	31.2	7.0	12.9	13.2	16.6	3.6	4.7	6.9	24.7	12.0	17.7	6.6	23.9	50.0	12.0	19.5	11.4	30.0	11.5	11.6	12.3	16.1	15.7	11.2	32.8	24.6	40.4	31.0	21.5	54.2	10.9	58.6	22.7	26.1	68.0	56.9	86.8	33.2	172.8	2.3	41.6	257.8	0.0	146.8	91.1	44.1	21.0	9.2	53.3	279.4	44.5	51.9	105.0	166.6	3.6	30.5	81.3	106.3	136.1	70.2	92.8	127.7	92.2	25.8	168.1	30.9	25.8	46.4	6.2	32.4	19.9	120.5	54.2	85.6	31.9
DBP	DABP	ENSG00000105516	"D-box binding PAR bZIP transcription factor"	Q10586	19	48630030-48637438	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Bipolar cells: 287.8;Cone photoreceptor cells: 82.5;Horizontal cells: 203.4;Muller glia cells: 180.9;Rod photoreceptor cells: 103.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 19.7;NB-4: 70.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.49e-1)"	"unprognostic (3.68e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.67e-2)"	"prognostic favorable (5.49e-4)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.16e-5)"	"unprognostic (3.32e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.24e-3)"	"unprognostic (4.75e-2)"	"prognostic favorable (2.41e-5)"	"unprognostic (2.23e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.61e-2)"	9.0	22.2	17.3	5.7	30.9	6.0	5.2	32.4	38.1	15.6	7.0	13.1	22.0	16.8	13.0	7.1	7.7	7.6	9.5	15.4	13.6	15.0	8.6	11.2	6.6	11.0	13.5	12.1	22.6	6.9	7.2	15.2	2.9	9.8	8.2	4.0	34.9	36.0	17.4	43.2	21.3	13.5	8.4	9.2	15.7	7.5	8.9	6.7	21.2	22.0	12.6	13.4	8.6	6.6	4.8	6.7	7.4	5.5	1.1	6.7	2.0	1.3	2.2	1.1	5.5	0.8	1.1	1.1	0.3	3.1	0.9	2.3	1.4	12.6	2.5	1.5	1.4	1.1	3.0	3.9	0.7	0.8	2.6	1.8	5.2	2.0	0.7	4.1	3.2	3.9	3.9	0.7	0.1	0.6	6.8	0.2	5.5	0.3	19.7	0.8	1.8	9.8	70.9	0.7	3.5	1.5	4.8	0.9	6.6	0.4	0.3	3.7	4.6	1.7	8.2	4.6	0.5	1.5	3.1	0.3	2.0	5.9	1.0	0.5	9.2	14.9	4.7	0.9	4.5	1.2	3.2	5.1	7.4	3.4	5.5	6.7	4.8	5.4	2.7	6.7	3.3	4.5	5.5	0.1	1.1	3.0	5.8	5.7	2.0	17.3	30.9	32.4	38.1	13.6	15.0	13.5	12.1	9.8	6.7	11.9	3.8	9.9	14.4	19.5	287.8	4.0	7.6	0.0	2.3	7.0	82.5	4.3	38.1	3.7	0.8	5.0	10.5	0.0	4.8	1.7	8.2	11.4	0.0	7.9	10.0	203.4	1.7	11.1	10.0	1.7	15.5	9.1	16.9	7.2	6.2	180.9	3.5	8.6	24.1	18.1	103.7	0.0	10.3	0.9	7.2	19.7	1.4	13.8	7.8	6.4
DEGS1	"DEGS-1, Des-1, DES1, FADS7, MLD"	ENSG00000143753	"Delta 4-desaturase, sphingolipid 1"	O15121	1	224175756-224193441	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 164.4"	"Cell type enhanced"	"Detected in all"	5	"Basal keratinocytes: 218.5;Cytotrophoblasts: 229.8;Suprabasal keratinocytes: 280.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA076422			Supported	Mitochondria		NA	NA			Mitochondria		"HPA076422: AB_2686799"	"unprognostic (2.34e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.48e-2)"	"prognostic unfavorable (7.74e-5)"	"unprognostic (1.50e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (4.29e-5)"	"unprognostic (7.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.20e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (6.83e-7)"	"unprognostic (2.87e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (2.53e-4)"	19.2	10.7	14.7	14.1	15.7	20.0	28.6	11.9	17.8	17.8	17.0	19.9	15.8	15.0	17.2	13.4	16.1	13.1	13.5	16.6	15.1	16.4	12.8	17.3	16.1	24.5	22.0	17.4	14.4	9.3	11.8	15.1	40.1	17.9	27.6	9.4	15.9	14.8	20.1	7.6	164.4	12.1	23.3	22.1	13.0	14.6	9.2	19.3	7.7	19.7	12.3	15.7	15.5	24.9	31.7	39.5	43.6	25.7	16.1	24.4	16.8	14.9	10.6	14.0	10.4	61.0	39.4	10.9	42.0	47.3	29.5	35.5	9.8	11.5	11.9	54.6	38.0	17.9	15.9	16.3	14.3	32.8	17.4	29.1	8.6	11.7	5.9	37.1	17.2	18.7	39.2	32.0	27.1	15.3	30.9	29.1	6.6	12.6	13.2	37.8	5.5	8.7	9.3	17.4	8.2	15.7	8.0	19.8	7.7	37.5	4.1	9.1	14.7	22.3	35.2	22.2	26.8	11.9	25.1	26.5	28.4	9.0	32.6	40.9	9.4	11.1	11.0	30.6	8.6	31.8	32.3	22.3	43.6	12.7	25.7	24.4	23.9	21.5	17.5	39.5	31.7	17.1	15.0	26.1	16.1	17.4	13.2	22.0	16.8	14.7	15.7	11.9	17.8	15.1	16.4	22.0	17.4	17.9	19.3	77.4	27.7	37.9	37.6	218.5	30.5	15.7	12.7	22.7	20.5	10.4	13.7	229.8	11.6	30.3	15.3	49.6	4.2	23.3	38.8	36.5	83.9	44.4	103.9	18.1	85.9	17.5	14.3	60.2	49.3	8.5	58.4	80.4	65.8	75.7	5.0	21.7	25.8	5.8	74.6	25.8	15.9	103.5	85.6	67.0	42.8	280.0	166.4	61.0	5.6	12.9
DEGS2	"C14orf66, DES2, FADS8"	ENSG00000168350	"Delta 4-desaturase, sphingolipid 2"	Q6QHC5	14	100143957-100160163	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.5;skin 1: 30.6"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 77.6;Collecting duct cells: 78.5;Intestinal endocrine cells: 53.2;Undifferentiated cells: 46.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 22.9"	"Cell type enhanced"	"Detected in many"		"memory B-cell: 11.9"	"Group enriched"	"Detected in many"	5	"B-cells: 11.9;granulocytes: 6.4"	"Group enriched"	"Detected in some"	16	"OE19: 29.1;T-47d: 45.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA046644			Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA046644: AB_2797231"	"unprognostic (8.18e-2)"	"unprognostic (3.83e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (7.94e-7)"	"unprognostic (1.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.66e-4)"	0.4	0.3	2.0	2.3	4.6	0.5	5.8	22.9	6.4	5.3	20.2	1.8	0.6	20.8	3.4	4.6	20.9	1.9	13.3	0.3	2.0	1.5	8.7	17.2	2.6	0.8	2.4	1.4	0.8	13.0	0.3	1.6	0.6	2.7	2.5	4.2	0.8	4.5	2.3	0.5	30.6	44.5	0.7	1.9	0.5	17.9	0.7	0.7	0.0	2.4	7.3	11.1	7.1	5.2	11.9	0.7	6.4	0.5	0.2	1.8	0.8	0.0	0.1	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	1.7	0.1	0.1	0.0	29.1	0.0	0.1	0.0	1.5	0.0	0.7	2.2	0.0	0.0	1.3	0.0	0.0	45.3	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	0.5	6.4	1.8	0.0	0.0	11.9	0.1	0.8	0.7	5.9	0.0	1.2	0.2	0.2	0.0	0.1	0.0	0.8	2.0	4.6	22.9	6.4	2.0	1.5	2.4	1.4	2.7	0.7	3.0	5.3	0.0	2.8	1.5	4.4	0.4	38.2	77.6	11.4	78.5	0.0	5.9	1.7	13.4	1.0	0.9	31.3	0.0	1.3	1.5	0.3	1.1	9.2	0.2	1.6	0.0	53.2	0.6	1.9	1.5	0.3	1.0	0.0	0.0	43.3	1.2	2.8	43.8	0.0	0.1	24.4	0.0	0.2	0.9	1.9	13.4	31.2	1.3	46.7	17.4
ENPP7	"alk-SMase, NPP7"	ENSG00000182156	"Ectonucleotide pyrophosphatase/phosphodiesterase 7"	Q6UWV6	17	79730919-79742222	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 71.1"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 8.5;Proximal tubular cells: 7.3"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 6.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"Hep G2: 2.9;Karpas-707: 5.2;U-266/70: 7.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024603	Approved				"Intracellular and membrane"	NA	NA		440000			"HPA024603: AB_1848174"	"unprognostic (4.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.01e-1)"		"unprognostic (8.45e-4)"	"unprognostic (4.83e-2)"		"unprognostic (1.18e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.80e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.7	1.3	0.1	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FUT1	"H, HSC"	ENSG00000174951	"Fucosyltransferase 1 (H blood group)"	P19526	19	48748011-48755390	"Blood group antigen proteins, Enzymes, Predicted membrane proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 19.5"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 5.1;Endothelial cells: 5.1;Ito cells: 8.6;Melanocytes: 5.0;Pancreatic endocrine cells: 4.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 8.2;HEL: 10.2;hTCEpi: 8.1;RT4: 9.8"	"Not detected"	"Not detected"													NA	NA						"unprognostic (2.90e-2)"	"unprognostic (3.09e-2)"	"unprognostic (8.05e-3)"	"unprognostic (4.65e-3)"	"unprognostic (2.92e-3)"	"unprognostic (8.73e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (3.99e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.67e-3)"	"unprognostic (3.98e-2)"	2.5	0.8	0.9	0.9	0.9	1.5	1.6	3.5	1.4	0.9	0.9	0.9	0.9	1.0	0.9	0.9	1.5	1.2	0.9	1.4	0.9	0.2	1.1	0.9	6.8	0.9	0.9	0.9	0.9	19.5	1.0	1.7	2.8	0.9	0.9	0.0	0.9	0.9	0.9	0.9	0.8	0.9	0.9	0.9	3.4	7.6	0.9	0.9	0.9	1.0	0.9	0.9	0.9	0.9	0.9	0.9	3.3	0.7	1.5	0.6	0.3	3.3	0.1	0.1	0.2	0.0	0.0	1.7	0.2	0.1	0.2	0.2	8.2	4.8	0.3	0.4	0.2	0.8	5.5	1.6	5.1	0.1	0.0	0.8	10.2	0.4	0.1	2.4	0.4	4.5	0.0	8.1	0.4	3.7	0.1	3.6	1.8	0.5	1.5	0.0	3.8	0.2	6.2	1.0	6.5	0.5	0.3	0.0	1.6	0.3	9.8	7.7	0.5	0.4	7.1	0.1	0.4	4.6	0.2	3.5	0.3	2.5	0.2	0.3	1.4	3.6	1.0	0.1	0.3	0.3	3.3	0.7	0.5	0.5	0.3	0.3	0.8	0.6	0.4	0.3	0.9	0.6	0.5	2.1	1.5	0.3	0.9	0.2	0.3	0.9	0.9	3.5	1.4	0.9	0.2	0.9	0.9	0.9	0.9	3.0	1.7	0.0	0.6	2.3	0.3	0.8	5.1	0.0	1.2	0.0	2.0	0.3	1.7	1.1	0.0	5.1	0.0	0.0	1.9	0.2	1.0	0.9	1.1	0.0	0.3	0.0	1.2	8.6	1.0	0.0	0.9	1.5	5.0	0.0	0.4	0.0	4.9	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.1	1.5	0.3	0.0	0.0	0.4
FUT10		ENSG00000172728	"Fucosyltransferase 10"	Q6P4F1	8	33370824-33473422	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 187.5;Late spermatids: 217.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053970, HPA058655"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Endoplasmic reticulum, Golgi apparatus"		"HPA053970: AB_2682327, HPA058655: AB_2683789"	"unprognostic (6.02e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.85e-3)"	"unprognostic (6.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.80e-2)"	"unprognostic (5.40e-3)"	"unprognostic (6.07e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.76e-4)"	"unprognostic (3.06e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-3)"	"unprognostic (6.01e-3)"	5.6	7.2	7.9	3.9	10.9	2.0	8.9	18.8	8.6	10.9	6.3	6.9	5.0	6.4	10.5	5.3	5.8	8.4	4.8	5.4	7.4	4.5	8.3	5.2	6.0	4.1	5.8	7.2	13.6	10.9	14.5	11.7	8.2	6.8	6.0	6.9	12.4	6.7	5.9	2.4	9.7	6.1	7.3	5.1	3.8	5.7	4.1	4.6	5.8	6.9	2.2	6.0	6.6	7.2	2.4	3.5	1.9	1.5	3.8	4.1	2.1	2.2	4.4	7.1	8.4	11.1	11.3	3.7	4.5	7.3	4.4	5.9	6.7	3.9	2.5	5.5	5.6	3.7	6.1	10.2	4.1	4.4	5.7	3.9	8.4	3.7	7.3	5.1	1.8	3.0	7.9	7.4	1.1	5.4	9.4	8.7	4.6	7.6	3.4	4.1	1.3	6.5	2.8	10.0	6.3	2.9	4.9	5.5	1.4	6.2	5.5	2.4	2.3	2.5	3.8	4.9	7.8	3.8	1.9	7.1	3.3	1.5	8.5	3.5	1.4	2.2	1.7	2.0	5.4	3.4	1.1	1.5	1.9	3.7	0.7	4.0	2.4	2.2	3.5	3.5	1.0	2.5	2.4	1.1	3.8	0.5	2.0	4.1	2.1	7.9	10.9	18.8	8.6	7.4	4.5	5.8	7.2	6.8	4.6	3.0	1.3	0.0	2.6	2.4	3.1	2.2	5.1	1.4	3.4	3.5	9.8	9.6	1.7	4.1	187.5	3.0	2.6	0.0	3.5	5.8	4.1	1.1	5.7	3.9	3.0	3.2	3.5	4.3	1.8	217.3	6.4	1.9	1.7	2.8	2.9	31.7	3.1	0.0	4.6	2.8	10.8	0.0	2.8	1.6	2.4	1.5	5.0	0.5	2.9	1.3
FUT11	MGC33202	ENSG00000196968	"Fucosyltransferase 11"	Q495W5	10	73772291-73780251	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 147.9;Late spermatids: 165.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014033	Approved		Approved	"Nuclear membrane,Golgi apparatus"	"Intracellular and membrane"	NA	NA		840000	"Nuclear membrane"	"Golgi apparatus"	"HPA014033: AB_1849192"	"prognostic unfavorable (6.78e-4)"	"prognostic unfavorable (2.39e-6)"	"unprognostic (1.47e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.27e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.51e-1)"	"unprognostic (9.30e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (2.59e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.66e-2)"	16.2	9.5	8.9	9.0	9.2	7.8	13.9	7.9	11.8	13.8	7.0	8.2	9.8	4.4	12.5	7.8	14.6	9.0	12.8	14.5	7.3	6.3	9.2	7.4	16.1	18.2	10.4	7.2	13.4	7.9	8.9	7.7	24.0	9.7	9.7	5.6	9.7	9.1	9.8	7.5	6.9	7.9	11.9	8.7	14.2	6.9	18.8	7.4	4.5	10.0	6.8	8.6	10.8	11.1	1.7	2.6	3.9	1.3	7.8	16.0	4.4	13.6	7.5	5.4	11.1	10.7	12.4	1.6	7.0	16.9	8.9	17.5	2.5	7.4	3.1	5.1	11.4	3.0	5.8	2.8	7.0	9.9	7.5	5.8	4.2	6.1	3.9	4.2	5.9	13.4	8.2	1.6	8.5	8.7	27.6	16.2	1.5	4.1	5.7	8.8	1.6	1.0	3.1	2.5	1.3	18.9	1.4	3.3	3.7	3.2	2.5	1.6	5.2	6.1	6.5	3.9	4.8	4.4	2.6	16.5	11.6	5.0	5.7	8.6	7.5	2.6	0.7	16.3	5.3	3.8	3.9	1.0	1.0	16.0	1.2	11.4	1.7	4.8	11.2	1.3	1.5	3.5	7.4	0.2	7.8	1.3	2.6	1.9	4.4	8.9	9.2	7.9	11.8	7.3	6.3	10.4	7.2	9.7	7.4	14.9	13.3	5.6	4.8	12.0	14.0	10.7	10.2	8.1	5.7	10.4	13.7	9.0	0.0	10.7	147.9	29.2	2.6	0.0	5.9	14.6	15.3	6.2	13.9	5.0	10.8	19.1	4.6	40.5	17.8	165.7	15.0	9.5	16.9	6.4	4.2	10.8	8.2	4.8	13.8	3.3	13.8	6.5	12.1	22.8	15.3	10.0	8.1	15.2	3.1	4.8
FUT2	"SE, Se2, SEC2, sej"	ENSG00000176920	"Fucosyltransferase 2"	Q10981	19	48695971-48705950	"Blood group antigen proteins, Enzymes, Predicted membrane proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.3;salivary gland: 58.1"	"Cell type enhanced"	"Detected in many"	12	"Cholangiocytes: 43.3;Enterocytes: 109.6;Exocrine glandular cells: 41.1;Mucus-secreting cells: 39.5;Paneth cells: 73.7;Undifferentiated cells: 44.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"cerebellum: 8.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 34.7;OE19: 38.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014402	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA014402: AB_1849194"	"unprognostic (2.95e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.80e-3)"	"unprognostic (4.63e-3)"	"unprognostic (2.63e-1)"	"prognostic favorable (5.83e-4)"	"unprognostic (6.30e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.44e-2)"	"unprognostic (7.89e-2)"	"unprognostic (5.11e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.87e-1)"	0.4	0.6	0.7	5.3	0.8	0.0	0.8	8.7	1.6	9.3	25.0	0.3	13.9	24.1	1.3	0.1	16.0	1.2	23.3	0.5	0.7	0.7	0.8	0.4	1.1	0.1	0.7	0.1	1.0	7.5	0.0	1.5	0.2	0.7	1.2	10.9	0.1	58.1	14.5	0.5	2.6	41.3	0.4	0.7	0.6	15.8	0.7	0.2	0.5	0.6	16.1	19.3	3.1	5.4	1.7	1.8	3.5	1.0	1.4	2.5	0.6	0.9	0.9	0.2	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	4.1	34.7	0.3	0.2	0.0	0.2	6.1	0.0	0.0	0.0	0.3	0.2	0.3	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.4	0.0	0.4	0.4	0.8	0.2	38.7	0.3	0.3	0.1	1.5	0.0	0.3	1.8	0.2	0.1	0.3	0.0	0.2	5.2	0.0	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.0	0.1	0.2	0.1	3.5	0.8	0.4	2.0	0.7	1.1	1.5	2.3	1.0	0.5	1.7	2.1	0.7	3.4	1.4	1.0	1.8	2.5	0.6	0.7	0.8	8.7	1.6	0.7	0.7	0.7	0.1	0.7	0.2	0.0	1.1	0.0	2.5	0.8	2.7	0.4	43.3	12.0	10.3	19.2	2.0	0.0	1.7	5.5	0.5	0.3	109.6	0.0	41.1	0.0	0.2	2.5	0.0	0.0	0.1	0.0	10.9	0.0	0.3	0.0	0.0	0.0	1.7	0.0	39.5	0.8	25.6	73.7	0.0	0.0	3.8	0.0	0.2	0.2	0.2	1.3	0.1	2.2	44.3	14.7
FUT4	"CD15, ELFT, FCT3A, FUC-TIV"	ENSG00000196371	"Fucosyltransferase 4"	P22083	11	94543840-94549898	"Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"bone marrow: 71.3"	"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 20.4;Mucus-secreting cells: 20.8;Pancreatic endocrine cells: 18.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HL-60: 20.8;NB-4: 13.5;THP-1: 26.3;U-937: 18.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB000014, CAB016129"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"CAB000014: , CAB016129: AB_626918"	"unprognostic (6.36e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.70e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.46e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (3.64e-4)"	"unprognostic (7.26e-2)"	"unprognostic (4.14e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.08e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.10e-3)"	5.5	2.4	5.5	6.1	6.2	71.3	6.3	3.0	6.0	4.4	8.3	6.7	4.7	10.9	5.9	2.5	3.0	4.6	7.5	3.7	6.2	2.2	4.1	3.0	6.0	5.4	8.1	2.5	4.9	11.4	1.4	2.9	3.4	4.8	3.4	8.3	3.8	6.3	2.9	1.7	1.9	10.1	5.8	5.7	6.5	9.7	2.9	4.5	10.4	2.9	1.9	3.1	4.4	3.0	0.7	1.9	2.5	3.9	0.8	1.9	0.8	1.6	0.8	1.0	0.0	3.2	2.9	5.3	1.5	0.7	1.3	1.5	7.1	2.3	0.0	3.6	2.5	0.7	0.8	1.7	0.1	1.3	10.7	1.7	5.3	1.2	0.1	1.6	20.8	4.7	2.5	0.0	1.7	0.0	0.3	2.1	4.8	5.3	0.0	1.6	0.8	4.3	13.5	2.0	6.5	2.0	3.9	0.0	0.0	1.4	1.1	1.4	0.5	0.9	2.1	0.8	3.1	1.2	26.3	1.9	1.1	2.9	0.0	0.5	0.6	0.3	0.0	0.9	18.7	0.6	2.0	3.1	2.5	1.1	1.5	0.7	0.6	1.0	1.3	1.8	0.7	1.1	0.7	1.7	0.8	3.9	1.9	1.9	0.8	5.5	6.2	3.0	6.0	6.2	2.2	8.1	2.5	4.8	4.5	0.0	0.0	0.0	2.3	1.4	0.6	0.8	20.4	2.7	2.3	1.8	3.9	12.9	0.0	12.8	0.2	1.3	12.1	0.0	15.5	2.0	4.6	1.6	0.0	0.8	7.7	0.0	9.8	2.5	10.6	0.2	4.0	3.3	3.3	10.0	20.8	0.5	18.4	3.5	1.1	1.9	8.8	0.0	1.4	0.9	3.2	0.5	1.8	2.5	14.4	1.2
FUT7		ENSG00000180549	"Fucosyltransferase 7"	Q11130	9	137030174-137033010	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 40.4;lymphoid tissue: 10.5"	"Cell type enhanced"	"Detected in some"	24	"Kupffer cells: 7.0;monocytes: 19.8;T-cells: 5.7"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"cerebellum: 3.2"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 40.4"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"NB-4: 14.4;THP-1: 18.5;U-937: 10.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042780			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA042780: AB_2678162"	"unprognostic (1.33e-2)"	"unprognostic (4.20e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.42e-2)"	"unprognostic (5.01e-6)"	"unprognostic (2.50e-1)"	"unprognostic (2.35e-2)"	"unprognostic (6.75e-4)"	"unprognostic (4.68e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.69e-6)"	"unprognostic (3.99e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.75e-2)"	0.4	0.1	0.2	2.5	0.2	5.9	0.2	3.2	0.3	0.2	0.2	0.2	0.2	0.0	1.4	0.2	0.4	0.5	4.4	0.2	0.3	0.3	0.2	0.2	1.5	6.2	1.7	0.2	0.2	0.2	0.0	0.4	0.2	0.9	0.2	0.0	0.2	0.2	0.2	0.2	0.4	0.6	0.2	0.4	10.5	0.3	0.2	0.2	0.2	0.3	0.2	4.6	0.5	0.2	4.2	40.4	18.3	1.5	22.1	16.3	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.4	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.3	1.5	0.3	2.1	0.3	10.5	4.2	10.3	5.7	4.4	1.2	0.2	0.8	18.3	22.1	0.0	40.4	16.3	3.4	0.2	0.2	3.2	0.3	0.3	0.3	1.7	0.2	0.9	0.2	0.0	0.0	3.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	7.0	0.0	0.0	2.9	0.0	19.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	5.7	0.2	0.0
FUT9	Fuc-TIX	ENSG00000172461	"Fucosyltransferase 9"	Q9Y231	6	96015984-96215612	"Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 37.7;stomach 1: 35.4"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 2.9;Exocrine glandular cells: 1.6"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.5"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"MCF7: 4.2;OE19: 4.1;RT4: 9.5;SCLC-21H: 9.7;SK-BR-3: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070923			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			Nucleoplasm	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA070923: AB_2686323"	"unprognostic (1.60e-1)"	"unprognostic (2.48e-1)"		"unprognostic (5.99e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.40e-1)"		"unprognostic (2.97e-1)"		"unprognostic (1.35e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.03e-2)"	1.1	1.7	18.5	1.1	22.5	1.1	1.9	37.7	28.6	1.1	1.1	10.7	0.0	4.1	1.4	1.2	1.1	1.4	1.1	1.1	20.0	6.2	1.2	1.1	1.1	1.1	10.2	24.0	1.1	8.0	1.1	0.9	1.7	13.8	1.5	1.2	0.0	1.1	1.5	1.2	1.1	1.1	1.1	10.2	1.1	35.4	1.1	16.5	0.0	1.2	0.0	1.1	2.2	0.4	0.3	0.2	1.5	0.1	0.2	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	2.1	4.1	0.0	0.0	0.0	0.0	0.0	9.5	9.7	0.2	0.0	5.5	0.0	0.2	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.8	0.2	0.0	0.2	0.0	0.0	18.5	22.5	37.7	28.6	20.0	6.2	10.2	24.0	13.8	16.5	0.0	0.0	0.0	0.6	0.0	2.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.1
GAL3ST1	CST	ENSG00000128242	"Galactose-3-O-sulfotransferase 1"	Q99999	22	30554635-30574587	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 28.7;gallbladder: 13.4;intestine: 25.1;kidney: 13.3;stomach 1: 7.2"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 38.2;Enterocytes: 17.4;Muller glia cells: 29.4;Proximal tubular cells: 18.9"	"Cancer enriched"	"Detected in many"	6	"renal cancer: 38.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 22.7;CACO-2: 6.3;EFO-21: 12.3;K-562: 5.3;OE19: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001220, HPA077138"	Approved		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			Vesicles	Nucleoplasm	"HPA001220: AB_1078933, HPA077138: "	"unprognostic (2.69e-2)"	"unprognostic (3.12e-4)"	"unprognostic (5.93e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (2.33e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.56e-2)"	0.8	0.6	8.4	0.7	9.6	1.2	0.8	1.4	12.3	1.4	11.3	25.8	0.0	24.2	1.3	2.3	0.8	2.2	13.4	0.5	12.1	8.3	13.3	1.6	1.5	0.9	14.0	2.6	1.2	2.9	0.6	0.5	1.3	12.4	1.2	2.8	0.3	1.0	1.9	1.9	2.1	25.1	0.7	28.7	0.7	7.2	2.5	7.8	0.0	0.6	0.0	0.4	1.0	0.7	2.3	2.8	2.3	0.7	0.3	0.8	0.0	0.1	22.7	0.4	0.2	0.0	0.0	1.7	0.0	0.1	0.0	0.0	6.3	3.1	0.3	12.3	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.8	0.3	0.2	4.1	0.5	0.1	0.3	0.2	0.0	0.1	0.1	0.0	0.0	0.3	5.3	0.6	0.0	0.1	0.3	0.9	3.3	8.5	0.3	0.2	0.1	0.6	0.9	0.1	0.3	1.5	0.0	0.4	0.2	0.6	0.1	0.1	0.6	0.2	0.1	0.2	0.0	2.0	1.2	0.3	0.1	0.1	0.2	0.9	0.7	0.1	0.4	0.5	0.7	1.8	0.7	0.8	0.2	2.3	0.5	0.8	2.3	0.3	0.3	2.8	0.1	0.0	8.4	9.6	1.4	10.3	12.1	8.3	14.0	2.6	12.4	7.8	0.0	0.0	0.0	0.1	0.3	0.7	0.6	38.2	0.0	0.0	3.5	0.0	0.0	13.3	5.6	0.9	0.1	17.4	0.0	9.7	0.0	0.0	0.2	0.0	1.3	0.1	0.0	10.5	0.0	0.8	0.6	1.4	0.0	0.0	0.0	7.4	29.4	4.6	7.0	2.1	18.9	1.1	0.0	0.0	3.1	7.5	0.3	0.2	0.0	8.0	0.0
GALC		ENSG00000054983	Galactosylceramidase	P54803	14	87837820-87993665	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism, Sphingolipid metabolism"	"Glycosidase, Hydrolase"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"granulocytes: 66.9;Kupffer cells: 62.6;Late spermatids: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 35.4;HMC-1: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022196	Approved				"Intracellular and membrane"	NA	NA		16000			"CAB022196: "	"unprognostic (1.27e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.44e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.72e-2)"	13.8	17.7	21.2	13.2	32.2	18.9	15.4	16.3	25.5	12.3	15.8	28.8	9.6	30.3	10.7	12.1	6.5	20.1	17.4	19.6	22.0	19.5	20.5	11.1	23.0	18.0	30.7	20.1	17.3	13.6	14.4	12.6	15.6	24.9	14.1	16.9	13.3	8.9	10.1	9.3	9.4	30.2	9.3	33.8	14.3	14.9	21.6	26.1	8.6	23.5	5.8	7.3	12.6	11.4	1.7	5.7	20.8	10.5	9.4	16.3	6.4	0.0	8.3	3.1	0.0	10.3	9.3	0.0	3.8	7.7	3.6	4.3	4.5	35.4	2.2	11.5	3.7	0.0	0.5	0.0	0.4	4.4	1.1	0.2	12.2	0.3	0.0	8.5	0.0	33.5	9.1	2.8	2.4	0.0	1.5	9.7	0.0	4.0	1.7	6.0	0.8	0.0	1.8	2.8	14.5	0.9	0.0	0.2	0.1	5.7	3.3	2.9	6.7	10.4	1.7	0.0	7.7	8.6	8.4	8.2	0.0	5.6	2.4	0.0	1.8	3.3	0.0	1.0	2.8	8.0	12.8	9.5	20.8	7.5	10.5	16.3	1.7	5.7	7.2	5.7	0.8	4.2	4.9	7.8	9.4	8.0	1.0	3.2	6.4	21.2	32.2	16.3	25.5	22.0	19.5	30.7	20.1	24.9	26.1	23.8	21.3	10.5	4.6	7.4	10.4	9.9	15.3	9.4	7.9	14.0	11.8	4.7	3.3	8.0	38.1	11.3	12.4	0.0	9.9	9.6	10.8	7.8	66.9	5.0	23.9	3.2	5.8	18.4	62.6	61.8	15.0	19.6	10.1	27.1	13.0	9.0	11.8	14.8	9.6	5.8	10.6	0.0	7.2	10.0	8.7	10.0	5.5	20.0	12.9	5.7
GALNS	"GALNAC6S, GAS"	ENSG00000141012	"Galactosamine (N-acetyl)-6-sulfatase"	P34059	16	88813734-88856970	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Dwarfism, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 7.1;granulocytes: 19.3;monocytes: 11.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026404, HPA042433, HPA074225"	Supported		Approved	Cytosol	"Intracellular and membrane"	NA	NA		2400000	Cytosol		"CAB026404: , HPA042433: AB_2732499, HPA074225: "	"unprognostic (3.16e-1)"	"unprognostic (9.98e-2)"	"unprognostic (4.03e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (4.15e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.00e-1)"	"unprognostic (3.53e-2)"	"unprognostic (4.12e-3)"	"unprognostic (4.24e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.84e-2)"	11.9	14.9	9.3	11.2	11.1	25.0	14.8	12.9	15.4	11.1	15.5	11.5	8.8	13.3	9.0	19.9	10.2	14.8	12.7	12.5	11.2	13.9	13.7	17.8	14.7	10.6	11.8	5.2	11.9	7.3	9.9	13.2	15.6	11.6	10.5	8.3	7.1	10.6	9.0	7.1	10.0	17.2	9.4	9.4	10.4	9.5	27.4	8.8	7.9	14.5	6.1	9.0	11.1	13.0	2.1	7.1	19.3	11.2	2.4	3.1	4.7	2.5	19.6	2.8	20.1	22.7	10.9	19.7	8.2	12.8	9.0	7.0	10.2	17.0	3.2	17.4	13.4	13.6	15.1	4.1	6.5	5.5	2.1	6.5	2.0	8.0	5.8	15.3	1.5	13.3	15.2	12.7	10.1	2.8	12.9	7.7	3.5	4.4	1.9	5.3	15.0	4.1	6.5	6.6	6.5	9.1	8.7	2.5	5.4	5.6	6.0	7.4	5.7	19.5	1.8	9.7	7.2	12.7	14.4	14.4	19.8	15.1	20.2	4.5	2.0	1.9	5.5	21.5	13.3	11.7	0.9	11.2	19.3	3.1	8.0	2.6	2.1	1.8	2.7	7.1	0.9	1.7	2.1	14.2	2.4	5.6	3.0	3.0	4.7	9.3	11.1	12.9	15.4	11.2	13.9	11.8	5.2	11.6	8.8	14.9	4.5	1.9	6.4	5.8	3.9	6.7	2.5	26.8	7.9	3.5	5.9	7.9	3.3	5.3	14.3	4.9	12.3	0.0	3.0	11.4	10.2	5.7	1.1	5.7	17.8	23.8	11.5	7.4	13.9	28.0	6.6	8.0	6.8	20.8	6.9	8.5	5.4	12.4	6.3	4.5	9.7	6.5	9.2	49.5	33.7	5.0	13.3	5.7	8.6	5.1
GALNT7	GALNAC-T7	ENSG00000109586	"Polypeptide N-acetylgalactosaminyltransferase 7"	Q86SF2	4	173168753-173323967	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 67.4"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 70.2;Glandular cells: 85.7;Mucus-secreting cells: 125.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064243, HPA065317"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		5000000	"Golgi apparatus"	Nucleoplasm	"HPA064243: AB_2685223, HPA065317: AB_2685465"	"unprognostic (1.81e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (4.53e-4)"	"unprognostic (1.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (6.86e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.34e-3)"	"unprognostic (5.97e-2)"	3.7	4.4	8.4	7.4	8.4	5.0	12.0	27.6	8.0	13.4	23.3	9.4	2.8	14.1	9.3	5.5	12.0	4.9	9.5	3.5	6.5	5.2	4.9	1.2	4.5	5.2	10.8	7.0	7.2	14.9	5.3	5.6	6.3	11.2	20.3	26.7	6.2	20.1	4.2	1.4	3.1	16.2	8.4	16.3	5.7	32.8	6.4	8.8	67.4	6.6	4.4	9.6	9.4	4.8	5.0	9.8	16.8	11.4	5.5	6.8	4.7	20.4	10.7	10.6	3.3	5.7	8.4	15.2	5.4	6.1	5.1	7.0	3.3	32.5	11.4	4.0	4.8	13.7	17.5	4.4	9.5	6.9	44.2	8.7	13.9	22.3	0.1	3.8	20.4	9.9	5.4	8.6	11.3	5.7	19.3	33.5	8.3	9.2	17.8	25.7	6.7	15.0	11.3	10.4	20.4	7.1	15.0	9.8	2.9	37.2	9.6	8.5	6.5	2.5	15.0	7.4	14.4	6.0	6.1	40.0	3.6	16.2	0.1	11.6	5.2	0.0	6.1	14.8	12.3	13.0	9.6	11.4	14.6	4.3	6.0	6.2	5.0	4.9	4.6	9.8	3.1	3.9	3.0	16.8	5.5	6.1	4.1	6.8	4.7	8.4	8.4	27.6	8.0	6.5	5.2	10.8	7.0	11.2	8.8	6.0	29.4	4.7	7.8	1.5	36.4	5.9	12.7	14.7	30.7	19.2	2.0	0.9	0.0	12.2	1.8	6.9	70.2	0.0	43.4	2.9	6.6	85.7	23.1	0.0	9.6	9.5	21.9	8.0	21.3	3.1	8.6	8.8	8.5	8.2	125.7	7.5	33.8	50.7	4.9	8.6	23.6	12.9	6.8	2.3	4.4	1.0	0.7	4.4	37.4	15.7
GALNTL5	"GalNAc-T5L, GALNT15"	ENSG00000106648	"Polypeptide N-acetylgalactosaminyltransferase like 5"	Q7Z4T8	7	151956379-152019934	"Disease related genes, Predicted membrane proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"testis: 45.0"	"Group enriched"	"Detected in some"	89	"Early spermatids: 360.6;Late spermatids: 297.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA011140	Enhanced					NA	NA					"HPA011140: AB_1078944"					"unprognostic (2.33e-2)"									"unprognostic (2.09e-1)"	"unprognostic (1.55e-1)"			0.0	0.0	1.2	0.0	0.7	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.7	0.0	1.9	1.1	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	360.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	297.5	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.7	1.5	0.0	0.0	0.0	0.0	0.0
GBA	"GBA1, GLUC"	ENSG00000177628	"Glucosylceramidase beta"	P04062	1	155234452-155244699	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism"	"Glycosidase, Glycosyltransferase, Hydrolase, Transferase"	"Disease mutation, Gaucher disease, Ichthyosis, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 101.2"	"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006667, CAB037171, CAB037289"	Supported				"Intracellular and membrane"	NA	NA		200000			"CAB037171: AB_1078958, CAB037289: AB_1078957, HPA006667: AB_1078979"	"unprognostic (6.03e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.00e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.04e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.94e-2)"	19.2	29.7	14.8	13.9	24.5	21.9	15.3	8.7	33.4	16.5	20.1	25.2	18.1	13.8	16.9	30.4	18.9	12.7	16.5	13.6	15.8	18.9	31.8	24.6	17.9	15.4	18.5	16.5	13.1	19.2	101.2	32.1	46.2	28.1	14.4	23.5	25.3	22.3	24.3	6.0	21.6	16.6	17.7	19.3	24.5	14.6	9.7	13.1	13.7	22.2	8.7	17.5	16.3	15.2	7.3	13.9	17.9	22.3	6.6	14.0	12.4	8.5	16.6	5.9	8.0	62.2	13.7	6.8	15.2	54.1	22.7	28.7	9.7	31.5	5.9	16.9	35.6	36.4	17.5	8.3	10.8	12.1	12.5	5.8	4.9	11.0	5.2	17.8	5.8	20.8	17.9	9.1	47.7	7.2	24.0	20.1	5.2	5.2	10.1	26.6	18.6	7.2	2.7	3.8	14.1	11.8	6.1	9.7	24.4	15.2	6.6	5.7	7.8	13.3	31.9	33.7	11.4	23.9	14.2	15.3	17.1	7.6	21.4	12.1	20.2	17.0	4.6	29.9	5.3	13.1	12.2	21.6	9.1	13.4	22.3	8.7	7.3	10.3	9.0	13.9	5.5	7.4	7.8	17.9	6.6	21.2	7.8	14.0	12.4	14.8	24.5	8.7	33.4	15.8	18.9	18.5	16.5	28.1	13.1	3.0	3.2	4.5	5.7	5.4	3.4	7.9	17.8	6.7	2.3	12.2	2.0	27.5	3.3	26.2	1.1	11.3	17.3	0.0	28.1	23.9	12.9	8.2	6.9	20.7	57.7	4.8	14.0	20.9	39.9	2.2	9.2	13.9	25.3	28.9	13.1	13.2	25.6	19.8	8.5	17.0	5.4	0.0	6.7	4.8	5.7	3.9	49.7	9.6	11.6	4.3
GBA2	"AD035, DKFZp762K054, KIAA1605, SPG46"	ENSG00000070610	"Glucosylceramidase beta 2"	Q9HCG7	9	35736866-35749228	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism"	"Glycosidase, Glycosyltransferase, Hydrolase, Transferase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 108.0;Rod photoreceptor cells: 95.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024026	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA024026: AB_1849530"	"unprognostic (3.34e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.83e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.99e-2)"	"unprognostic (8.69e-2)"	"prognostic favorable (6.00e-4)"	"unprognostic (9.01e-3)"	"prognostic favorable (1.24e-11)"	"unprognostic (7.62e-3)"	"unprognostic (2.94e-1)"	"unprognostic (7.69e-2)"	"prognostic favorable (6.60e-4)"	15.6	19.3	28.9	17.0	23.3	11.0	24.3	42.3	41.6	14.8	35.1	17.0	28.4	41.5	19.0	22.3	16.6	16.8	21.4	34.6	22.4	21.0	34.8	25.0	20.9	17.3	23.7	19.5	16.4	20.9	27.9	27.1	19.3	36.6	23.9	32.8	28.4	27.7	25.5	46.1	23.5	51.1	23.3	21.0	23.4	26.9	11.6	19.5	10.9	25.4	15.5	16.4	18.2	16.9	5.6	6.8	12.2	6.1	3.1	7.3	3.1	7.9	13.2	18.2	17.6	8.9	5.4	18.5	10.8	8.5	11.0	11.7	14.6	6.4	8.5	7.9	6.6	23.8	8.3	17.4	7.3	5.6	12.1	11.9	9.2	34.4	15.6	9.8	13.6	22.8	9.3	13.7	9.3	9.8	26.9	28.8	8.6	8.9	16.4	10.2	7.9	3.7	14.1	18.8	16.2	20.9	6.8	7.3	7.2	15.3	18.8	14.9	19.9	6.1	15.2	10.7	23.3	10.4	12.4	20.1	12.0	14.5	10.2	13.1	11.2	7.1	7.1	15.0	5.0	9.3	12.2	4.4	2.9	6.0	6.1	4.1	5.0	5.8	7.3	4.2	5.6	3.7	3.2	4.9	3.1	3.7	6.8	4.0	3.1	28.9	23.3	42.3	41.6	22.4	21.0	23.7	19.5	36.6	19.5	11.9	10.1	8.0	16.1	6.5	73.4	10.9	20.4	21.4	14.8	26.2	108.0	8.7	18.3	9.9	12.7	13.7	68.4	0.0	10.4	7.6	7.4	14.9	13.9	16.3	7.9	49.3	34.3	26.4	15.4	17.0	11.5	10.1	11.8	7.2	32.8	15.5	12.6	56.1	9.2	16.5	95.2	12.9	9.9	8.6	4.9	8.7	18.5	12.5	30.3	22.5
GBGT1	"A3GALNT, FS, MGC44848, UDP-GalNAc"	ENSG00000148288	"Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (FORS blood group)"	Q8N5D6	9	133152948-133163945	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"granulocytes: 11.5;Hofbauer cells: 19.5;Kupffer cells: 23.4;Macrophages: 13.6;monocytes: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 30.7;HMC-1: 28.7;HUVEC TERT2: 11.9;NB-4: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051298	Approved				"Intracellular and membrane"	NA	NA					"HPA051298: AB_2681428"	"unprognostic (4.63e-3)"	"unprognostic (8.03e-2)"	"prognostic unfavorable (6.22e-4)"	"unprognostic (2.70e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.38e-1)"	"unprognostic (2.97e-2)"	"unprognostic (7.43e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.27e-3)"	"unprognostic (2.35e-1)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (3.46e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.35e-2)"	10.2	12.9	6.7	13.7	5.7	10.3	15.5	8.1	7.8	5.8	5.6	6.3	4.7	4.1	8.5	5.7	6.7	7.8	9.0	7.2	7.0	4.6	7.7	2.0	11.2	20.4	6.7	4.3	15.8	4.4	5.6	5.6	19.7	8.8	8.4	3.9	16.7	6.3	8.2	2.9	4.2	7.3	8.2	7.2	11.2	21.7	4.3	5.7	1.7	8.1	3.2	11.5	8.3	9.0	3.4	3.2	5.2	11.2	0.9	0.5	2.5	0.0	0.8	0.8	0.0	0.5	0.6	0.2	2.3	1.8	1.3	0.0	0.0	0.4	0.6	7.8	2.3	0.9	8.6	5.1	0.5	0.0	0.0	0.2	30.7	0.5	0.0	6.3	1.1	28.7	2.7	0.8	0.3	0.0	5.4	11.9	0.4	8.9	0.1	0.4	0.1	0.1	13.8	2.5	0.2	0.2	2.2	0.2	0.8	0.8	0.1	0.2	0.9	0.0	1.2	0.0	1.0	0.0	6.8	7.4	0.0	1.0	0.9	0.0	0.0	0.0	0.0	0.1	4.9	0.4	4.7	11.2	5.2	0.2	7.7	0.5	1.7	0.4	0.0	3.2	3.4	0.1	0.1	2.0	0.9	6.4	2.3	0.2	2.5	6.7	5.7	8.1	7.8	7.0	4.6	6.7	4.3	8.8	5.7	0.0	1.7	0.9	2.6	0.7	0.1	2.0	0.0	0.0	1.2	1.8	0.0	2.0	0.0	3.6	0.0	1.1	0.0	0.0	0.5	0.8	3.7	1.2	11.5	0.0	19.5	0.0	0.0	0.6	23.4	0.0	6.9	13.6	0.0	11.8	0.0	2.4	1.2	10.4	1.8	1.4	0.3	0.0	3.5	0.0	0.1	1.0	3.0	1.0	1.2	1.0
GCNT7	"C20orf105, dJ1153D9.2"	ENSG00000124091	"Glucosaminyl (N-acetyl) transferase family member 7"	Q6ZNI0	20	56491492-56525925	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"blood: 3.9;bone marrow: 9.6"	"Cell type enhanced"	"Detected in single"	33	"Early spermatids: 1.7"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 3.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA052617, HPA059403"	Uncertain		Approved	"Nuclear bodies,Vesicles,Cytosol"		NA	NA			"Nuclear bodies, Vesicles"	Cytosol	"HPA052617: AB_2681886, HPA059403: "	"unprognostic (3.57e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.96e-2)"	"unprognostic (9.08e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.69e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.69e-2)"	0.2	0.2	0.0	0.7	0.0	9.6	0.3	0.6	0.3	0.0	0.2			0.3	0.2	0.0	0.3	0.1	0.5	0.1	0.0	0.0	0.1	0.3	0.4	0.4	0.0		0.5	0.5	0.0	0.6	0.1		0.3	0.0		0.4	0.0	0.3	1.0	0.4	0.0	0.1	0.5	0.3	1.6			0.3		0.0	0.6	0.3	1.0	0.9	3.9	0.7	0.3	1.1	0.1	0.6	1.0	0.8	0.5	0.0	0.0	1.1	1.0	0.0	0.0	0.0	2.1	0.5	0.1	0.4	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.1	1.2	1.7	0.5	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.5	0.0	0.4	1.0	1.5	0.0	1.3	0.7	1.4	0.5	0.1	0.7	0.1	0.4	0.5	0.0	1.9	1.0	0.5	1.2	1.0	0.2	0.5	0.8	0.2	0.0	2.2	0.4	0.5	0.6	1.6	0.1	0.5	0.3	0.6	0.5	1.1	0.7	0.9	0.8	0.5	0.8	0.7	0.7	0.5	0.4	1.0	1.1	0.4	3.9	0.3	0.7	0.9	0.9	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
GLA	GALA	ENSG00000102393	"Galactosidase alpha"	P06280	X	101397803-101407925	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 85.3;Melanocytes: 84.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 81.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000237, HPA000966"	Enhanced				"Intracellular and membrane"	NA	NA		910000			"HPA000237: AB_1078968, HPA000966: AB_1078969"	"unprognostic (7.27e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (5.62e-5)"	"unprognostic (2.53e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.73e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (1.13e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.21e-1)"	21.1	22.2	5.2	10.0	6.3	15.6	19.2	6.2	5.7	10.8	12.7	7.3	23.2	14.8	11.7	14.1	9.4	11.5	9.1	10.5	5.2	6.3	28.7	18.9	18.7	12.0	9.4	3.2	9.7	8.3	9.8	10.5	17.9	8.6	8.3	11.2	9.4	9.5	47.7	5.9	8.9	21.3	10.8	11.9	20.8	8.5	4.9	5.8	10.2	8.3	13.4	11.2	12.2	8.9	5.4	15.9	12.8	20.9	3.0	6.1	10.1	7.2	28.4	8.2	8.4	19.0	7.4	3.7	8.3	13.0	15.9	45.3	15.4	11.2	8.0	17.7	8.5	37.5	17.3	16.1	9.0	13.8	4.9	12.0	4.4	23.6	18.1	4.9	6.1	81.0	6.5	2.9	18.3	5.3	4.4	12.8	4.9	6.8	17.7	15.1	12.9	6.1	12.7	12.0	17.3	11.5	4.4	10.1	19.5	23.2	14.7	3.0	5.1	19.3	8.2	7.7	14.2	3.8	12.6	7.3	5.5	6.6	13.1	6.7	5.4	6.2	6.1	9.5	10.2	6.1	9.5	20.8	6.2	4.6	20.9	6.1	5.4	3.7	5.7	15.9	4.9	3.8	4.7	12.8	3.0	20.8	6.7	4.3	10.1	5.2	6.3	6.2	5.7	5.2	6.3	9.4	3.2	8.6	5.8	14.9	12.2	18.9	23.0	26.9	3.8	6.7	0.0	22.7	17.0	10.4	5.9	35.6	14.9	19.5	2.6	19.0	23.9	0.0	16.1	22.7	43.3	16.3	30.1	5.7	85.3	7.9	32.5	5.5	21.1	0.8	10.3	80.3	84.4	37.9	6.8	17.7	15.1	17.5	17.0	7.9	4.6	6.5	71.0	6.0	5.5	20.7	63.2	10.7	12.3	13.2
GLB1	"EBP, ELNR1"	ENSG00000170266	"Galactosidase beta 1"	P16278	3	32996608-33097230	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 139.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008382, HPA040610, HPA069503"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		1700000	Vesicles	"Golgi apparatus"	"CAB008382: AB_590642, HPA040610: AB_2677039, HPA069503: AB_2686142"	"unprognostic (1.51e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.02e-3)"	"unprognostic (9.66e-3)"	"unprognostic (9.61e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.14e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.85e-2)"	17.3	33.1	9.6	14.9	14.7	9.5	18.4	8.9	19.8	18.3	21.9	12.1	19.8	21.2	18.3	55.0	12.7	15.2	25.8	13.7	9.7	10.0	35.0	33.2	24.3	25.0	9.2	9.7	18.3	25.3	28.4	16.4	26.5	14.0	13.6	23.7	23.5	21.1	17.7	6.1	12.9	28.3	15.6	9.8	21.4	22.7	10.0	8.0	8.3	26.9	7.7	19.5	18.4	13.6	11.1	45.2	22.7	39.2	6.8	20.9	20.9	5.8	10.0	6.5	7.7	39.9	20.7	139.7	9.3	25.2	12.0	15.4	14.2	13.8	2.8	8.3	19.0	8.9	5.6	6.1	11.9	8.9	16.3	5.1	11.2	6.0	7.3	20.5	7.7	11.4	23.9	11.4	10.8	6.4	23.6	18.4	3.9	10.1	10.9	13.1	6.8	4.6	5.1	4.4	12.2	4.4	4.0	4.3	13.2	12.9	8.5	2.0	6.8	12.0	19.4	11.7	12.0	12.9	20.4	10.7	7.7	5.4	10.5	7.9	8.6	13.7	0.9	16.2	11.2	5.8	10.5	39.2	22.7	8.3	34.6	11.8	11.1	10.2	9.1	45.2	10.0	5.4	6.5	15.5	6.8	23.7	9.5	20.9	20.9	9.6	14.7	8.9	19.8	9.7	10.0	9.2	9.7	14.0	8.0	17.9	22.3	15.9	10.2	5.4	11.3	7.1	35.7	14.7	17.0	26.2	5.9	80.5	23.2	42.1	22.3	10.5	31.5	0.0	31.3	47.6	24.4	11.4	26.5	36.5	70.6	4.8	16.3	18.4	38.2	3.1	14.1	38.3	13.5	81.2	22.4	20.0	27.0	39.5	19.8	24.2	15.0	12.9	10.8	1.1	7.2	3.0	41.1	20.0	28.4	8.4
GLB1L	MGC10771	ENSG00000163521	"Galactosidase beta 1 like"	Q6UWU2	2	219236606-219245478	"Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 57.0"	"Cell type enhanced"	"Detected in many"	12	"Spermatocytes: 80.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 18.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043058	Enhanced				"Secreted - unknown location"	NA	NA					"HPA043058: AB_10806375"	"unprognostic (4.30e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.32e-2)"	"unprognostic (4.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.48e-3)"	"unprognostic (3.27e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.50e-2)"	6.9	5.4	2.7	2.0	3.7	2.3	5.6	1.6	3.3	4.0	5.8	4.6	4.5	1.6	5.3	7.9	2.5	14.3	8.6	3.4	3.1	3.5	18.5	3.5	4.1	2.5	2.1	2.1	6.1	3.1	11.7	6.7	7.4	5.6	4.5	2.0	13.2	5.8	3.0	1.4	2.5	4.4	3.4	2.3	3.9	2.1	57.0	1.4	3.1	5.0	1.4	2.4	4.0	2.0	1.7	2.8	3.2	8.9	1.4	1.8	2.2	2.4	4.3	6.7	5.4	7.4	9.1	3.4	4.1	8.7	5.2	4.9	1.6	6.9	0.8	3.7	3.6	3.9	1.3	1.9	4.0	4.1	2.2	3.3	2.5	6.2	3.9	18.3	0.9	4.0	10.8	2.5	4.9	3.0	12.3	4.6	3.8	1.5	4.8	4.8	3.5	2.1	2.5	1.1	0.9	1.2	2.2	3.7	3.4	10.5	1.4	4.3	3.9	3.4	4.8	4.0	4.7	7.5	2.2	3.6	4.4	5.3	2.5	2.2	4.6	1.3	1.3	8.1	1.1	11.0	2.0	7.0	0.5	1.1	8.9	0.6	0.6	0.9	1.1	2.8	1.7	1.8	1.3	3.2	1.4	6.7	1.2	0.3	2.2	2.7	3.7	1.6	3.3	3.1	3.5	2.1	2.1	5.6	1.4	3.0	3.2	0.8	2.5	1.5	4.8	1.7	2.5	24.1	7.9	3.5	11.8	2.9	3.3	3.1	21.1	2.5	2.1	0.0	1.6	1.5	4.4	2.7	0.0	1.0	11.7	3.2	4.7	9.8	6.1	17.2	10.0	4.5	8.5	1.0	2.8	3.5	1.7	2.3	6.0	15.3	9.5	6.5	1.2	80.3	5.4	1.5	1.1	2.1	1.7	1.6
GLT6D1	GLTDC1	ENSG00000204007	"Glycosyltransferase 6 domain containing 1"	Q7Z4J2	9	135623656-135639540	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	28	"testis: 10.3"	"Group enriched"	"Detected in some"	22	"Early spermatids: 13.2;Late spermatids: 4.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA023424	Uncertain				"Intracellular and membrane"	NA	NA					"HPA023424: AB_1849729"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0
GLT8D1	"AD-017, FLJ14611"	ENSG00000016864	"Glycosyltransferase 8 domain containing 1"	Q68CQ7	3	52694488-52706032	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010588	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA010588: AB_1078098"	"unprognostic (1.37e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (3.17e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.82e-3)"	"unprognostic (2.42e-3)"	"unprognostic (3.97e-1)"	"unprognostic (3.34e-2)"	"unprognostic (6.21e-2)"	18.6	23.7	16.1	14.5	20.9	4.7	21.0	15.3	19.9	29.3	17.3	18.3	22.1	14.6	23.5	26.8	14.1	31.9	19.9	19.3	16.6	17.0	23.2	39.4	16.8	16.0	17.9	14.4	32.4	23.6	24.3	40.8	34.7	18.1	21.1	18.9	19.7	22.0	25.2	11.5	13.0	15.2	18.7	17.4	14.8	16.0	43.3	21.6	17.5	37.8	11.6	14.7	21.8	16.8	8.6	15.7	20.5	8.4	20.1	16.3	6.6	8.1	9.7	19.7	15.5	43.7	55.6	11.0	20.6	31.9	18.2	20.9	4.5	15.5	6.9	5.9	35.7	22.0	9.3	12.4	21.1	24.1	12.4	9.0	6.5	17.8	20.6	21.0	9.7	20.5	31.9	18.8	15.6	20.2	42.3	27.0	12.0	8.3	16.0	23.8	8.3	6.5	14.9	10.0	14.4	18.2	5.0	11.2	23.3	21.2	8.9	8.1	13.9	17.1	8.4	13.9	19.2	14.1	12.8	19.7	13.2	10.3	19.1	11.4	18.1	20.5	7.7	23.1	15.5	16.6	20.5	8.4	14.1	13.3	5.7	13.2	8.6	16.0	14.3	8.1	6.4	16.3	11.5	4.8	20.1	6.0	15.7	10.6	6.6	16.1	20.9	15.3	19.9	16.6	17.0	17.9	14.4	18.1	21.6	0.0	8.1	11.5	17.3	10.8	37.5	11.3	7.6	33.5	15.9	17.4	11.8	47.2	19.9	28.5	40.0	19.6	13.1	0.0	23.8	55.2	49.3	12.9	5.7	29.3	23.5	20.6	17.9	35.0	14.5	13.6	49.8	10.6	23.6	34.3	18.6	33.9	21.1	19.2	45.6	19.8	17.9	25.8	15.9	90.1	50.7	6.9	21.9	21.5	17.5	6.7
GLT8D2	FLJ31494	ENSG00000120820	"Glycosyltransferase 8 domain containing 2"	Q9H1C3	12	103988984-104064183	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 28.7;Fibroblasts: 28.3;Ito cells: 20.9;Leydig cells: 51.8;Peritubular cells: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 27.9;BJ hTERT+: 34.4;HSkMC: 25.8;hTERT-RPE1: 20.6;RPTEC TERT1: 17.6"	"Group enriched"	"Detected in many"	5	"amygdala: 8.0;cerebral cortex: 20.1;hippocampal formation: 16.6"	"Low region specificity"	"Detected in many"			"HPA012740, HPA026904, HPA070791"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA012740: , HPA026904: AB_1849731, HPA070791: "	"unprognostic (4.02e-1)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (9.53e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.03e-2)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (1.58e-6)"	"prognostic unfavorable (7.92e-4)"	"unprognostic (7.15e-2)"	"unprognostic (7.70e-3)"	"unprognostic (7.03e-3)"	10.2	5.2	2.2	9.9	3.3	0.2	12.0	0.7	2.4	32.8	10.3	1.4	8.8	2.5	24.5	23.1	13.5	13.3	19.1	18.8	2.2	1.8	3.4	2.8	6.9	2.2	2.1	2.1	25.5	2.5	5.9	12.5	6.9	3.5	19.6	5.3	21.8	6.7	8.3	4.0	2.7	6.7	17.3	2.2	1.0	5.5	7.8	0.8	1.0	26.0	10.9	5.7	11.2	13.1	0.8	0.9	0.2	0.6	0.0	2.1	0.0	0.1	0.2	0.2	8.7	11.4	27.9	0.2	12.5	34.4	3.2	4.2	0.1	0.0	0.3	0.7	14.3	0.1	0.0	0.1	4.6	2.8	0.6	3.9	0.2	4.6	0.0	5.1	0.3	0.2	25.8	0.2	3.9	5.5	20.6	1.7	0.2	0.1	0.5	14.1	0.1	0.2	0.1	1.0	0.0	2.6	0.3	13.4	0.1	17.6	0.1	0.5	0.7	13.1	0.3	0.1	1.0	2.3	0.2	0.2	5.3	2.5	0.5	0.7	1.5	0.3	0.1	0.4	0.2	0.4	0.0	0.0	0.0	2.1	0.6	0.7	0.8	0.3	1.3	0.2	0.0	0.0	0.3	0.2	0.0	0.1	0.9	0.0	0.0	2.2	3.3	0.7	2.4	2.2	1.8	2.1	2.1	3.5	0.8	0.0	5.8	0.0	3.5	2.5	0.8	2.4	0.0	0.0	0.0	0.0	2.0	3.5	0.0	0.0	28.7	5.9	0.0	0.0	0.0	0.8	28.3	0.5	0.0	0.2	0.5	0.0	1.7	20.9	0.6	9.6	51.8	0.0	3.3	1.0	0.4	0.3	0.5	0.0	48.8	0.0	0.3	6.5	17.0	1.1	0.9	2.0	1.1	0.5	0.0	0.0
GM2A	SAP-3	ENSG00000196743	"GM2 ganglioside activator"	P17900	5	151212150-151270440	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase	"Disease mutation, Gangliosidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 108.7"	"Cell type enhanced"	"Detected in many"	9	"Extravillous trophoblasts: 163.9;Hofbauer cells: 98.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"B-cells: 15.9;dendritic cells: 19.0;monocytes: 19.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 44.5;HBEC3-KT: 61.5;hTCEpi: 61.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008063	Enhanced		Approved	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		23000000	"Vesicles, Cytosol"		"HPA008063: AB_1849842"	"unprognostic (4.33e-2)"	"unprognostic (8.97e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (1.77e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.33e-3)"	"unprognostic (9.81e-2)"	"unprognostic (4.24e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.65e-1)"	55.8	16.1	17.8	15.5	18.8	9.6	15.2	8.1	15.2	20.5	10.3	31.7	6.4	8.4	9.5	17.3	39.5	8.8	12.6	13.8	18.0	12.6	7.5	13.2	24.8	30.2	22.4	13.0	12.2	9.3	11.7	5.6	108.7	18.9	11.9	14.5	14.1	13.3	10.4	3.9	42.8	11.2	10.9	35.9	28.5	8.2	8.9	15.3	21.9	7.1	25.9	39.7	21.0	32.0	15.9	19.0	4.2	19.4	1.9	3.3	8.0	4.6	3.0	3.2	15.3	21.3	10.6	44.5	7.3	15.8	4.0	5.5	6.3	5.4	15.0	7.7	5.6	11.0	12.7	3.5	61.5	5.8	8.4	2.2	2.4	3.8	7.7	5.2	3.9	25.2	14.2	61.3	5.2	3.5	5.6	5.8	19.1	2.3	6.5	6.3	1.9	8.2	3.7	2.2	2.3	6.9	3.7	1.5	9.4	3.9	9.1	0.8	2.9	6.0	28.4	12.0	11.7	6.5	4.6	5.1	10.0	3.9	8.2	2.2	16.2	19.3	41.1	11.4	6.2	4.1	3.5	19.4	1.1	1.9	6.5	1.4	14.9	2.3	2.0	19.0	15.9	3.3	2.5	4.2	1.9	1.4	13.7	2.4	8.0	17.8	18.8	8.1	13.9	18.0	12.6	22.4	13.0	18.9	15.3	14.9	23.1	14.7	13.3	13.3	4.5	26.2	0.0	13.4	12.5	17.4	2.0	45.1	1.7	5.8	0.4	6.3	4.6	0.0	6.9	163.9	8.0	7.4	66.0	16.3	98.1	6.4	3.5	7.4	38.4	1.1	7.5	34.4	8.5	55.1	5.0	8.0	5.4	3.5	13.1	4.5	3.1	0.0	5.7	1.4	4.9	20.8	43.8	3.8	5.6	32.5
HEXA		ENSG00000213614	"Hexosaminidase subunit alpha"	P06865	15	72340919-72376476	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 207.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA018082, HPA054583"	Supported		Supported	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		20000000	Vesicles	Cytosol	"HPA018082: , HPA054583: AB_2682531"	"unprognostic (1.51e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (5.63e-8)"	"unprognostic (6.58e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.98e-1)"	"unprognostic (7.05e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (8.69e-2)"	30.1	37.4	23.1	18.0	22.9	35.5	37.8	23.3	28.1	30.6	20.5	19.4	30.1	18.5	25.9	65.7	11.7	21.8	29.2	33.8	23.4	12.8	34.6	29.5	43.9	31.4	24.9	21.1	20.9	22.2	18.1	22.9	37.9	18.8	18.1	26.0	26.9	24.8	22.0	17.7	17.9	24.6	23.4	21.4	31.5	22.6	18.0	22.9	12.1	31.2	11.1	16.4	26.7	17.1	16.1	37.9	22.4	32.7	17.8	18.1	21.3	7.5	12.8	5.5	10.6	45.5	51.9	7.9	10.6	53.8	23.0	36.8	6.7	55.4	6.3	10.2	21.3	12.0	15.1	14.6	6.7	14.6	5.1	5.8	7.9	12.7	11.6	35.2	18.9	22.7	44.1	20.2	10.0	17.9	42.2	21.0	9.4	12.2	39.2	30.6	6.5	4.1	9.5	3.1	24.7	0.1	4.2	12.0	14.2	25.7	11.9	4.8	5.3	26.5	25.1	59.9	11.7	4.6	23.9	10.6	34.5	14.4	31.7	11.2	20.9	28.2	6.5	12.5	25.3	16.7	8.9	32.7	22.4	18.1	13.7	15.8	16.1	12.0	15.8	37.9	15.6	9.5	14.0	3.1	17.8	4.8	14.4	10.7	21.3	23.1	22.9	23.3	28.1	23.4	12.8	24.9	21.1	18.8	22.9	59.6	55.5	41.1	30.3	19.7	40.2	22.6	35.7	17.4	28.4	62.8	100.1	116.3	51.4	65.3	16.3	43.0	46.2	0.0	33.3	55.3	62.5	30.5	29.9	37.8	207.1	25.4	45.3	44.2	76.0	10.5	68.7	108.5	89.4	50.5	39.4	48.4	43.8	84.5	42.1	55.5	56.1	45.3	20.6	20.4	28.2	13.7	131.8	47.5	44.4	25.0
HEXB		ENSG00000049860	"Hexosaminidase subunit beta"	P07686	5	74640023-74722647	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 174.3"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 395.6;Hofbauer cells: 319.1;Syncytiotrophoblasts: 412.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 108.4;GAMG: 90.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055409, HPA056010"	Enhanced				"Intracellular and membrane"	NA	NA		43000000			"HPA055409: AB_2682808, HPA056010: AB_2683008"	"unprognostic (3.45e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.44e-3)"	"prognostic unfavorable (3.36e-8)"	"unprognostic (2.21e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.64e-2)"	48.0	21.9	7.7	13.6	11.6	11.1	26.1	7.4	11.2	25.8	34.2	9.5	18.0	21.6	22.1	77.3	20.6	17.3	28.1	46.3	7.1	9.1	30.4	44.5	40.9	19.3	8.5	6.7	22.7	30.4	21.8	14.3	174.3	9.3	22.6	26.3	21.0	34.6	13.3	21.0	15.3	33.6	21.0	8.7	20.5	20.7	16.2	6.1	10.8	33.7	15.2	15.4	24.0	19.7	8.9	59.8	23.8	65.9	7.6	16.4	42.9	20.3	16.0	5.6	18.5	108.4	33.5	18.2	25.0	81.1	24.4	53.0	18.8	26.6	0.0	19.8	20.5	90.2	16.4	6.0	25.4	32.3	11.4	10.8	2.6	15.5	14.1	31.8	2.2	22.0	29.5	15.0	25.6	17.2	38.5	27.9	6.4	7.5	33.3	26.7	20.6	2.6	5.1	5.2	19.3	7.2	6.2	8.1	26.5	16.8	18.6	3.6	4.5	19.4	13.2	24.1	10.1	13.9	15.1	16.6	16.1	4.0	29.6	23.0	15.4	26.5	0.1	36.7	20.0	29.2	14.5	65.9	18.6	14.2	24.5	16.4	8.9	11.7	13.1	59.8	5.5	11.2	10.9	23.8	7.6	14.6	18.0	13.7	42.9	7.7	11.6	7.4	11.2	7.1	9.1	8.5	6.7	9.3	6.1	38.7	35.5	39.5	70.4	39.0	9.5	18.9	63.7	20.1	18.2	27.9	7.9	395.6	16.6	123.0	1.1	60.6	71.9	0.0	111.0	143.1	100.1	65.8	69.2	62.8	319.1	9.5	21.9	83.4	134.6	1.7	78.9	151.2	69.2	83.8	50.0	34.8	68.2	51.8	67.8	65.5	10.6	45.3	54.5	0.2	1.1	28.4	412.8	37.3	76.2	54.8
KDSR	"DHSR, FVT1, SDR35C1"	ENSG00000119537	"3-ketodihydrosphingosine reductase"	Q06136	18	63327726-63367510	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation, Palmoplantar keratoderma, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-266/70: 38.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003673, HPA044884"	Approved					NA	NA					"CAB003673: AB_425440, HPA044884: AB_2679131"	"unprognostic (4.44e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.56e-2)"	"unprognostic (5.88e-3)"	"unprognostic (7.50e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.81e-2)"	"prognostic favorable (9.53e-6)"	"unprognostic (3.32e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.16e-3)"	21.1	19.4	19.0	11.1	22.4	6.4	29.7	12.5	17.2	18.2	17.3	23.9	14.2	10.0	19.4	30.0	17.8	14.3	17.7	15.8	19.7	16.9	21.3	52.6	15.3	11.5	32.1	14.6	29.1	14.3	19.6	10.5	24.9	19.5	18.0	11.0	15.9	16.1	17.4	12.4	28.8	13.1	18.9	39.0	9.1	11.8	10.4	23.3	8.8	21.2	12.3	9.9	19.9	22.8	4.0	5.6	0.9	5.6	9.8	19.5	3.7	5.9	2.7	2.8	3.1	22.4	16.8	5.5	19.8	12.2	4.4	5.9	1.1	4.1	6.1	8.5	7.7	7.3	26.5	3.5	11.1	5.4	11.4	5.9	4.7	3.6	1.3	17.1	8.5	3.3	16.0	21.2	7.0	20.1	8.1	4.3	4.1	3.7	8.7	11.6	2.4	9.4	3.9	3.3	1.5	10.0	6.4	8.3	8.6	12.1	3.9	3.6	6.9	9.6	4.7	8.5	3.8	2.5	4.9	10.1	18.6	4.5	6.2	8.6	38.2	17.4	3.5	14.0	5.3	5.5	0.0	3.7	0.3	4.8	5.6	19.5	4.0	10.2	7.6	5.6	3.6	7.3	4.6	0.9	9.8	2.6	2.8	12.9	3.7	19.0	22.4	12.5	15.9	19.7	16.9	32.1	14.6	19.5	23.3	32.8	41.4	40.4	112.3	140.9	36.2	21.8	68.8	46.8	48.9	36.6	25.5	53.1	13.3	45.0	0.7	35.9	29.0	0.0	32.1	57.8	53.6	62.1	25.4	77.0	31.7	38.1	19.7	44.8	25.0	3.6	65.9	36.3	54.0	30.7	30.6	57.7	41.5	46.0	66.4	36.6	40.8	32.3	42.2	0.9	5.3	125.1	76.4	20.3	40.8	94.6
LCT		ENSG00000115850	Lactase	P09848	2	135787840-135837180	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	133	"intestine: 255.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	19	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 1.9"	"Group enriched"	"Detected in some"	4	"JURKAT: 3.6;MOLT-4: 6.9;RPMI-8226: 13.7"	"Region enriched"	"Detected in single"	16	"hippocampal formation: 17.3"											NA	NA						"unprognostic (2.21e-2)"	"unprognostic (1.65e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.39e-2)"	"unprognostic (8.03e-4)"	"unprognostic (3.55e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.64e-4)"	"unprognostic (4.90e-2)"	"unprognostic (8.92e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.02e-1)"	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.1	0.1	209.8	0.0	0.0	67.7	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	255.5	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.7	0.0	0.0	6.9	1.1	0.0	0.0	0.0	1.6	0.0	13.7	0.0	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.1	0.2	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LPIN1	KIAA0188	ENSG00000134324	"Lipin 1"	Q14693	2	11677595-11827409	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 88.4"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1310.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 38.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024591, HPA038021"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA024591: , HPA038021: AB_10669514"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.02e-1)"	18.1	10.1	13.0	10.7	18.3	6.0	22.1	20.0	16.4	10.5	8.6	10.9	7.3	8.9	11.0	15.0	20.0	7.0	10.4	12.8	11.6	11.9	7.6	13.2	8.0	15.4	13.2	11.2	19.3	7.5	17.2	32.0	9.0	17.9	9.6	7.1	9.0	14.4	11.6	88.4	6.5	9.2	11.0	10.3	8.4	7.6	39.0	13.2	8.3	8.1	14.0	19.2	10.4	21.7	6.5	9.6	11.6	2.8	8.0	11.1	3.2	5.5	6.6	5.5	12.3	25.5	28.4	2.8	7.8	13.4	5.0	8.7	2.4	5.5	2.7	1.0	6.6	14.8	6.0	6.2	17.0	4.6	11.4	3.4	6.8	3.7	3.5	9.0	4.7	32.1	25.6	7.7	20.8	7.9	14.7	9.7	6.7	9.4	24.7	3.7	2.1	4.4	4.1	5.7	1.8	6.7	6.1	10.1	17.3	12.7	3.6	15.3	12.1	2.8	6.8	17.5	5.5	1.7	2.6	6.8	8.0	7.2	5.1	6.7	38.8	30.0	5.2	11.3	8.4	5.9	9.5	2.8	11.6	10.3	2.1	11.1	6.5	9.6	9.7	2.5	5.0	8.4	7.1	1.1	8.0	2.1	9.6	10.5	3.2	13.0	18.3	20.0	14.4	11.6	11.9	13.2	11.2	17.9	13.2	20.8	49.1	22.9	38.9	16.9	40.6	49.5	25.5	61.6	63.7	10.4	80.5	7.3	6.6	18.7	314.7	24.6	9.7	0.0	24.2	5.3	24.6	29.2	33.6	21.9	8.1	46.1	34.7	15.4	15.7	1310.7	110.1	27.2	16.9	7.2	23.9	16.4	25.5	11.6	169.0	3.4	47.2	32.3	20.6	18.4	17.8	10.5	10.3	57.5	13.6	26.8
LPIN2	KIAA0249	ENSG00000101577	"Lipin 2"	Q92539	18	2916994-3013315	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase	"Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 83.9"	"Cell type enhanced"	"Detected in all"	5	"Cholangiocytes: 140.1;Hepatocytes: 111.5;Horizontal cells: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"granulocytes: 20.8;NK-cells: 10.1;T-cells: 9.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015223, HPA017857, HPA030550"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		Yes	No			Cytosol	"Plasma membrane, Actin filaments"	"CAB015223: , HPA017857: AB_1852904, HPA030550: AB_2673519"	"unprognostic (7.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (8.01e-4)"	"unprognostic (9.85e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.44e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.15e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-2)"	6.8	5.6	13.0	10.5	18.4	9.2	7.7	11.9	16.5	6.6	25.2	10.4	2.4	31.6	6.7	3.9	5.9	6.3	14.3	5.1	11.0	14.5	20.7	83.9	11.8	11.8	11.2	9.8	8.8	9.0	9.7	8.2	16.3	15.3	5.8	7.4	6.8	4.4	5.3	2.2	2.7	43.3	6.1	9.6	10.7	15.6	13.5	9.6	6.3	7.5	1.5	10.0	6.8	6.7	1.2	1.1	20.8	2.0	10.1	9.5	2.1	4.9	6.7	10.6	3.7	18.4	17.1	6.3	12.0	14.6	11.9	11.6	8.7	4.2	3.6	7.3	18.3	18.6	0.2	8.7	3.7	9.4	7.0	1.8	9.2	5.2	9.9	17.2	7.3	10.2	17.2	2.5	11.8	10.3	17.3	14.8	8.8	8.3	1.9	16.7	3.7	9.1	6.3	3.4	7.4	9.6	16.1	9.2	13.4	9.5	11.1	9.0	6.2	11.2	5.3	3.8	6.4	0.0	10.1	20.8	15.4	18.7	19.7	8.8	3.5	5.3	7.8	13.6	7.5	5.4	6.5	2.0	6.1	9.3	1.3	9.5	0.9	7.1	5.3	0.8	1.2	7.3	4.7	20.8	10.1	0.6	1.1	6.3	2.1	13.0	18.4	11.9	16.5	11.0	14.5	11.2	9.8	15.3	9.6	62.5	38.2	16.9	8.2	4.9	31.9	10.4	140.1	21.4	35.2	36.6	13.7	17.4	14.9	9.7	2.1	17.5	52.0	46.7	16.6	9.6	15.9	14.5	11.6	111.5	19.6	109.7	14.3	20.3	21.0	6.9	21.0	19.9	8.5	24.4	30.3	16.0	18.6	10.5	29.4	40.8	14.8	6.5	9.9	28.8	59.6	1.8	41.4	39.9	11.9	3.4
LPIN3	"LIPN3L, SMP2"	ENSG00000132793	"Lipin 3"	Q9BQK8	20	41340920-41360582	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 49.1"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 49.9;Late spermatids: 82.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 6.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.8;NK-cells: 6.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA051466, HPA052667, HPA070640"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA051466: , HPA052667: AB_2681908, HPA070640: AB_2686288"	"unprognostic (2.31e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (9.74e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.91e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (4.29e-2)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.37e-3)"	11.6	3.7	3.0	8.1	5.2	0.1	23.4	1.5	3.0	10.9	29.2	2.8	13.5	26.8	12.8	21.6	16.3	7.5	11.2	8.8	3.6	0.7	28.2	14.4	4.5	1.6	2.8	3.7	7.9	7.4	8.1	6.7	4.4	4.2	10.1	8.8	8.7	11.0	15.1	1.8	26.1	49.1	5.5	2.4	2.7	7.4	2.5	1.5	1.2	14.2	10.6	9.0	8.0	12.5	0.9	0.7	1.8	0.9	6.3	0.8	0.2	6.9	6.8	0.4	4.1	11.2	17.5	5.3	4.3	6.0	5.3	7.2	12.7	6.2	0.3	5.4	9.4	5.6	17.7	2.1	11.2	3.3	0.1	4.0	0.3	9.6	6.4	1.8	0.0	4.8	12.6	14.3	8.9	3.5	6.2	1.3	0.1	1.8	0.2	6.6	14.9	0.0	0.1	0.6	4.3	7.1	0.0	0.1	0.5	18.4	8.8	0.5	0.1	5.7	7.4	3.6	3.5	8.6	3.5	0.4	0.3	1.7	5.9	0.0	3.4	1.8	0.0	0.1	0.1	0.3	1.8	0.5	0.7	0.5	0.5	0.8	0.6	0.7	0.4	0.3	0.9	0.7	0.6	1.8	6.3	0.9	0.7	0.5	0.2	3.0	5.2	1.5	3.0	3.6	0.7	2.8	3.7	4.2	1.5	6.0	10.5	0.8	8.2	12.8	0.0	0.6	10.2	1.4	4.5	10.4	0.0	2.3	5.0	7.4	10.4	2.1	49.9	0.0	3.3	2.2	7.7	3.5	1.1	33.7	2.7	0.0	14.3	4.3	1.3	82.8	2.8	1.5	10.1	0.0	16.6	7.5	5.5	21.6	2.5	5.9	0.3	32.3	6.4	0.9	2.1	11.0	2.2	1.3	16.2	3.9
MGAT4D	GnT1IP	ENSG00000205301	"MGAT4 family member D"	A6NG13	4	140442262-140498377	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	56	"testis: 33.8"	"Cell type enhanced"	"Detected in some"	33	"Early spermatids: 12.4;Late spermatids: 20.4;Spermatocytes: 70.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEL: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036523	Enhanced					NA	NA					"HPA036523: AB_10670110"										"unprognostic (2.70e-1)"		"unprognostic (3.16e-2)"						0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	70.7	1.0	0.0	0.0	0.0	0.0	0.0
MGAT5B	"FLJ25132, GnT-IX, GnT-VB"	ENSG00000167889	"Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B"	Q3V5L5	17	76868456-76950393	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 28.1"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 5.1;Early spermatids: 6.3;Extravillous trophoblasts: 2.8;Late spermatids: 6.8"	"Group enriched"	"Detected in many"	5	"glioma: 2.6;melanoma: 7.1;testis cancer: 2.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 21.8;SCLC-21H: 11.2;U-138 MG: 13.2;U-2 OS: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011082			Approved	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	No			"Nucleoplasm, Mitotic spindle"	"Cytokinetic bridge"	"HPA011082: AB_2668423"	"unprognostic (6.37e-2)"	"unprognostic (9.16e-3)"	"unprognostic (8.51e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.68e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.52e-3)"	"unprognostic (5.30e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.46e-7)"	"unprognostic (1.66e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.01e-1)"	1.1	1.2	9.3	1.1	13.4	1.0	0.9	4.4	28.1	1.0	0.9	1.1	0.0	0.8	1.1	0.7	0.9	1.0	0.9	0.8	5.5	2.8	0.9	0.7	1.0	0.9	2.3	8.1	1.2	0.8	1.0	0.6	1.1	2.6	0.8	0.8	1.1	0.8	0.8	0.7	0.9	0.9	0.8	0.7	1.4	1.0	2.3	1.7	0.0	0.8	0.0	0.9	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	21.8	4.4	2.2	0.0	0.0	2.3	0.3	0.9	8.0	4.7	0.0	0.5	0.0	1.7	1.0	9.4	0.1	1.0	0.2	2.1	0.0	0.3	0.0	1.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	1.3	3.6	1.4	0.4	0.1	0.0	0.0	1.0	0.0	0.0	1.2	0.5	2.3	3.0	3.9	4.5	6.2	0.0	11.2	4.3	3.8	1.7	3.4	0.2	0.1	0.1	4.0	13.2	14.3	0.2	4.1	0.0	0.0	0.5	0.4	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	13.4	4.4	27.4	5.5	2.8	2.3	8.1	2.6	1.7	0.0	0.0	0.0	0.1	0.1	5.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	2.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	6.8	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	2.1	0.0	0.2	0.9	2.2	0.0	0.1	0.0	0.0	0.0
NAGA	D22S674	ENSG00000198951	Alpha-N-acetylgalactosaminidase	P17050	22	42058354-42070842	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Cancer-related genes, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 80.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"classical monocyte: 38.5;intermediate monocyte: 47.6;myeloid DC: 37.9;non-classical monocyte: 46.1;plasmacytoid DC: 23.2"	"Group enriched"	"Detected in all"	9	"dendritic cells: 37.9;monocytes: 47.6"	"Cell line enhanced"	"Detected in all"		"HMC-1: 66.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000649	Enhanced				"Intracellular and membrane"	NA	NA		2300000			"HPA000649: AB_1079448"	"unprognostic (3.74e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.27e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.92e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.53e-1)"	23.7	13.5	12.1	20.3	14.5	11.3	12.5	11.8	10.3	16.3	18.3	15.0	10.7	13.2	18.9	16.1	14.5	17.3	16.5	15.8	10.1	8.6	17.9	28.2	19.9	32.6	12.6	7.3	18.1	9.5	27.8	13.1	45.3	11.5	15.2	18.0	19.8	16.6	14.5	9.2	9.9	25.6	18.7	11.4	22.0	14.1	9.3	13.2	12.0	15.0	11.4	17.9	17.3	14.5	2.1	37.9	4.9	47.6	3.4	3.4	19.2	9.2	4.7	7.5	13.4	13.1	15.1	5.5	7.6	15.7	13.2	13.8	10.5	13.6	4.5	4.7	16.6	8.0	6.5	5.7	9.3	7.9	10.3	7.2	11.2	7.3	7.1	7.7	9.2	66.6	10.3	8.2	11.8	5.0	6.8	21.8	3.9	4.0	19.3	10.4	10.7	3.4	3.8	2.0	8.4	6.3	7.6	3.8	8.0	10.2	11.0	2.3	2.6	10.1	9.3	10.0	6.9	13.9	17.1	11.7	9.3	11.4	5.9	6.9	10.7	10.7	3.6	9.9	17.7	11.4	4.9	38.5	4.6	2.8	47.6	2.8	2.1	2.9	2.6	37.9	1.5	1.9	1.8	1.9	3.4	46.1	23.2	3.4	19.2	12.1	14.5	11.8	10.3	10.1	8.6	12.6	7.3	11.5	13.2	8.9	7.0	6.7	6.8	3.0	2.8	3.4	5.1	16.0	7.9	7.0	7.9	40.8	3.3	14.3	9.9	6.0	26.2	23.3	7.2	55.8	12.9	7.8	9.2	29.8	80.8	0.0	5.8	9.2	52.1	12.0	6.6	49.9	18.6	47.7	13.7	5.6	11.1	19.5	6.3	8.4	5.7	19.4	12.3	10.5	5.3	3.0	48.7	7.7	12.1	8.6
NEU1	NEU	ENSG00000204386	"Neuraminidase 1"	Q99519	6	31857659-31862906	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 38.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015634, HPA021506"	Approved		Supported	"Vesicles,Cell Junctions"		NA	NA		86000	Vesicles	"Cell Junctions"	"HPA015634: AB_1854386, HPA021506: AB_1854385"	"unprognostic (3.84e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.38e-3)"	"unprognostic (8.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.13e-3)"	10.5	30.2	8.6	9.4	11.1	5.2	10.5	15.5	14.6	13.4	14.1	7.4	16.1	14.1	9.8	13.9	9.0	8.3	16.1	9.8	8.0	9.5	29.7	24.2	16.1	7.2	9.4	6.6	12.7	20.6	13.6	16.5	19.8	10.3	15.1	9.1	14.7	18.1	13.8	10.0	9.1	23.5	9.8	4.7	13.4	12.7	6.5	10.0	5.8	22.7	7.0	9.6	13.6	9.5	4.2	7.7	15.2	13.4	3.0	5.1	7.4	2.4	2.4	2.4	5.6	8.2	3.1	4.8	2.2	7.5	6.5	9.6	14.1	2.6	0.8	5.7	2.9	38.4	1.3	5.1	2.0	2.5	2.0	3.4	1.2	1.4	16.5	14.7	1.5	6.9	5.1	3.8	7.9	4.1	3.9	5.8	1.6	2.6	5.8	3.3	4.3	1.2	2.3	1.9	4.3	1.9	1.7	1.3	8.5	10.8	5.2	1.8	1.1	2.4	3.3	5.8	3.2	6.2	7.1	2.4	4.3	2.5	6.0	3.9	7.2	11.5	1.7	3.1	3.9	3.0	6.4	13.4	8.7	5.1	10.3	4.2	3.9	3.9	4.1	7.7	4.2	4.0	3.9	15.2	3.0	9.2	4.3	4.8	7.4	8.6	11.1	15.5	14.6	8.0	9.5	9.4	6.6	10.3	10.0	23.8	47.7	44.6	42.4	30.5	24.5	18.7	38.2	10.7	17.0	45.4	23.6	52.4	8.3	82.1	0.8	27.6	80.5	0.0	51.5	49.0	63.2	112.7	66.9	21.3	139.8	9.5	108.9	26.4	42.3	0.7	25.6	53.4	67.4	25.2	37.4	48.4	45.4	80.7	21.9	55.3	29.8	25.8	42.2	5.0	7.5	36.4	164.8	28.7	38.6	31.8
NEU2	SIAL2	ENSG00000115488	"Neuraminidase 2"	Q9Y3R4	2	233032672-233035057	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	16	"skin 1: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 1.1;BEWO: 1.6;PC-3: 3.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 2.2;hippocampal formation: 1.1"	CAB022336	Uncertain					NA	NA		9000			"CAB022336: "						"unprognostic (1.30e-1)"												0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0			0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NEU3		ENSG00000162139	"Neuraminidase 3"	Q9UQ49	11	74988134-75018893	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 44.6"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 58.9;Spermatocytes: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038729, HPA070381"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA038729: AB_2676179, HPA070381: "	"unprognostic (1.67e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.95e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.91e-3)"	"unprognostic (8.50e-2)"	"prognostic favorable (5.98e-4)"	"unprognostic (3.57e-3)"	"unprognostic (3.80e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.84e-1)"	5.4	13.4	3.7	10.5	6.9	17.0	5.4	7.9	9.1	4.0	3.9	3.0	4.1	3.6	5.4	4.8	3.9	4.4	3.6	5.9	4.0	4.5	4.3	6.7	8.7	9.0	3.8	6.6	7.2	7.3	15.1	11.2	3.1	4.2	9.7	5.4	5.6	4.8	4.6	19.1	6.7	4.7	4.0	3.5	5.5	5.1	44.6	3.0	19.0	6.8	3.5	7.5	4.5	3.1	3.2	3.8	5.8	6.4	1.2	4.2	2.2	4.6	4.0	3.4	6.6	2.6	2.5	3.8	4.5	2.9	5.2	4.0	13.7	3.9	13.3	4.6	3.6	6.6	4.3	8.2	5.8	7.9	7.0	4.4	10.9	7.4	5.6	2.9	17.2	10.6	3.0	4.9	5.2	8.1	3.4	3.7	19.0	17.7	10.0	5.9	5.0	16.9	8.9	4.2	9.1	5.4	14.8	9.0	11.7	6.4	4.9	6.3	4.0	6.9	4.6	20.2	4.2	9.8	4.4	5.6	6.5	6.5	4.3	4.5	8.2	8.0	26.6	1.9	8.9	5.5	2.1	6.4	5.8	4.1	3.7	3.0	2.8	3.2	3.9	3.8	3.2	3.5	4.2	3.3	1.2	4.6	2.7	2.3	2.2	3.7	6.9	7.9	9.1	4.0	4.5	3.8	6.6	4.2	3.0	3.0	5.8	2.2	1.8	0.5	7.2	7.3	2.5	2.7	4.5	1.8	58.9	1.8	0.0	1.0	5.7	1.6	1.3	0.0	2.6	1.2	1.5	2.7	1.1	7.2	4.8	11.1	6.9	4.3	8.6	5.3	1.4	4.5	0.0	4.6	2.9	2.9	2.7	0.0	1.8	3.3	5.8	0.0	2.2	32.5	1.7	0.5	1.1	3.5	3.2	0.4
OGT	"FLJ23071, HRNT1, MGC22921, O-GLCNAC, OGT1"	ENSG00000147162	"O-linked N-acetylglucosamine (GlcNAc) transferase"	O15294	X	71533083-71575897	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	"Chromatin regulator, Glycosyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030751, HPA030752, HPA030753, HPA030754, CAB034099"	Approved		Supported	"Nucleoplasm,Plasma membrane"		Yes	No			Nucleoplasm	"Plasma membrane"	"CAB034099: AB_2157067, HPA030751: AB_10600217, HPA030752: AB_10601445, HPA030753: AB_2673594, HPA030754: AB_2673595"	"unprognostic (1.37e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (8.33e-4)"	"unprognostic (3.40e-2)"	"prognostic favorable (1.97e-4)"	"unprognostic (9.56e-3)"	"unprognostic (1.96e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.74e-3)"	"prognostic unfavorable (2.36e-6)"	"unprognostic (2.99e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.03e-3)"	"prognostic favorable (6.85e-7)"	26.1	24.0	33.3	39.7	36.6	38.7	33.7	75.7	43.8	25.0	23.0	22.0	31.1	22.5	36.7	48.3	24.3	33.4	21.2	25.1	29.3	15.4	27.4	20.3	31.0	47.9	30.2	25.6	42.8	46.1	26.5	34.5	19.5	26.6	34.2	30.3	29.9	35.9	30.9	35.0	45.4	38.4	31.1	32.3	56.7	28.2	11.8	36.6	35.7	34.1	27.6	41.4	24.9	31.0	9.7	7.6	3.2	7.2	12.5	9.9	6.0	14.2	13.3	17.3	15.2	18.7	17.3	11.7	10.9	19.8	11.9	18.3	14.0	16.4	17.0	7.7	13.4	12.4	17.8	18.9	10.7	14.7	14.5	19.4	10.7	31.9	10.0	14.2	22.0	17.8	16.5	21.8	13.0	24.6	20.6	11.1	36.5	10.8	59.1	11.3	12.1	16.9	26.5	11.5	12.7	18.3	16.8	19.5	21.7	18.4	16.5	8.9	7.8	17.0	11.3	10.5	13.7	8.3	15.0	12.8	12.9	10.5	13.4	6.3	16.1	11.6	20.4	9.1	23.2	7.8	3.2	5.3	2.3	9.9	7.2	9.0	9.7	8.3	8.0	7.5	8.5	9.7	9.5	2.4	12.5	6.5	7.6	7.6	6.0	33.3	36.6	75.7	43.8	29.3	15.4	30.2	25.6	26.6	36.6	32.8	80.7	38.6	31.8	78.3	24.7	38.6	20.4	20.1	31.8	47.1	7.9	11.8	8.3	11.5	1.7	42.7	29.0	46.7	12.1	7.0	45.0	42.9	26.6	24.9	14.0	38.1	33.6	45.4	64.9	1.8	49.5	36.1	33.7	15.4	36.2	13.8	15.0	31.6	28.0	12.2	23.2	32.3	32.5	1.8	6.0	73.5	9.2	59.0	30.2	38.6
PIGB		ENSG00000069943	"Phosphatidylinositol glycan anchor biosynthesis class B"	Q92521	15	55318960-55355648	"Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039929	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039929: AB_10673539"	"unprognostic (1.91e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.52e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.56e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.93e-2)"	"unprognostic (4.24e-2)"	9.5	11.9	5.7	13.0	11.9	11.2	10.4	3.9	9.3	7.1	8.5	8.2	6.6	9.1	10.5	13.2	11.1	9.5	10.0	6.3	5.9	5.9	12.4	10.3	8.8	20.1	6.9	6.8	8.7	8.1	19.2	12.5	8.7	8.6	9.7	9.4	13.0	9.6	8.4	3.2	8.1	11.6	7.0	8.9	14.2	9.3	17.4	6.0	11.5	16.3	6.2	16.2	10.7	9.3	8.4	8.1	20.1	11.5	5.6	8.9	6.4	7.5	8.7	4.0	3.1	4.4	9.0	5.7	6.3	12.7	7.1	11.4	3.8	7.9	7.3	8.4	8.8	11.0	12.7	2.5	6.6	6.0	7.3	5.7	7.2	10.9	4.7	7.9	20.5	6.3	9.4	8.2	5.6	7.2	9.1	8.8	6.6	8.5	6.2	9.4	6.6	2.5	8.0	2.5	5.8	4.4	3.2	3.9	16.7	11.0	8.3	2.3	4.5	5.8	9.4	11.0	3.8	10.1	14.9	6.7	9.6	3.2	2.5	12.7	6.2	11.1	6.5	8.5	23.1	6.9	10.5	8.9	4.1	8.3	10.4	8.9	8.4	8.3	8.6	8.1	5.4	7.0	7.8	20.1	5.6	11.5	6.3	8.6	6.4	5.7	11.9	3.9	9.3	5.9	5.9	6.9	6.8	8.6	6.0	8.9	7.4	8.6	8.7	4.0	2.7	2.6	2.5	8.1	12.5	0.0	11.8	10.0	1.7	6.2	16.8	4.5	5.2	0.0	9.7	9.3	4.1	4.1	8.1	3.8	7.5	1.6	6.3	7.4	6.5	2.4	1.4	6.3	3.3	8.2	3.7	3.1	5.9	4.2	1.4	8.2	9.1	6.5	4.7	2.6	3.0	3.4	5.5	8.6	3.7	3.3
PIGM	GPI-MT-I	ENSG00000143315	"Phosphatidylinositol glycan anchor biosynthesis class M"	Q9H3S5	1	160024953-160031991	"Disease related genes, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047418	Uncertain					NA	NA					"HPA047418: AB_2680039"	"unprognostic (1.55e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.89e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.85e-2)"	"prognostic favorable (3.27e-4)"	"unprognostic (2.63e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.01e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.50e-1)"	6.5	9.1	7.4	6.7	9.9	2.9	9.7	7.7	8.7	7.9	6.7	17.1	8.8	7.8	7.3	11.7	8.0	7.3	7.7	6.2	7.6	6.7	7.7	14.9	6.6	7.1	17.3	5.2	8.8	18.3	14.9	10.4	6.2	12.6	11.3	7.9	10.2	10.5	9.1	3.0	9.8	8.4	5.8	21.8	8.0	9.1	9.6	12.5	14.9	11.0	3.1	7.5	7.8	6.1	6.2	10.4	8.3	14.6	9.5	10.6	7.7	5.0	4.6	5.7	8.2	7.5	6.3	1.9	7.7	4.9	5.1	4.8	2.5	9.5	3.6	6.3	5.0	4.4	10.4	6.2	6.2	6.6	7.6	6.6	8.3	6.0	3.7	4.6	10.6	6.5	5.6	4.1	6.1	4.8	4.5	4.3	8.0	4.4	6.8	5.9	8.5	6.8	5.7	5.9	9.5	6.6	2.2	5.8	15.7	5.6	7.0	8.0	12.4	8.4	9.9	6.0	5.7	18.7	12.7	6.0	6.8	6.0	10.1	4.7	12.4	13.6	0.2	6.2	5.5	7.5	8.3	14.6	5.6	8.1	11.4	8.4	5.8	8.3	6.4	8.8	6.2	10.6	8.3	2.6	9.5	14.2	10.4	8.5	7.7	7.4	9.9	7.7	8.7	7.6	6.7	17.3	5.2	12.6	12.5	11.9	16.6	6.1	4.5	3.8	14.8	3.7	20.4	13.4	17.0	15.7	9.8	6.5	1.7	11.1	4.3	8.4	7.5	0.0	15.9	3.1	6.7	5.8	4.7	19.2	6.4	15.9	12.1	12.9	12.7	2.3	7.8	5.8	8.5	3.6	13.9	38.7	10.4	3.5	8.5	5.5	11.7	19.4	4.4	24.7	8.3	4.0	1.5	4.8	11.1	3.0
PIGV	FLJ20477	ENSG00000060642	"Phosphatidylinositol glycan anchor biosynthesis class V"	Q9NUD9	1	26787472-26798398	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Late spermatids: 65.1;Spermatocytes: 82.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054181			Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			Cytosol	"Endoplasmic reticulum"	"HPA054181: "	"unprognostic (2.08e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.44e-2)"	"prognostic favorable (7.60e-7)"	"unprognostic (1.71e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.92e-2)"	"unprognostic (5.96e-3)"	6.2	14.6	8.1	5.3	8.9	4.6	9.2	6.1	10.3	10.5	7.5	9.9	9.3	7.3	8.3	14.7	8.7	10.6	8.9	4.4	7.2	6.6	10.6	24.6	6.8	5.1	11.6	6.8	9.0	13.5	15.8	13.5	9.3	9.7	11.5	8.4	6.6	9.9	10.6	5.0	10.1	10.7	7.1	7.5	7.2	7.7	31.3	10.0	7.2	20.0	8.2	7.8	9.3	7.6	8.3	9.7	23.5	12.9	18.0	19.1	9.2	9.4	5.7	4.6	4.0	8.9	11.0	3.9	6.5	15.4	6.2	7.6	3.1	19.6	5.6	5.9	8.1	6.9	16.9	2.4	7.6	7.7	9.5	4.0	4.9	7.6	7.8	10.0	8.9	12.1	11.4	31.6	8.5	10.4	13.2	4.7	9.1	8.9	9.0	11.1	5.3	4.4	5.0	6.9	13.9	4.6	3.2	5.3	10.6	9.8	2.4	6.6	3.5	6.4	3.2	6.3	8.3	11.0	4.4	7.8	11.2	4.8	5.4	2.2	3.2	2.1	3.0	9.2	9.5	6.6	23.5	10.3	7.7	13.3	10.1	19.1	7.4	9.0	13.0	9.7	8.3	9.1	11.1	12.5	18.0	12.9	3.8	7.7	9.2	8.1	8.9	6.1	10.3	7.2	6.6	11.6	6.8	9.7	10.0	3.0	5.9	6.7	10.3	3.8	2.9	1.8	2.5	8.1	1.2	7.0	7.9	22.6	6.6	6.3	40.4	5.0	6.1	23.3	4.0	12.3	8.7	6.7	0.0	14.1	8.1	7.9	3.4	7.4	4.7	65.1	6.6	4.0	6.8	10.0	6.5	10.3	4.6	2.9	9.2	7.9	2.7	0.0	5.1	82.9	13.9	3.6	11.8	6.1	9.8	5.8
PIGZ	"FLJ12768, MGC52163, SMP3"	ENSG00000119227	"Phosphatidylinositol glycan anchor biosynthesis class Z"	Q86VD9	3	196946343-196969060	"Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 26.5"	"Group enriched"	"Detected in many"	4	"Enterocytes: 66.9;Mucus-secreting cells: 56.2;Paneth cells: 75.0;Undifferentiated cells: 35.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.3"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.6;granulocytes: 1.4;monocytes: 3.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA058599, HPA059920"	Approved					NA	NA					"HPA058599: AB_2683771, HPA059920: AB_2684162"	"unprognostic (1.46e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.25e-3)"	"unprognostic (4.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (5.60e-5)"	"unprognostic (1.02e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.38e-5)"	"unprognostic (5.02e-3)"	6.6	3.1	5.7	5.3	8.6	1.9	3.4	18.5	16.3	3.3	26.5	3.2	2.0	2.9	2.3	1.7	3.2	2.8	4.5	6.4	5.3	7.5	1.6	1.6	3.1	2.0	4.4	6.4	0.8	5.9	2.7	2.9	2.1	10.8	4.6	24.5	4.3	4.7	4.6	10.0	4.5	7.4	5.3	2.8	1.8	3.1	1.4	3.0	3.2	1.7	2.8	2.1	9.9	2.9	0.1	1.6	1.4	3.3	0.0	0.2	0.3	2.0	1.4	0.8	3.3	9.3	4.5	0.9	3.0	8.6	2.3	1.9	1.9	1.7	0.3	6.1	6.8	1.6	3.5	0.2	0.4	0.6	0.6	0.4	0.9	0.7	7.4	4.4	0.0	3.4	4.5	6.6	0.3	1.1	2.6	2.9	5.5	0.2	2.6	2.3	3.6	0.3	1.7	0.1	2.5	1.1	0.5	0.1	0.6	3.6	3.8	1.3	1.5	4.3	0.4	1.6	0.4	8.5	3.0	7.0	1.9	0.5	5.5	1.0	1.2	0.2	0.1	0.4	1.2	0.7	0.0	1.1	0.8	0.2	3.3	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.1	1.4	0.0	1.4	0.3	0.0	0.3	5.7	8.6	18.5	16.3	5.3	7.5	4.4	6.4	10.8	3.0	0.0	0.6	3.7	8.0	6.9	6.1	6.5	2.5	1.4	1.2	8.7	2.0	0.0	5.0	1.9	1.7	4.4	66.9	0.0	3.2	0.0	2.3	9.3	5.7	7.3	1.7	14.3	13.3	12.3	4.9	3.1	3.7	1.1	8.5	2.8	56.2	1.5	2.8	75.0	6.0	2.1	6.9	0.0	8.5	0.5	0.1	4.4	0.1	1.9	35.8	10.1
PLPP1	"LPP1, PAP-2a, PPAP2A"	ENSG00000067113	"Phospholipid phosphatase 1"	O14494	5	55424854-55535050	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Ito cells: 254.8;Leydig cells: 203.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 200.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 93.3;fHDF/TERT166: 28.4;HMC-1: 48.9;HSkMC: 35.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033331, HPA047815"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB033331: AB_2168044, HPA047815: AB_2680164"	"unprognostic (1.22e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (6.06e-4)"	"unprognostic (2.81e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (3.94e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.11e-2)"	56.3	26.7	12.5	14.8	14.6	0.6	57.9	10.6	18.5	34.5	30.9	26.1	18.0	17.3	36.8	26.0	18.4	20.4	61.0	33.7	13.4	10.8	34.5	42.0	15.9	17.3	20.8	10.1	16.5	17.6	16.9	10.1	22.4	21.4	82.0	24.7	29.8	9.8	24.0	18.4	16.6	25.4	39.6	28.2	10.2	21.7	18.1	14.5	4.4	32.7	9.6	10.0	43.1	18.1	5.4	13.6	3.3	0.7	2.7	9.5	1.6	2.0	4.9	1.4	2.9	93.3	10.9	2.0	4.4	12.4	2.4	5.8	3.4	3.6	2.0	4.2	28.4	6.7	1.3	5.1	2.5	2.8	1.3	4.0	0.2	2.1	4.2	14.7	0.5	48.9	35.8	5.3	3.6	2.2	4.9	4.0	1.9	0.0	5.7	4.9	1.2	1.3	1.0	3.3	0.2	4.0	0.4	2.4	0.1	9.3	15.9	1.8	1.2	4.4	0.9	2.6	6.4	3.2	0.3	4.9	0.8	1.5	3.7	3.1	3.5	1.4	2.4	3.3	0.2	4.0	0.0	0.4	3.3	1.5	0.4	1.6	5.4	5.2	3.2	1.9	3.4	9.5	7.5	0.3	2.7	0.7	13.6	2.2	1.6	12.5	14.6	10.6	18.5	13.4	10.8	20.8	10.1	21.4	14.5	6.0	10.3	3.9	48.9	0.0	5.2	0.0	15.3	4.0	10.3	27.9	2.0	2.2	5.0	22.3	30.3	45.0	26.9	0.0	24.7	9.6	32.8	109.6	25.6	50.5	11.0	1.6	1.2	254.8	14.9	19.1	203.1	3.6	0.0	7.2	23.2	14.3	28.1	29.4	83.1	24.5	4.8	58.2	0.0	47.0	18.1	0.0	4.1	4.3	14.9	41.0
PLPP2	"LPP2, PAP-2c, PPAP2C"	ENSG00000141934	"Phospholipid phosphatase 2"	O43688	19	281040-291504	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 188.5;Ciliated cells: 167.3;Ductal cells: 295.2;Rod photoreceptor cells: 190.0;Urothelial cells: 167.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 4.4;MAIT T-cell: 9.4"	"Lineage enriched"	"Detected in single"	52	"T-cells: 9.4"	"Cell line enhanced"	"Detected in many"		"A549: 34.1;CAPAN-2: 37.1;OE19: 63.6"	"Low region specificity"	"Detected in many"							HPA055540	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA055540: AB_2682839"	"prognostic unfavorable (4.55e-4)"	"unprognostic (8.91e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.21e-8)"	"unprognostic (2.95e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.83e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.85e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.36e-3)"	1.4	4.7	8.3	5.3	20.9	0.2	17.5	2.0	11.1	30.4	18.2	28.1	13.4	27.5	7.7	4.1	9.1	38.1	31.2	1.5	13.6	7.1	4.7	1.1	3.7	0.8	37.1	6.5	2.4	19.8	0.6	4.1	1.8	16.6	10.7	15.3	6.7	45.8	19.0	0.3	19.0	21.9	3.3	26.0	1.4	22.2	2.2	25.8	0.7	2.2	5.9	5.0	12.1	5.7	0.0	0.1	0.1	0.0	0.0	9.4	0.3	20.0	34.1	0.5	0.0	0.0	0.1	0.0	2.0	0.0	6.3	4.9	9.8	37.1	0.0	21.9	2.9	0.0	11.1	0.0	4.4	2.9	0.2	0.6	0.0	13.7	0.0	7.6	0.0	1.3	1.3	1.9	3.2	4.3	13.9	1.0	0.0	0.1	0.0	0.0	22.8	0.1	0.0	15.2	63.6	0.0	0.0	0.0	0.5	16.0	3.2	4.3	10.2	5.6	9.4	14.7	1.5	12.3	0.6	1.1	13.9	9.2	0.1	14.8	0.1	23.3	16.5	3.9	0.0	11.4	0.0	0.0	0.0	4.4	0.0	9.4	0.0	2.0	2.2	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	8.3	20.9	2.0	11.1	13.6	7.1	37.1	6.5	16.6	25.8	6.0	6.9	0.0	113.1	0.0	17.7	0.0	188.5	167.3	64.8	21.0	9.8	0.2	3.3	295.2	0.2	3.3	108.1	0.0	125.6	5.1	0.0	71.8	1.1	0.4	0.9	15.9	8.2	0.0	1.3	1.4	0.0	1.3	0.0	4.6	39.9	12.1	100.4	109.1	0.0	1.0	190.0	0.0	0.0	0.3	28.1	0.0	0.7	0.0	113.0	167.4
PLPP3	"LPP3, PAP-2b, PPAP2B"	ENSG00000162407	"Phospholipid phosphatase 3"	O14495	1	56494747-56645301	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Ito cells: 854.4;Leydig cells: 1011.7;Peritubular cells: 374.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 168.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 5.4;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	7	"B-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 105.3;ASC TERT1: 52.6;HSkMC: 65.0;U-2197: 95.5"									"HPA028892, HPA072751"	Uncertain		Supported	"Golgi apparatus"		NA	Yes			"Golgi apparatus"		"HPA028892: AB_10602149, HPA072751: AB_2686555"	"unprognostic (2.50e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.22e-3)"	"unprognostic (5.86e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.09e-1)"	46.4	17.2	29.0	10.8	30.7	4.2	39.1	13.5	27.5	102.7	15.5	33.8	22.1	8.1	32.7	36.9	20.8	36.7	24.0	23.3	39.9	13.5	30.2	57.7	24.3	6.7	19.2	30.1	27.9	12.2	30.7	7.2	70.9	20.0	37.7	14.4	34.7	22.4	58.7	16.6	24.4	12.5	32.9	16.5	7.9	18.7	23.4	29.7	5.2	107.1	19.4	6.7	35.8	44.0	5.4	0.0	0.8	0.3	0.0	0.0	0.2	0.4	1.5	2.0	0.2	105.3	52.6	5.0	5.5	5.6	5.1	2.5	4.4	0.8	0.7	0.6	8.3	5.7	0.8	0.3	0.1	1.0	0.0	1.3	0.1	0.6	6.1	2.5	0.0	0.0	65.0	0.4	4.9	4.1	3.6	4.8	0.0	0.4	0.0	5.5	0.4	0.0	0.0	6.2	1.2	6.1	0.0	0.0	0.2	0.8	4.6	0.0	4.1	1.7	2.3	0.5	6.4	0.7	0.0	3.0	25.8	2.1	95.5	0.2	0.0	0.0	0.0	4.5	0.2	1.8	0.0	0.3	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	4.5	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.2	29.0	30.7	13.5	27.5	39.9	13.5	19.2	30.1	20.0	29.7	23.8	20.5	11.5	20.0	0.0	3.2	0.0	56.0	8.1	23.9	21.0	0.0	102.0	18.3	16.0	5.7	50.7	10.7	23.3	7.9	10.3	54.5	13.7	3.5	84.4	36.2	0.0	2.4	854.4	45.1	12.0	1011.7	10.2	0.0	1.0	10.3	146.0	8.7	7.0	374.8	18.2	2.5	135.8	0.0	4.3	2.5	0.0	179.8	4.3	7.8	16.5
PLPP4	"DPPL2, PPAPDC1, PPAPDC1A"	ENSG00000203805	"Phospholipid phosphatase 4"	Q5VZY2	10	120456954-120589855	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 26.5;kidney: 12.6"	"Cell type enhanced"	"Detected in some"	11	"Cholangiocytes: 12.7;Distal tubular cells: 6.6;Early spermatids: 7.1;Late spermatids: 7.9;Leydig cells: 17.8;Peritubular cells: 7.4;Proximal tubular cells: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"eosinophil: 2.2"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.2"	"Group enriched"	"Detected in some"	4	"hTERT-RPE1: 62.8;U-251 MG: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045188	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA045188: AB_2679246"	"unprognostic (8.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.90e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.62e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.40e-3)"	"unprognostic (3.49e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.21e-3)"	0.6	1.7	11.4	1.2	13.6	4.9	3.1	11.6	18.2	3.4	1.2	12.1	1.0	0.7	1.7	2.7	0.9	1.2	11.3	0.7	15.9	17.4	12.6	2.8	0.5	0.6	15.5	6.0	0.6	0.6	0.4	0.5	0.6	26.5	3.0	0.8	0.0	2.0	6.1	0.4	1.7	0.8	1.5	19.1	0.5	1.2	11.1	12.5	0.0	1.5	0.0	0.5	0.8	0.7	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.8	1.7	1.0	0.0	1.0	0.0	0.0	8.0	6.3	0.1	0.7	0.1	0.9	1.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.8	0.0	62.8	6.5	0.0	0.7	1.6	0.7	0.0	0.0	0.0	0.7	0.0	2.0	0.0	0.0	0.0	3.3	0.0	0.6	0.1	0.5	0.0	0.5	3.5	1.4	0.0	9.0	7.2	4.0	0.3	34.8	0.0	0.0	0.0	6.6	0.0	1.9	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	13.6	11.6	10.0	15.9	17.4	15.5	6.0	26.5	12.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	12.7	0.0	0.0	3.5	0.0	0.0	6.6	0.0	7.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	1.9	0.0	0.0	2.5	0.0	7.9	17.8	0.0	0.0	0.0	0.0	0.0	1.5	0.0	7.4	7.6	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.3
PLPP5	"DPPL1, HTPAP, PPAPDC1B"	ENSG00000147535	"Phospholipid phosphatase 5"	Q8NEB5	8	38263130-38269243	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 77.8"	"Cell type enhanced"	"Detected in many"	4	"Glandular cells: 138.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"memory B-cell: 37.2;naive B-cell: 65.4"	"Lineage enriched"	"Detected in all"	5	"B-cells: 65.4"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 51.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055777			Approved	Vesicles		NA	NA			Vesicles		"HPA055777: AB_2682915"	"unprognostic (4.54e-2)"	"unprognostic (2.51e-3)"	"unprognostic (3.66e-2)"	"prognostic favorable (1.48e-5)"	"unprognostic (1.80e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.58e-2)"	"prognostic favorable (8.72e-5)"	"unprognostic (9.79e-2)"	"prognostic favorable (2.42e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (8.33e-10)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.57e-2)"	5.5	9.3	6.9	11.9	7.9	4.8	8.8	7.5	6.7	11.2	11.5	3.9	33.9	14.4	5.7	30.9	6.6	10.2	21.0	4.6	6.1	6.1	9.6	20.3	7.5	12.0	4.5	5.1	8.4	77.8	4.2	29.9	8.3	6.7	27.9	12.8	16.2	52.0	36.5	2.3	4.7	18.4	5.2	3.5	12.8	16.1	4.6	4.4	3.8	11.9	5.0	14.8	8.0	6.7	65.4	5.3	13.3	3.6	4.3	5.0	3.7	5.5	11.1	6.6	13.5	13.0	12.7	9.1	15.8	19.9	8.1	10.6	5.1	8.5	0.4	13.5	16.3	11.7	6.2	5.4	11.5	6.9	3.5	3.5	9.8	4.7	14.8	22.1	2.8	11.8	9.9	12.0	11.2	14.8	14.3	13.1	13.1	0.4	25.5	9.8	11.4	6.3	4.7	10.0	22.5	3.8	6.9	4.9	51.3	20.2	7.2	5.2	8.0	6.5	10.1	9.2	6.1	21.6	5.5	7.8	5.7	5.0	9.6	4.1	15.8	10.4	1.6	15.8	7.5	9.8	13.3	2.7	4.5	3.0	2.7	5.0	37.2	3.9	3.8	2.5	65.4	2.0	1.9	1.6	4.3	3.6	5.3	3.4	3.7	6.9	7.9	7.5	6.7	6.1	6.1	4.5	5.1	6.7	4.4	8.9	44.0	74.7	61.1	0.0	5.3	0.0	38.2	101.7	39.8	71.5	15.7	39.2	36.5	59.1	22.7	13.5	17.2	0.0	78.1	37.8	35.3	138.3	29.1	20.7	32.8	58.8	43.3	16.5	9.1	6.2	16.4	24.8	0.0	10.0	73.6	37.6	56.5	36.8	8.9	20.3	3.5	12.9	0.0	24.7	4.3	0.0	73.7	17.0	51.4	46.1
PLPPR2	"LPPR2, PRG-4"	ENSG00000105520	"Phospholipid phosphatase related 2"	Q96GM1	19	11355386-11365698	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 32.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 32.3"	"Cell line enhanced"	"Detected in many"		"U-2197: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048973	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA048973: AB_2680580"	"unprognostic (1.29e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (6.82e-4)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (7.46e-11)"	"unprognostic (1.99e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.17e-1)"	12.0	17.1	32.5	10.5	39.9	14.1	6.6	17.7	51.2	14.0	11.1	10.8	5.1	6.0	12.7	8.4	8.4	9.7	13.7	10.4	37.0	22.3	5.5	18.0	10.0	5.4	11.8	17.9	15.2	12.4	11.7	22.7	11.5	12.3	18.5	5.1	11.8	13.1	15.1	23.1	16.2	5.7	16.8	10.5	10.6	9.3	7.6	9.4	0.5	7.7	4.4	3.3	9.8	8.1	0.0	2.9	32.3	7.2	0.0	0.3	2.3	8.8	5.5	3.0	12.6	12.8	12.3	0.8	15.8	14.7	9.8	10.1	1.0	1.6	1.7	9.4	20.1	2.0	1.6	1.7	4.7	5.3	4.6	3.2	0.5	3.8	1.0	6.7	0.5	18.0	11.0	8.6	8.4	1.6	14.2	6.6	2.8	8.5	14.1	8.2	13.1	0.2	2.4	3.3	3.0	30.7	0.2	0.4	4.8	4.6	4.2	3.3	10.9	6.6	5.7	3.3	1.0	8.2	11.3	7.6	22.2	4.7	37.5	8.3	8.8	5.4	0.6	21.6	8.1	8.7	0.8	7.2	3.7	0.3	6.7	0.0	0.0	0.1	0.0	2.9	0.0	0.1	0.0	32.3	0.0	4.4	0.1	0.3	2.3	32.5	39.9	17.7	51.2	37.0	22.3	11.8	17.9	12.3	9.4	6.0	8.8	0.5	5.5	0.0	5.1	0.0	7.6	2.7	2.3	3.5	11.8	0.5	1.7	6.2	11.0	6.9	0.0	0.0	7.6	2.1	2.1	16.2	2.3	6.7	4.0	7.9	16.4	8.0	9.7	8.2	13.3	3.9	0.0	0.0	2.5	15.3	7.5	0.0	15.6	1.3	6.3	6.5	0.0	1.8	4.9	0.0	2.4	0.0	0.8	4.1
PLPPR3	"FLJ11535, LPPR3, PRG-2, PRG2"	ENSG00000129951	"Phospholipid phosphatase related 3"	Q6T4P5	19	812488-821977	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"bone marrow: 18.2;brain: 30.0;fallopian tube: 12.6"	"Cell type enhanced"	"Detected in single"	21	"Horizontal cells: 1.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"eosinophil: 1.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.6"	"Group enriched"	"Detected in some"	6	"NB-4: 24.1;THP-1: 51.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052293, HPA057034"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA052293: AB_2681787, HPA057034: AB_2683316"	"unprognostic (7.65e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.32e-1)"	"unprognostic (4.51e-4)"	"unprognostic (8.06e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-12)"	"unprognostic (1.21e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.91e-1)"	0.7	0.7	20.5	1.2	30.0	18.2	2.1	0.1	21.3	0.9	0.7	0.7	0.0	0.7	1.3	0.7	0.7	12.6	1.1	0.7	14.4	13.1	0.7	0.7	2.6	0.9	3.9	14.9	1.0	0.7	0.7	0.1	0.8	4.7	0.9	0.7	0.1	0.7	0.8	0.9	0.8	1.0	0.7	1.1	0.9	0.9	3.0	3.1	0.0	0.7	0.0	0.7	0.8	0.0	0.1	0.0	1.6	0.0	0.0	0.1	0.0	0.1	0.6	5.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.3	0.0	0.0	3.5	0.0	0.0	0.1	0.9	0.0	0.0	0.0	2.1	0.0	0.6	0.0	0.2	1.7	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.1	0.0	0.4	0.0	24.1	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	6.4	0.1	0.0	0.0	2.7	2.2	51.0	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	3.9	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	30.0	0.1	21.3	14.4	13.1	3.9	14.9	4.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0
PLPPR4	"KIAA0455, LPPR4, PHP1, PRG-1"	ENSG00000117600	"Phospholipid phosphatase related 4"	Q7Z2D5	1	99263953-99309590	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 55.3"	"Group enriched"	"Detected in some"	5	"Horizontal cells: 28.6;Muller glia cells: 25.5"	"Cancer enhanced"	"Detected in many"		"glioma: 7.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"non-classical monocyte: 2.1"	"Lineage enriched"	"Detected in single"	22	"monocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 20.3;BJ hTERT+ SV40 Large T+ RasG12V: 7.9;fHDF/TERT166: 6.8;SH-SY5Y: 15.3;U-138 MG: 7.6;U-87 MG: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.32e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.09e-2)"	"unprognostic (9.70e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.25e-12)"	"unprognostic (1.67e-5)"	"unprognostic (3.47e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.16e-3)"	3.0	1.7	25.1	1.2	25.8	0.8	1.8	2.0	55.3	4.6	1.5	2.6	0.0	1.2	1.7	1.7	3.2	1.3	6.0	1.4	39.2	10.8	1.4	0.8	3.5	1.5	5.2	16.7	0.8	1.5	1.7	9.0	1.9	6.1	1.1	1.9	0.6	1.4	1.3	1.2	4.6	1.5	2.1	2.2	1.3	1.1	5.2	2.7	0.0	1.5	0.4	1.7	7.0	1.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	0.0	0.0	3.9	20.3	4.5	7.9	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.1	0.0	0.1	0.0	0.0	0.0	12.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	25.1	25.8	2.0	33.8	39.2	10.8	5.2	16.7	6.1	2.7	0.0	1.1	0.0	0.0	0.0	3.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.6	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	25.5	0.0	0.0	1.4	0.6	4.3	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0
POGLUT1	"9630046K23Rik, C3orf9, hCLP46, KDELCL1, KTELC1, MDS010, MDSRP, MGC32995, Rumi"	ENSG00000163389	"Protein O-glucosyltransferase 1"	Q8NBL1	3	119468938-119494708	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Gastrulation	"Developmental protein, Glycosyltransferase, Transferase"	"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	13	"monocytes: 247.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037855, HPA037856"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA037855: AB_10672728, HPA037856: AB_2732477"	"unprognostic (2.43e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.02e-7)"	"unprognostic (3.08e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (2.23e-4)"	11.9	12.1	7.6	10.7	12.0	3.9	10.9	13.9	10.6	10.1	9.5	9.8	27.4	5.9	13.7	11.7	9.3	10.1	6.9	8.3	7.3	8.9	8.3	10.3	9.1	14.3	15.0	5.6	10.5	29.2	12.1	14.5	11.5	10.9	9.4	10.9	8.7	7.8	25.7	5.1	14.0	12.1	15.2	14.0	14.9	8.2	4.7	8.9	11.7	8.6	4.1	15.6	10.6	10.2	9.9	14.3	9.4	11.5	19.8	16.0	10.3	7.5	5.1	8.8	9.8	22.3	12.8	6.3	12.1	12.4	9.9	13.5	8.3	4.9	11.7	16.4	15.2	7.9	9.0	11.8	12.0	15.7	10.1	7.7	13.7	8.0	8.9	14.6	15.0	16.2	13.2	7.9	9.7	13.7	11.5	11.2	7.9	7.5	14.3	10.0	7.6	8.6	14.6	9.1	13.3	9.3	8.5	9.0	17.2	8.6	9.8	9.7	14.8	5.8	3.6	9.4	9.0	9.7	12.6	14.1	9.7	6.0	2.8	6.2	19.7	17.1	15.9	8.4	15.3	13.6	1.9	11.5	9.4	12.0	10.8	13.8	9.9	13.6	12.5	14.3	7.0	16.0	15.2	0.9	19.8	7.0	8.0	14.7	10.3	7.6	12.0	13.9	10.6	7.3	8.9	15.0	5.6	10.9	8.9	0.0	3.8	8.8	5.8	14.9	14.7	3.4	15.3	6.7	7.9	19.2	5.9	9.2	0.0	6.3	0.5	13.9	6.5	0.0	4.5	12.3	10.1	5.0	17.3	9.8	7.5	4.8	9.1	11.1	13.0	0.0	8.1	16.5	11.8	247.1	11.4	12.1	5.1	7.0	15.9	5.5	12.5	12.9	9.9	1.4	0.9	13.0	5.5	14.6	12.1	5.8
POMGNT1	"FLJ20277, LGMD2O, MEB, MGAT1.2"	ENSG00000085998	"Protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)"	Q8WZA1	1	46188682-46220305	"Disease related genes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044518	Approved					NA	NA		6300000			"HPA044518: AB_10795985"	"unprognostic (4.59e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (3.52e-4)"	"unprognostic (1.82e-1)"	"unprognostic (5.74e-2)"	"unprognostic (5.37e-2)"	"prognostic favorable (4.27e-4)"	"unprognostic (5.86e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.36e-1)"	12.8	17.8	17.9	8.2	26.7	2.8	14.3	12.9	21.6	13.9	9.7	29.5	11.1	12.4	11.7	19.1	9.2	15.8	12.4	43.6	18.8	16.7	19.1	19.2	13.8	7.1	39.4	18.0	10.0	17.2	47.1	19.4	16.6	24.7	21.1	10.7	13.0	13.8	17.2	29.7	13.3	11.3	16.3	36.3	11.7	12.5	16.1	25.0	7.7	22.4	7.5	9.1	11.3	9.0	3.2	6.4	1.6	5.2	9.4	6.2	1.9	12.3	13.3	16.3	15.7	18.0	19.7	21.1	16.7	28.2	22.8	18.0	7.5	10.4	11.5	27.7	27.7	39.0	7.1	11.6	23.9	13.7	15.0	13.2	9.1	11.9	11.3	15.8	7.0	8.9	19.8	31.3	25.5	23.8	41.1	23.2	15.9	10.7	7.5	37.2	8.6	12.3	5.0	13.5	7.1	18.7	9.0	16.7	10.7	20.1	15.4	6.2	22.2	15.4	17.9	23.3	24.5	11.9	9.9	16.8	17.2	15.3	19.4	31.9	18.9	21.0	5.3	26.2	6.9	18.2	0.0	1.6	1.6	5.1	2.8	3.5	2.1	3.4	4.0	2.2	3.2	6.2	4.8	0.0	9.4	5.2	6.4	3.3	1.9	17.9	26.7	12.9	21.6	18.8	16.7	39.4	18.0	24.7	25.0	11.9	45.5	9.8	35.8	7.4	40.4	36.8	20.4	21.4	33.0	33.2	47.1	21.1	11.6	38.1	28.2	13.4	14.6	0.0	34.5	23.8	14.1	34.3	25.5	18.4	13.6	25.4	25.9	8.6	11.0	10.4	18.7	11.0	23.6	25.2	11.8	23.2	31.7	14.4	12.4	17.7	36.4	12.9	15.5	5.0	11.0	6.6	19.6	13.1	15.8	26.0
PSAP	"GLBA, SAP1"	ENSG00000197746	Prosaposin	P07602	10	71816298-71851375	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Lipid metabolism, Sphingolipid metabolism"		"Disease mutation, Gangliosidosis, Gaucher disease, Leukodystrophy, Metachromatic leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Hofbauer cells: 2783.3;Kupffer cells: 2077.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 252.0;intermediate monocyte: 322.1;myeloid DC: 97.2;neutrophil: 80.8;non-classical monocyte: 263.2"	"Group enriched"	"Detected in all"	12	"dendritic cells: 97.2;granulocytes: 80.8;monocytes: 322.1"	"Cell line enhanced"	"Detected in all"		"ASC diff: 260.8;hTERT-RPE1: 353.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004426, CAB004647"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA		86000000	Vesicles		"CAB004647: AB_425625, HPA004426: AB_1079701"	"unprognostic (4.43e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.64e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.62e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.06e-1)"	151.5	178.6	106.6	95.1	137.9	79.7	93.3	93.2	143.4	136.7	74.4	134.2	89.5	53.7	116.0	118.2	71.7	88.1	129.7	164.0	99.5	93.7	108.5	119.6	125.5	136.8	135.4	128.0	137.1	93.7	134.8	76.0	165.5	106.7	94.1	73.4	118.2	88.1	117.0	151.6	67.6	63.3	133.5	109.3	159.8	87.4	60.5	126.1	84.4	103.1	54.1	61.4	102.8	76.3	13.4	97.2	80.8	322.1	9.5	12.5	306.2	21.6	40.9	26.6	55.6	260.8	150.1	94.1	39.4	117.3	31.0	37.1	37.8	55.3	11.8	81.4	64.3	52.0	47.5	10.0	32.0	21.9	23.0	18.9	13.8	18.6	21.3	100.5	8.9	79.4	95.4	73.9	31.0	59.5	353.1	55.0	16.7	19.6	57.1	38.4	13.8	39.5	13.4	12.2	27.5	19.9	8.2	15.2	32.8	36.1	37.3	29.6	26.2	36.8	111.8	148.5	36.6	22.7	20.6	71.5	43.9	31.2	29.2	32.1	63.8	48.5	20.9	69.7	17.9	32.1	19.4	252.0	30.1	12.5	322.1	10.3	13.4	10.3	10.8	97.2	11.8	11.3	10.6	80.8	9.5	263.2	48.5	11.3	306.2	106.6	137.9	93.2	143.4	99.5	93.7	135.4	128.0	106.7	126.1	235.2	379.3	166.5	219.5	202.9	179.8	542.8	254.8	219.5	234.3	451.9	119.8	794.0	59.7	786.8	15.8	344.2	354.0	46.7	402.9	741.7	528.5	293.5	382.9	394.5	2783.3	314.6	251.7	411.3	2077.6	30.6	424.6	1465.0	629.3	1297.6	227.4	506.4	336.4	285.1	518.7	243.0	122.0	271.7	278.1	42.5	119.8	173.1	897.4	139.5	183.5	185.3
SGMS1	"MGC17342, MOB, SMS1, TMEM23"	ENSG00000198964	"Sphingomyelin synthase 1"		10	50305586-50625163	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Suprabasal keratinocytes: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045191	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA045191: AB_10959605"	"unprognostic (1.13e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.69e-3)"	"unprognostic (8.34e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.30e-2)"	"unprognostic (5.75e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.05e-1)"	"prognostic favorable (1.95e-7)"	"unprognostic (8.38e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.05e-1)"	14.7	19.6	16.9	12.3	19.4	17.6	13.2	17.5	20.1	15.8	12.8	24.0	11.9	11.7	12.5	18.1	13.7	14.8	13.6	16.6	18.2	14.6	17.9	23.5	18.6	11.6	22.9	14.0	16.9	19.1	64.6	22.9	20.7	18.6	17.6	10.7	15.5	19.8	15.8	13.2	25.6	13.7	15.2	31.7	13.6	12.8	9.6	24.9	11.4	21.5	8.7	14.9	15.2	21.3	5.3	3.7	20.1	6.7	7.6	11.0	4.2	16.1	7.7	2.3	5.0	8.2	10.8	10.5	10.8	10.9	7.6	7.2	6.4	16.8	12.0	6.3	14.1	6.9	10.3	5.3	11.3	8.0	10.4	5.6	17.2	10.3	4.8	9.5	3.9	4.3	6.9	13.3	10.1	12.4	4.9	10.7	4.4	33.1	18.0	8.1	6.8	1.7	2.2	5.1	7.4	7.4	2.9	10.3	4.6	11.1	17.1	3.4	2.7	7.9	7.9	4.1	6.6	11.9	1.5	14.9	8.3	10.1	7.9	7.9	6.1	4.8	3.4	10.3	6.5	6.7	2.4	6.7	20.1	3.7	3.4	8.2	5.3	4.9	5.4	3.7	5.0	6.8	4.3	12.5	7.6	2.7	2.3	11.0	4.2	16.9	19.4	17.5	20.1	18.2	14.6	22.9	14.0	18.6	24.9	41.7	27.0	11.0	24.2	48.3	16.3	20.6	7.6	25.4	38.7	27.9	3.9	8.7	13.3	15.3	12.1	17.0	9.3	23.3	18.7	6.6	21.6	31.8	19.7	14.5	23.8	4.8	14.3	20.9	40.7	21.3	15.0	16.6	11.8	5.4	11.2	16.5	10.7	3.5	9.9	7.9	35.9	0.0	15.5	8.1	1.9	72.9	4.1	10.7	11.5	23.2
SGMS2	"MGC26963, SMS2"	ENSG00000164023	"Sphingomyelin synthase 2"	Q8NHU3	4	107824563-107915047	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 144.6;Ciliated cells: 116.4;Club cells: 131.9;Urothelial cells: 179.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"pons and medulla: 17.0"	"Group enriched"	"Detected in some"	8	"classical monocyte: 5.7;eosinophil: 3.9;intermediate monocyte: 2.4;myeloid DC: 6.6;non-classical monocyte: 2.0"	"Group enriched"	"Detected in many"	32	"dendritic cells: 6.6;granulocytes: 3.9;monocytes: 5.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA015076	Supported					NA	NA					"HPA015076: AB_1857298"	"unprognostic (7.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.88e-3)"	"unprognostic (9.53e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.82e-3)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.37e-4)"	"unprognostic (6.18e-2)"	"unprognostic (5.63e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.22e-3)"	7.5	3.3	1.9	8.6	2.9	2.1	8.0	1.7	1.9	8.3	22.2	3.4	5.6	11.4	12.5	9.7	14.9	7.5	24.9	7.8	2.5	2.6	13.2	12.6	20.7	6.4	2.7	1.4	5.4	8.4	4.6	48.5	30.7	17.0	8.0	6.4	11.8	14.2	3.2	5.0	4.5	38.1	18.5	4.6	1.5	9.8	8.6	1.0	0.2	22.0	12.2	5.3	10.7	11.2	0.1	6.6	3.9	5.7	0.0	0.1	1.4	10.0	3.8	0.6	2.9	6.7	15.6	0.2	12.4	9.4	5.9	6.2	1.7	21.0	0.7	4.9	19.7	5.1	3.8	7.2	10.9	10.6	2.8	2.8	0.4	8.5	0.6	7.7	6.8	0.0	5.4	7.7	11.5	14.0	12.4	13.0	0.1	0.1	0.2	9.3	3.4	0.2	0.0	0.3	5.9	4.3	0.2	5.0	1.4	15.7	4.9	1.0	0.0	9.5	13.6	1.6	1.6	7.3	0.1	22.1	7.1	11.2	10.1	5.7	0.7	0.2	0.4	9.5	1.6	2.9	0.0	5.7	3.9	0.0	2.4	0.0	0.1	0.0	0.0	6.6	0.1	0.1	0.0	0.5	0.0	2.0	0.0	0.0	1.4	1.9	2.9	1.7	1.9	2.5	2.6	2.7	1.4	17.0	1.0	80.4	97.5	2.7	144.6	49.7	0.4	17.1	28.1	116.4	131.9	15.7	0.0	0.8	3.3	16.4	47.7	9.0	30.7	0.0	16.7	0.6	20.1	102.6	9.3	20.2	5.9	1.6	8.5	4.9	31.9	5.9	2.3	23.7	8.5	1.0	19.0	0.0	26.8	38.6	0.4	9.1	0.0	0.0	30.9	0.5	2.8	63.7	11.6	1.3	9.3	179.5
SGPL1	SPL	ENSG00000166224	"Sphingosine-1-phosphate lyase 1"	O95470	10	70815961-70881173	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Lipid metabolism, Sphingolipid metabolism"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 45.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021125, HPA023086"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA021125: AB_1856803, HPA023086: AB_1856804"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.21e-2)"	"unprognostic (4.68e-3)"	9.6	11.2	12.0	20.2	11.4	4.9	24.4	10.8	10.6	16.2	17.1	16.0	21.9	13.3	15.5	16.8	26.7	13.5	13.4	8.3	11.3	9.8	18.2	27.1	10.4	20.1	11.9	9.5	10.0	34.6	15.4	10.2	11.3	10.4	16.1	15.6	7.6	15.0	19.5	7.6	28.6	32.5	12.1	15.7	22.9	10.3	15.3	11.0	14.7	17.6	12.8	18.0	21.4	26.8	5.6	9.7	8.9	24.8	10.9	11.5	6.6	10.7	14.4	13.9	15.9	3.8	5.0	9.2	6.3	6.8	6.9	9.0	15.6	23.9	9.7	7.5	6.4	6.7	18.2	11.9	12.8	9.9	15.5	6.4	1.0	7.3	18.6	14.5	4.2	8.8	9.4	21.7	9.3	24.5	14.7	4.3	9.2	2.8	8.5	9.8	11.9	5.1	2.8	6.3	14.3	8.0	6.6	10.6	3.6	11.1	45.7	9.5	11.6	12.7	19.5	11.6	11.4	10.1	3.0	8.3	6.3	16.5	4.8	12.1	3.5	4.8	4.5	6.2	7.8	4.4	0.6	11.5	7.9	11.5	20.3	10.4	4.7	7.5	9.4	9.7	5.6	5.7	9.0	8.9	10.9	24.8	5.4	6.8	6.6	12.0	11.4	10.8	10.4	11.3	9.8	11.9	9.5	10.4	11.0	14.9	5.4	9.9	14.9	10.9	6.5	5.6	30.6	14.7	14.8	43.6	19.6	6.6	3.3	32.5	2.3	6.4	38.8	0.0	33.2	10.9	12.4	23.9	14.9	39.5	25.3	14.3	24.1	6.2	30.2	4.5	10.6	15.9	6.8	16.2	20.8	9.3	41.0	17.3	19.1	11.5	8.2	6.5	11.4	19.9	31.5	19.8	5.3	11.4	16.2	20.4
SGPP1		ENSG00000126821	"Sphingosine-1-phosphate phosphatase 1"	Q9BX95	14	63684214-63728039	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 49.4"	"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 48.8;Kupffer cells: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.9;U-698: 31.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053149, HPA064908"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053149: AB_2682057, HPA064908: AB_2797270"	"unprognostic (1.57e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.82e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-3)"	10.5	12.1	12.1	15.7	11.6	4.3	7.6	14.3	12.9	9.2	9.6	15.1	3.9	6.2	8.4	10.3	5.7	5.9	8.9	5.5	13.1	12.6	24.7	29.4	10.3	18.5	13.0	7.0	7.4	14.1	15.5	6.4	49.4	11.1	9.0	8.7	6.7	5.7	7.0	4.4	4.8	8.9	7.9	19.6	16.5	5.8	8.2	9.8	15.4	7.8	3.7	19.1	8.6	7.3	3.2	0.5	8.8	3.3	0.5	2.0	0.5	10.5	3.4	1.7	4.8	6.2	5.8	20.3	8.7	6.1	5.4	6.1	1.5	6.0	23.9	2.6	4.4	4.5	11.3	2.7	5.1	8.8	9.3	3.1	2.2	2.0	2.4	7.6	3.9	6.9	4.2	8.3	4.7	7.5	5.5	2.6	4.5	1.2	0.7	7.8	3.9	4.5	0.0	1.1	1.7	7.3	1.1	4.7	1.9	8.6	5.3	1.0	2.8	6.1	5.7	4.5	5.4	7.4	1.4	2.9	7.6	5.2	5.3	4.3	5.7	3.5	31.1	5.5	0.0	3.2	8.8	0.3	2.8	1.0	2.3	1.0	3.2	1.0	0.7	0.5	0.8	1.5	1.1	0.4	0.5	3.3	0.3	2.0	0.5	12.1	11.6	14.3	12.9	13.1	12.6	13.0	7.0	11.1	9.8	11.9	14.4	11.2	4.9	8.7	3.5	3.2	25.5	2.7	3.4	48.8	0.0	19.1	0.0	5.2	1.6	5.4	6.7	0.0	7.7	24.8	16.2	8.0	10.5	37.6	19.7	9.5	17.9	8.0	53.2	0.8	5.8	20.6	16.9	3.6	9.4	7.3	11.2	11.6	15.9	20.9	5.1	6.5	19.4	6.7	2.7	11.8	27.6	7.5	8.1	4.8
SLC33A1	"ACATN, AT-1, AT1, SPG42"	ENSG00000169359	"Solute carrier family 33 member 1"	O00400	3	155821024-155854456	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Cataract, Deafness, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042430, HPA060345"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042430: AB_10806238, HPA060345: AB_2732647"	"unprognostic (5.12e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.57e-2)"	"unprognostic (5.65e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.73e-2)"	"unprognostic (5.74e-2)"	11.3	17.3	6.5	9.9	8.6	3.1	12.1	9.4	9.4	18.8	13.1	10.5	29.9	11.3	14.0	22.9	11.8	12.3	11.5	12.9	7.8	6.7	19.4	38.3	12.8	13.6	9.4	5.6	13.6	42.4	18.8	24.6	13.9	8.9	15.0	10.5	9.2	26.6	33.9	7.0	9.4	15.2	10.4	8.2	11.9	12.4	8.9	8.8	14.9	26.1	5.8	10.7	10.2	11.6	6.0	16.7	12.1	8.3	6.9	10.8	6.0	14.9	10.4	5.4	6.7	20.0	17.3	10.2	11.2	15.0	13.6	13.4	5.9	16.0	7.7	18.1	9.1	14.2	12.7	9.3	11.0	15.4	10.9	9.6	8.0	5.0	11.6	29.0	8.8	7.1	13.8	22.1	7.2	28.1	15.2	14.9	7.3	6.4	18.6	12.2	9.5	3.5	5.2	5.2	12.6	10.0	4.0	6.0	23.1	13.9	9.5	6.3	5.2	9.4	21.9	19.9	8.0	6.9	11.2	15.4	8.0	4.0	14.7	11.7	21.9	7.7	8.1	11.5	7.2	11.4	12.1	8.3	6.0	9.4	6.5	10.8	6.0	6.8	7.4	10.7	4.1	6.5	6.3	1.8	6.9	6.3	16.7	6.1	6.0	6.5	8.6	9.4	9.4	7.8	6.7	9.4	5.6	8.9	8.8	20.8	20.6	11.9	10.4	7.9	16.4	21.8	22.9	21.4	18.2	10.4	25.5	15.7	5.0	13.3	10.1	11.3	14.8	0.0	13.5	23.4	14.7	16.8	11.5	43.1	17.3	17.5	12.0	18.4	16.2	9.1	17.3	15.9	11.8	14.4	14.7	17.2	15.0	3.5	20.1	15.5	19.9	12.9	17.2	17.2	7.2	8.3	31.5	15.8	12.1	9.1
SMPD1	ASM	ENSG00000166311	"Sphingomyelin phosphodiesterase 1"	P17405	11	6390431-6394998	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Neurodegeneration, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 155.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 41.6;fHDF/TERT166: 41.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		2000000				"unprognostic (8.76e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.28e-3)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (9.46e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.90e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (4.35e-2)"	"prognostic favorable (4.57e-6)"	"unprognostic (4.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.71e-1)"	14.7	21.4	12.4	10.9	18.7	5.4	10.7	17.2	32.4	14.5	17.4	30.6	15.7	14.3	12.2	15.0	11.6	7.9	18.5	26.8	14.5	13.2	47.1	77.5	17.1	10.7	17.4	15.9	12.9	19.9	35.4	23.8	23.1	21.6	17.6	12.9	23.3	21.5	18.5	20.9	19.7	15.8	14.9	17.8	11.7	13.3	7.4	14.1	18.8	20.2	10.3	11.8	12.5	11.4	3.2	1.8	3.4	2.7	6.8	11.4	3.1	4.6	3.7	2.8	7.6	41.6	21.7	5.0	17.6	27.3	8.0	9.7	6.4	3.3	1.2	8.2	41.0	17.4	1.9	2.4	3.6	3.8	5.9	2.8	1.4	6.0	1.7	18.6	1.0	11.0	28.6	6.9	7.4	5.0	29.6	17.6	0.5	2.5	8.8	17.1	4.7	0.0	1.8	1.1	6.5	6.6	0.3	1.6	1.9	6.9	1.7	4.9	2.8	7.9	5.5	10.8	3.8	2.1	1.9	15.2	29.9	3.2	17.3	4.1	11.3	12.0	0.9	27.7	3.0	13.3	1.8	2.7	3.4	6.9	2.1	5.6	1.6	5.9	5.5	1.4	3.2	11.3	11.4	2.7	6.8	0.6	1.8	4.8	3.1	12.4	18.7	17.2	32.4	14.5	13.2	17.4	15.9	21.6	14.1	23.8	15.6	18.0	17.3	7.0	11.9	31.1	22.9	2.7	9.1	24.4	23.6	33.4	10.0	42.6	42.2	13.5	58.4	0.0	33.0	11.7	31.4	37.7	10.4	72.3	30.5	19.1	22.8	27.6	12.7	155.2	10.6	8.6	52.3	4.6	17.5	16.4	24.7	17.5	12.7	60.8	4.9	0.0	24.5	1.2	1.8	6.9	28.7	20.3	10.9	12.0
SMPD2	"ISC1, nSMase"	ENSG00000135587	"Sphingomyelin phosphodiesterase 2"	O60906	6	109440763-109443919	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 151.6;Late spermatids: 248.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA018110, HPA018125"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Vesicles, Plasma membrane"	"Cell Junctions"	"HPA018110: AB_1857292, HPA018125: AB_1857293"	"unprognostic (1.61e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.79e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (7.08e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (1.00e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.14e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.45e-2)"	"prognostic favorable (1.70e-4)"	6.0	6.8	4.2	20.2	4.9	8.5	8.5	5.4	6.4	9.0	12.6	9.8	16.4	10.5	6.1	16.0	17.2	17.4	12.6	5.1	4.9	3.7	10.2	7.8	8.4	9.4	4.7	4.2	6.7	15.5	17.9	8.8	19.5	4.8	10.1	10.2	8.4	16.6	11.9	3.3	16.9	15.4	7.8	4.3	10.1	11.1	35.1	4.7	18.3	10.5	13.5	23.0	6.3	10.1	18.3	13.4	9.3	7.8	6.2	8.0	5.3	8.9	10.4	5.5	8.6	9.7	5.3	18.3	3.0	11.2	7.6	7.2	9.8	7.3	4.9	6.4	6.4	16.0	11.5	5.5	13.2	4.6	6.2	14.2	5.7	10.7	6.0	8.1	6.2	6.7	5.6	15.3	6.7	13.3	8.5	6.9	8.7	11.0	8.7	3.7	12.9	10.0	13.5	1.5	11.9	5.0	7.1	2.6	5.3	13.7	15.3	7.2	6.0	5.7	17.9	13.5	4.6	5.7	12.0	4.4	3.4	4.9	2.7	11.2	5.9	1.5	3.1	6.6	6.0	6.0	5.7	7.8	9.3	6.6	7.5	7.3	12.8	7.4	8.0	10.2	18.3	5.6	5.7	2.3	6.2	6.6	13.4	7.2	5.3	4.2	4.9	5.4	6.4	4.9	3.7	4.7	4.2	4.8	4.7	11.9	7.4	4.2	8.5	8.8	1.3	2.0	12.7	58.9	7.9	12.2	3.9	8.2	1.7	14.7	151.6	3.8	27.2	0.0	17.1	16.1	6.0	12.7	0.0	3.2	8.5	0.0	8.1	4.3	6.6	248.2	8.6	10.8	8.5	11.8	21.2	2.3	13.7	24.6	8.5	7.9	5.2	12.9	2.8	36.6	10.6	16.3	14.2	4.9	13.8	13.7
SMPD3	NSMASE2	ENSG00000103056	"Sphingomyelin phosphodiesterase 3"	Q9NY59	16	68358325-68448688	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Lipid metabolism, Sphingolipid metabolism"	"Developmental protein, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.5;intestine: 46.4;lymphoid tissue: 73.0"	"Cell type enriched"	"Detected in many"	6	"Horizontal cells: 284.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"plasmacytoid DC: 44.5"	"Lineage enriched"	"Detected in many"	7	"dendritic cells: 44.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 9.6;MOLT-4: 13.6;RPMI-8226: 11.3;SCLC-21H: 13.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 103.1"	"Low region specificity"	"Detected in all"			"CAB033885, HPA065535, HPA069383"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB033885: AB_1126788, HPA065535: , HPA069383: "	"unprognostic (1.21e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (5.61e-3)"	"prognostic favorable (3.86e-4)"	"unprognostic (2.46e-1)"	"unprognostic (5.85e-4)"	"unprognostic (7.87e-2)"	"unprognostic (8.12e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.02e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-3)"	3.5	2.3	6.0	3.1	18.3	1.8	1.6	9.4	15.4	1.0	9.6	2.5	0.0	46.4	1.7	0.7	1.8	2.7	17.2	1.2	8.7	3.6	0.9	3.8	2.1	3.5	2.5	5.0	2.7	1.9	0.7	10.7	0.8	3.9	2.2	5.8	4.3	2.2	0.9	1.8	8.1	42.7	1.2	1.4	3.0	18.6	4.2	4.4	73.0	1.3	1.3	4.3	1.6	1.2	0.6	44.5	6.1	0.0	0.0	0.7	0.3	0.3	0.7	0.3	0.1	0.0	0.0	5.3	0.4	0.0	0.4	0.1	2.9	0.9	0.4	0.5	0.2	0.2	1.1	0.0	0.0	0.1	0.3	0.7	0.1	2.1	0.3	0.0	0.0	9.6	0.0	0.0	0.0	0.2	0.5	0.0	0.9	0.8	0.3	0.3	0.2	13.6	2.6	0.6	4.6	0.1	0.6	0.2	11.3	0.0	0.1	13.1	2.6	0.4	1.5	0.6	0.3	1.0	0.9	0.0	0.4	0.8	1.4	0.1	2.2	1.1	0.2	0.2	0.9	0.2	1.0	0.0	6.1	0.7	0.0	0.1	0.6	0.0	0.2	0.0	0.2	0.2	0.1	0.0	0.0	0.0	44.5	0.5	0.3	6.0	18.3	9.4	15.4	8.7	3.6	2.5	5.0	3.9	4.4	3.0	0.6	0.0	1.4	0.1	39.5	2.5	5.1	16.0	1.2	0.0	0.0	0.0	0.0	0.9	6.0	0.0	51.1	0.0	0.8	0.2	0.3	3.7	0.0	5.0	0.2	284.4	24.8	0.0	0.6	13.0	14.1	0.0	0.0	0.0	25.6	0.8	1.2	43.0	43.2	0.0	3.3	0.0	0.0	5.4	0.3	0.9	0.0	5.0	18.7	4.7
SMPD4	"FLJ20297, FLJ20756, KIAA1418, NET13, nSMase-3, NSMASE3"	ENSG00000136699	"Sphingomyelin phosphodiesterase 4"	Q9NXE4	2	130151392-130182750	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046279, HPA049426"	Approved		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane"	Cytosol	"HPA046279: AB_2679611, HPA049426: AB_2680762"	"unprognostic (5.02e-2)"	"unprognostic (9.61e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (7.47e-5)"	"unprognostic (1.69e-1)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (3.27e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (1.73e-4)"	"prognostic unfavorable (8.16e-8)"	"unprognostic (1.74e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.09e-1)"	13.2	16.1	12.4	17.1	20.7	39.1	14.8	22.1	25.1	19.9	15.8	31.4	15.3	15.5	22.5	14.1	19.3	19.5	12.7	13.4	13.2	16.0	14.3	18.5	14.7	20.5	21.3	12.2	22.2	22.2	24.1	31.2	24.3	19.5	16.3	16.7	17.7	17.1	15.2	17.0	17.5	15.2	18.3	16.0	16.4	14.5	23.6	21.6	27.9	22.8	19.6	27.1	16.9	16.6	10.5	9.8	14.5	11.4	11.7	15.2	9.7	32.0	15.8	20.0	14.8	10.3	7.6	26.1	17.1	12.7	25.2	21.1	45.8	16.5	20.9	15.2	17.1	14.4	18.2	25.5	22.6	17.5	27.7	24.7	23.5	17.0	36.3	8.8	26.2	15.0	8.8	15.2	28.3	11.3	9.3	14.5	20.9	29.2	17.0	14.1	17.3	27.4	13.2	30.7	13.7	21.1	29.1	15.2	22.7	10.7	15.2	27.8	15.6	16.8	20.6	7.5	11.6	14.0	11.5	11.2	21.6	21.0	14.1	20.0	14.8	16.6	28.1	19.5	15.0	15.3	1.8	9.3	14.5	13.9	11.4	15.2	9.5	10.4	12.4	9.8	10.5	10.2	11.4	4.5	11.7	8.0	6.4	9.4	9.7	12.4	20.7	22.1	25.1	13.2	16.0	21.3	12.2	19.5	21.6	3.0	9.9	10.2	9.1	13.4	20.0	3.2	5.1	6.7	6.8	7.0	11.8	19.8	8.3	8.1	17.4	7.4	7.1	0.0	10.5	21.1	10.3	8.6	5.8	13.5	12.1	14.3	12.6	9.8	9.4	32.6	13.6	6.5	15.1	5.4	12.5	7.8	11.0	9.1	17.3	5.6	15.1	0.0	8.0	24.0	22.0	18.1	13.0	12.8	12.1	7.9
SPHK1	SPHK	ENSG00000176170	"Sphingosine kinase 1"	Q9NYA1	17	76376584-76387860	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Ductal cells: 89.4;monocytes: 99.2;Muller glia cells: 144.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 34.4;hTEC/SVTERT24-B: 30.0;TIME: 30.0;U-138 MG: 30.2;U-251 MG: 38.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"olfactory region: 11.7"	"HPA022829, HPA028761"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA022829: AB_1857438, HPA028761: AB_10600814"	"unprognostic (1.04e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (9.32e-3)"	"unprognostic (3.13e-1)"	"unprognostic (7.43e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (5.14e-6)"	"unprognostic (1.39e-1)"	"unprognostic (4.82e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.10e-3)"	9.3	2.2	4.7	10.5	3.5	15.0	20.4	0.4	3.2	5.5	5.0	4.0	0.4	1.9	6.3	8.3	13.8	5.3	12.7	10.5	5.3	2.1	4.1	2.4	12.9	10.1	4.4	1.5	5.5	15.1	3.1	2.7	7.4	4.7	4.3	1.1	11.0	11.5	1.7	6.8	8.7	6.3	5.2	4.0	2.7	3.8	3.7	6.3	3.0	9.4	16.2	12.1	5.6	7.0	0.2	8.0	2.4	3.4	0.1	1.4	1.3	9.8	1.0	4.3	0.2	2.2	2.0	4.4	22.8	15.1	19.2	11.6	5.3	1.0	0.4	2.1	16.8	8.2	2.1	3.2	29.2	4.7	0.4	1.7	0.1	7.3	34.4	4.8	0.3	0.8	3.9	0.6	30.0	11.8	8.2	18.5	1.0	4.6	0.0	3.7	12.6	0.9	0.1	0.2	2.2	8.3	0.6	1.1	0.7	1.0	0.1	0.5	1.0	2.3	0.2	19.7	2.7	0.8	1.4	30.0	30.2	5.8	23.1	38.5	0.4	0.1	0.4	22.9	1.7	4.5	2.4	3.4	0.0	1.4	1.7	0.4	0.0	0.2	0.4	1.0	0.2	0.0	0.3	0.4	0.1	0.3	8.0	0.0	1.3	4.7	3.5	0.4	3.2	5.3	2.1	4.4	1.5	4.7	6.3	0.0	0.0	0.5	42.7	11.2	1.3	3.9	33.1	0.0	3.4	1.8	0.0	0.6	0.0	89.4	0.2	35.0	0.7	0.0	10.7	14.8	17.3	28.4	6.9	0.0	31.0	31.8	0.0	4.3	5.7	0.9	3.4	17.1	11.8	99.2	1.1	144.5	62.5	0.3	18.7	1.1	1.8	0.0	39.2	0.0	7.7	9.4	1.1	5.7	0.2	22.4
SPHK2		ENSG00000063176	"Sphingosine kinase 2"	Q9NRA0	19	48619291-48630717	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 66.9;Cone photoreceptor cells: 72.6;Rod photoreceptor cells: 83.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049062			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049062: "	"unprognostic (5.33e-2)"	"unprognostic (4.11e-2)"	"unprognostic (9.61e-2)"	"prognostic unfavorable (5.19e-4)"	"unprognostic (2.10e-1)"	"unprognostic (7.19e-3)"	"unprognostic (3.04e-1)"	"unprognostic (4.45e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (9.30e-4)"	"unprognostic (1.25e-1)"	"prognostic favorable (2.59e-5)"	"unprognostic (1.18e-2)"	"unprognostic (9.97e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.06e-2)"	9.3	8.9	12.6	9.9	13.0	5.2	5.1	13.6	22.0	7.2	12.9	13.4	4.9	33.2	7.4	4.2	4.9	7.3	7.8	4.7	22.5	14.8	19.3	15.2	6.1	8.7	26.3	14.9	9.1	7.2	15.0	9.5	4.1	22.3	8.7	6.2	7.2	7.5	8.0	6.1	4.3	22.2	4.9	14.1	8.4	11.3	17.2	13.7	4.0	9.1	3.1	5.3	6.2	12.4	10.4	7.4	12.5	9.4	7.2	7.0	4.2	4.1	11.9	4.4	8.1	4.9	2.0	8.4	4.5	3.8	5.2	6.3	20.3	5.4	7.7	3.1	2.9	3.1	3.1	4.1	3.6	0.7	8.7	9.8	8.5	5.2	7.0	7.7	5.4	9.4	3.7	2.0	3.6	2.5	2.5	2.9	10.5	5.5	6.9	2.6	4.3	12.8	33.8	5.9	3.1	5.8	11.8	3.6	5.0	2.4	2.8	16.1	12.7	4.3	6.8	4.3	2.6	3.7	3.7	4.5	7.5	4.2	5.8	8.9	13.3	15.3	8.5	4.3	6.3	6.7	12.5	8.3	3.6	6.0	9.4	5.9	6.5	4.8	5.8	7.4	10.4	6.6	7.0	3.3	7.2	7.4	6.6	4.6	4.2	12.6	13.0	13.6	22.0	22.5	14.8	26.3	14.9	22.3	13.7	6.0	7.7	5.4	4.8	3.0	66.9	1.0	7.6	2.7	4.5	10.4	72.6	5.9	1.7	5.3	8.2	6.4	28.6	0.0	4.4	5.3	5.2	5.4	4.6	17.3	7.6	42.9	15.5	4.9	10.7	9.0	15.3	6.3	3.3	7.2	9.2	22.9	6.0	11.5	12.0	13.5	83.3	6.5	5.4	18.7	6.4	2.5	3.8	16.6	12.8	3.6
SPTLC1	"hLCB1, HSAN1, HSN1, LCB1, SPTI"	ENSG00000090054	"Serine palmitoyltransferase long chain base subunit 1"	O15269	9	92000087-92115384	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 76.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010860, CAB018747, HPA063907"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB018747: AB_2195864, HPA010860: AB_1080086, HPA063907: AB_2685148"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.37e-2)"	"prognostic favorable (1.36e-6)"	"unprognostic (1.13e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.49e-1)"	16.4	17.7	13.3	11.4	17.1	9.9	16.8	19.9	17.6	20.3	17.2	20.9	18.1	14.0	17.3	15.1	30.5	19.2	15.5	11.4	13.9	15.3	19.0	13.5	14.8	10.6	18.0	12.2	35.3	15.8	23.6	23.1	28.3	20.5	14.5	18.8	12.0	18.5	13.3	9.4	20.1	17.8	15.1	20.8	10.7	16.0	19.8	14.1	9.7	26.2	16.0	16.5	17.4	20.9	9.3	21.0	21.1	22.1	10.2	15.2	16.0	18.4	16.8	11.6	9.7	28.4	22.2	20.1	19.4	24.9	16.8	18.3	10.5	38.7	10.2	12.4	24.6	20.4	48.5	12.5	16.5	19.6	11.8	7.3	9.4	9.5	10.2	21.4	15.5	12.7	19.9	20.0	17.4	18.9	16.0	15.3	11.0	21.9	12.7	19.1	19.9	9.7	3.8	15.6	20.9	12.2	10.8	14.1	7.8	16.7	11.3	9.4	8.8	26.2	20.1	11.8	14.5	10.3	9.2	19.4	16.4	12.7	18.8	13.5	9.2	12.6	5.7	19.6	7.7	19.6	14.6	22.1	11.9	11.5	21.6	11.0	8.9	11.6	11.6	21.0	9.3	14.2	10.7	21.1	10.2	19.2	10.8	15.2	16.0	13.3	17.1	19.9	17.6	13.9	15.3	18.0	12.2	20.5	14.1	35.7	41.3	10.3	9.6	9.4	8.1	3.7	2.5	40.2	35.2	34.9	13.7	10.9	8.3	46.0	76.8	8.7	7.7	0.0	49.5	11.1	12.2	7.8	23.2	4.4	9.7	6.4	2.4	6.7	6.5	22.6	5.8	22.2	11.8	28.9	6.2	11.3	47.8	4.0	5.6	22.6	7.9	12.9	10.3	33.1	25.8	8.0	18.2	11.4	6.0	13.2
SPTLC2	"hLCB2a, KIAA0526, LCB2, LCB2A"	ENSG00000100596	"Serine palmitoyltransferase long chain base subunit 2"	O15270	14	77505997-77616773	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027552			Approved	Mitochondria		Yes	No			Mitochondria		"HPA027552: AB_10601717"	"unprognostic (3.16e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.09e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (6.69e-8)"	"unprognostic (1.29e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.32e-1)"	30.0	12.8	15.4	11.4	27.0	27.3	25.6	6.9	18.5	15.3	17.0	32.4	8.5	13.4	10.2	7.6	22.8	13.7	11.1	7.8	20.8	14.1	17.1	7.2	12.2	17.5	33.1	13.3	10.2	7.6	12.8	9.8	18.8	21.2	8.2	18.8	6.0	16.6	9.6	5.5	11.3	15.8	11.0	47.6	23.5	18.8	4.7	34.9	10.0	10.3	8.8	12.0	13.2	17.1	4.8	18.2	15.1	18.2	10.0	4.2	6.9	12.1	8.0	6.1	6.7	6.3	8.0	10.5	18.1	13.4	12.5	13.1	10.1	27.1	12.1	4.6	18.3	6.4	15.0	16.3	10.1	19.0	5.3	4.8	34.4	6.2	6.0	5.4	3.5	11.4	5.2	5.0	8.1	9.1	7.1	17.5	8.4	6.7	5.9	7.1	10.5	9.1	11.9	4.0	19.2	7.2	9.9	6.3	4.1	14.4	27.3	5.9	7.5	6.5	21.8	6.8	11.3	26.8	6.4	11.0	11.5	8.2	4.2	4.1	3.3	5.5	8.2	7.6	12.4	6.5	8.8	18.2	15.1	3.8	13.8	3.5	4.1	3.2	4.2	18.2	4.8	2.2	3.6	11.2	10.0	16.7	6.5	3.3	6.9	15.4	27.0	6.9	18.5	20.8	14.1	33.1	13.3	21.2	34.9	26.8	23.5	25.0	21.1	28.7	13.3	7.3	10.2	24.1	27.3	45.4	33.4	10.3	1.7	21.2	1.4	32.3	28.5	46.7	14.2	10.9	16.6	24.2	49.7	6.6	21.7	4.8	12.7	57.1	63.4	1.5	13.6	29.2	18.6	15.4	36.9	10.3	24.7	28.1	14.9	9.1	18.8	32.3	8.6	6.7	16.0	25.5	5.5	22.7	27.5	47.7
SPTLC3	"C20orf38, FLJ11112, hLCB2b, LCB2B, SPTLC2L"	ENSG00000172296	"Serine palmitoyltransferase long chain base subunit 3"	Q9NUV7	20	13008979-13169103	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"placenta: 154.0"	"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 22.9;Syncytiotrophoblasts: 38.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"pons and medulla: 10.5"	"Group enriched"	"Detected in some"	5	"MAIT T-cell: 3.0;NK-cell: 4.1"	"Group enriched"	"Detected in many"	13	"NK-cells: 4.1;T-cells: 3.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 16.4;RPTEC TERT1: 21.8;U-2197: 15.2;U-87 MG: 28.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA044247, HPA048079"	Enhanced		Approved	Microtubules		NA	NA			Microtubules		"HPA044247: AB_2678872, HPA048079: AB_2680252"	"unprognostic (6.81e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.70e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (5.08e-2)"	"prognostic favorable (4.51e-7)"	"unprognostic (2.80e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.18e-1)"	3.2	4.5	1.3	1.6	2.2	0.0	4.3	1.7	1.7	4.3	5.0	2.2	4.4	8.3	4.8	9.6	5.6	3.4	5.8	4.8	2.0	1.5	15.6	11.9	5.7	0.7	2.5	2.2	4.3	3.8	10.2	4.2	154.0	10.5	4.5	3.8	3.8	7.8	5.8	1.0	25.1	9.0	3.0	6.9	1.9	2.2	4.2	1.4	5.7	24.3	3.6	1.9	4.8	6.0	0.0	0.2	0.1	0.0	4.1	3.0	0.2	0.7	1.1	0.9	0.0	7.1	10.3	5.5	0.0	1.5	1.0	4.1	8.9	4.5	0.0	0.5	0.2	9.0	12.2	0.0	3.4	1.4	0.0	0.0	0.0	2.8	12.6	0.6	0.0	0.1	5.8	10.7	4.0	1.4	3.8	0.7	2.1	0.0	16.4	11.5	0.2	0.0	0.0	0.0	1.0	1.4	1.1	2.0	7.2	21.8	8.7	0.0	0.1	0.1	1.1	0.0	1.6	9.1	0.2	1.6	4.6	1.5	15.2	1.0	0.1	0.0	0.0	28.8	0.0	0.0	0.1	0.0	0.0	0.5	0.0	3.0	0.0	0.4	0.1	0.0	0.0	0.7	0.1	0.1	4.1	0.0	0.2	0.0	0.2	1.3	2.2	1.7	1.7	2.0	1.5	2.5	2.2	10.5	1.4	6.0	18.2	0.0	4.8	2.2	0.0	15.1	5.1	4.0	6.8	8.7	0.0	22.9	6.6	2.2	15.0	2.2	4.9	0.0	3.8	10.5	7.2	3.4	1.1	18.7	2.5	0.0	0.0	0.6	2.5	8.5	3.4	0.9	0.0	0.0	4.7	13.6	2.5	8.0	2.5	11.9	0.0	0.0	0.3	0.9	0.1	1.9	38.6	1.3	6.1	1.8
ST3GAL1	"SIAT4A, SIATFL, ST3GalA.1, ST3O"	ENSG00000008513	"ST3 beta-galactoside alpha-2,3-sialyltransferase 1"	Q11201	8	133454848-133571940	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 143.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 47.7;RT4: 36.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040466	Approved				"Intracellular and membrane"	NA	NA		290000			"HPA040466: AB_10805712"	"unprognostic (1.36e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.83e-3)"	"unprognostic (5.53e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.83e-3)"	"unprognostic (1.67e-2)"	"unprognostic (3.29e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.95e-2)"	14.4	14.4	5.1	11.8	3.6	10.2	7.8	3.7	6.5	9.8	5.4	4.1	18.1	1.8	8.5	11.8	9.0	9.0	17.0	35.4	4.2	3.4	23.1	44.5	11.9	12.4	4.7	2.5	10.3	8.2	4.4	7.6	49.8	6.4	7.1	2.9	11.2	18.2	15.1	20.9	4.0	6.5	12.3	3.9	17.3	9.4	5.0	1.4	6.3	40.2	7.9	16.8	14.0	14.3	22.7	7.0	21.3	9.8	21.9	19.9	9.5	4.7	2.5	1.0	2.9	10.3	5.4	5.3	5.4	13.1	2.1	1.6	4.4	5.3	1.1	3.7	9.9	1.0	1.4	3.4	4.0	1.9	13.3	0.6	9.9	7.6	8.8	7.9	2.0	7.9	6.3	2.0	7.5	4.2	9.7	9.2	2.6	0.1	15.3	1.5	5.0	2.8	2.7	0.7	25.6	47.7	3.3	1.3	8.1	0.9	36.7	0.2	0.8	2.4	8.2	2.5	5.8	1.5	2.7	8.9	6.5	10.3	5.6	2.3	18.9	13.6	1.2	14.7	6.9	6.6	20.5	4.7	21.3	14.4	4.5	13.3	12.8	14.6	16.4	2.9	22.7	19.9	18.5	8.6	21.9	9.8	7.0	8.9	9.5	5.1	3.6	3.7	6.5	4.2	3.4	4.7	2.5	6.4	1.4	6.0	58.6	36.0	6.4	5.0	7.4	59.9	12.7	8.1	21.6	1.8	2.0	8.2	5.0	34.3	2.8	41.9	0.0	23.3	21.6	34.2	37.0	10.6	8.1	143.6	32.3	57.2	0.0	33.7	44.5	0.9	33.9	42.2	13.5	78.5	0.4	10.1	25.8	0.0	67.5	39.3	21.7	12.9	32.2	0.2	1.9	3.0	22.1	43.7	0.0	37.3
ST3GAL2	"SIAT4B, ST3GalA.2, ST3GALII"	ENSG00000157350	"ST3 beta-galactoside alpha-2,3-sialyltransferase 2"	Q16842	16	70375978-70439237	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017270	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA017270: AB_1857523"	"unprognostic (2.76e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.99e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (1.14e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.91e-2)"	"prognostic favorable (2.33e-4)"	"unprognostic (9.54e-2)"	"prognostic unfavorable (3.34e-6)"	"unprognostic (7.42e-2)"	"unprognostic (8.83e-3)"	"unprognostic (4.64e-2)"	"unprognostic (5.20e-2)"	12.6	9.1	9.3	17.2	11.9	14.3	8.9	24.1	10.6	11.3	8.8	5.1	9.3	9.2	13.9	5.6	5.8	9.0	6.8	9.2	10.4	6.0	8.8	12.9	9.3	14.9	5.1	4.7	13.6	4.2	8.8	7.2	8.8	6.8	7.5	4.7	9.9	4.9	9.0	33.3	6.0	10.5	12.0	4.0	17.7	5.4	9.6	5.9	16.0	6.6	4.9	12.6	9.1	12.0	3.2	14.3	11.2	2.2	2.8	4.2	1.1	1.4	8.5	7.4	9.8	4.0	5.4	1.7	6.0	6.4	6.7	3.3	5.1	3.3	4.1	10.8	6.5	6.0	1.0	2.9	2.5	3.2	9.7	4.7	17.5	3.5	7.6	4.9	6.4	28.9	4.1	1.4	6.8	1.2	8.2	9.2	7.1	23.9	4.0	3.7	0.7	6.7	17.5	10.0	2.8	4.6	12.9	2.8	5.5	4.5	1.1	3.3	9.7	15.1	0.3	6.6	8.0	1.6	7.1	9.8	8.5	10.2	3.6	4.4	8.4	3.3	8.4	9.3	5.4	11.9	2.7	2.0	5.7	2.0	2.2	1.9	1.7	2.4	2.2	1.0	3.2	4.2	3.3	11.2	2.8	1.3	14.3	2.7	1.1	9.3	11.9	24.1	10.6	10.4	6.0	5.1	4.7	6.8	5.9	8.9	6.9	13.0	3.6	3.0	15.1	5.6	10.2	1.4	2.3	8.7	13.7	3.7	0.0	5.4	14.0	13.1	5.1	46.7	3.8	1.6	10.6	2.2	17.3	11.5	11.6	17.5	12.7	14.7	10.0	25.8	10.9	14.4	1.7	23.4	4.0	5.1	2.4	0.0	7.8	5.0	10.2	6.5	7.1	5.4	8.1	2.0	1.5	8.6	5.2	1.8
ST3GAL4	"CGS23, FLJ11867, NANTA3, SAT3, SIAT4, SIAT4C, STZ"	ENSG00000110080	"ST3 beta-galactoside alpha-2,3-sialyltransferase 4"	Q11206	11	126355640-126440344	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 74.2"	"Cell type enriched"	"Detected in many"	9	"Syncytiotrophoblasts: 804.9"	"Cancer enhanced"	"Detected in all"		"melanoma: 57.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 31.3;neutrophil: 22.8;plasmacytoid DC: 29.6"	"Group enriched"	"Detected in many"	11	"dendritic cells: 29.6;granulocytes: 31.3"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 45.3;WM-115: 102.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA049827	Approved				"Intracellular and membrane"	NA	NA					"HPA049827: AB_2680900"	"unprognostic (8.89e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.93e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.90e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.16e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.36e-3)"	"unprognostic (8.78e-3)"	7.8	38.0	6.2	6.5	12.2	7.8	12.9	4.0	13.6	8.3	27.0	26.4	5.1	2.0	6.0	42.1	25.5	6.0	11.4	26.5	8.6	6.2	16.7	11.5	12.4	9.0	18.7	9.0	39.3	5.1	0.8	5.6	74.2	13.8	12.1	31.5	35.7	14.4	8.0	1.9	5.6	3.8	11.0	23.0	17.0	4.8	18.8	12.4	2.2	6.1	4.3	10.1	21.1	13.2	0.1	29.6	31.3	2.6	1.2	1.7	1.8	4.9	4.1	3.2	2.7	9.5	7.9	8.0	5.7	11.1	5.2	3.6	2.4	8.5	1.4	4.3	9.0	17.7	7.7	6.7	3.7	4.1	5.3	1.9	12.6	10.2	2.7	6.2	15.0	25.8	6.3	6.0	7.8	12.4	9.6	6.9	5.5	7.8	3.8	6.4	20.2	4.7	15.4	2.0	31.9	26.8	4.9	9.9	0.6	1.2	14.2	6.1	3.9	6.3	38.2	45.3	2.2	13.3	10.0	2.5	12.5	2.8	8.8	10.7	0.3	0.8	0.7	5.7	23.0	102.8	31.3	1.6	0.2	1.7	2.6	1.6	0.1	0.6	1.1	6.6	0.0	0.1	0.8	22.8	1.2	1.2	29.6	0.0	1.8	6.2	12.2	4.0	13.6	8.6	6.2	18.7	9.0	13.8	12.4	8.9	1.1	3.7	5.3	9.4	4.2	26.6	7.6	1.4	4.5	29.6	9.8	90.3	41.4	4.3	1.1	9.8	34.8	0.0	5.6	59.0	44.0	13.8	41.5	8.9	16.2	4.8	5.1	36.8	4.1	3.8	70.5	7.2	74.2	10.8	43.5	5.0	7.3	93.0	88.1	3.4	8.3	12.9	23.6	1.4	3.8	5.8	804.9	12.2	8.8	13.1
ST3GAL5	"SIAT9, SIATGM3S, ST3GalV"	ENSG00000115525	"ST3 beta-galactoside alpha-2,3-sialyltransferase 5"	Q9UNP4	2	85837120-85905199	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 40.1"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 80.4;Alveolar cells type 2: 105.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 41.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 26.2;RT4: 22.2;SK-MEL-30: 18.4;U-266/84: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034708, HPA040425, HPA068928"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA034708: AB_10601594, HPA040425: AB_2676978, HPA068928: AB_2686060"	"unprognostic (7.90e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.45e-2)"	"unprognostic (5.03e-3)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.25e-7)"	"unprognostic (2.22e-1)"	"unprognostic (5.74e-2)"	"prognostic favorable (4.99e-4)"	"prognostic favorable (4.48e-4)"	8.0	40.1	15.3	7.2	18.5	4.1	4.2	9.9	34.9	3.3	3.8	18.8	0.0	2.7	8.0	2.9	2.9	4.9	11.8	2.1	14.8	12.0	2.4	7.0	18.0	11.5	14.0	13.4	7.2	2.9	1.5	7.4	24.1	18.1	4.8	5.0	18.7	4.8	2.2	9.5	5.0	3.4	6.2	18.0	11.1	4.1	9.0	13.4	5.5	36.7	0.4	6.9	30.9	7.8	2.5	1.1	1.3	6.1	1.4	1.8	0.5	0.1	12.8	1.2	26.2	10.9	5.9	3.9	2.8	8.6	2.7	2.4	0.2	9.3	0.3	0.1	4.8	1.2	0.5	1.7	3.0	3.4	0.1	1.5	0.2	0.5	0.4	8.7	0.1	3.8	3.3	0.4	1.0	0.4	4.9	6.5	3.5	0.3	14.5	8.8	0.8	0.8	1.4	0.1	4.4	0.0	1.6	8.3	5.1	1.4	22.2	1.8	1.8	0.1	0.0	18.4	2.7	0.1	0.5	2.1	0.0	1.3	0.0	0.2	14.6	19.3	0.2	2.1	2.6	13.2	0.9	1.8	0.1	1.4	6.1	1.8	2.5	0.8	0.9	1.1	1.5	0.7	0.8	1.3	1.4	5.1	0.4	0.3	0.5	15.3	18.5	9.9	21.9	14.8	12.0	14.0	13.4	18.1	13.4	80.4	105.8	40.9	24.7	4.9	49.5	1.6	30.6	14.7	50.0	3.5	55.0	0.3	3.3	8.1	9.5	5.2	0.0	0.0	14.5	0.5	10.3	8.0	33.5	15.5	30.3	68.3	6.4	33.2	46.9	8.7	7.5	25.6	30.4	12.6	0.0	52.2	6.7	0.0	1.8	2.9	41.0	0.0	5.0	6.9	20.0	3.3	0.2	19.7	0.0	5.1
ST6GALNAC2	"SIAT7, SIAT7B, SIATL1, ST6GalNAII, STHM"	ENSG00000070731	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2"	Q9UJ37	17	76565379-76586956	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 78.2"	"Group enriched"	"Detected in many"	11	"Early spermatids: 447.7;Late spermatids: 1248.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"pons and medulla: 19.2"	"Cell type enriched"	"Detected in some"	9	"neutrophil: 23.5"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 23.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 9.6;HaCaT: 11.8;HBEC3-KT: 10.7;hTCEpi: 30.0;MCF7: 11.6;SK-MEL-30: 39.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA						"unprognostic (8.93e-3)"	"unprognostic (5.86e-3)"	"unprognostic (1.67e-2)"	"unprognostic (5.18e-3)"	"unprognostic (3.37e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.37e-2)"	"unprognostic (5.69e-2)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (1.57e-1)"	"unprognostic (5.17e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	4.3	1.7	0.6	2.7	1.8	0.4	7.0	0.4	1.3	8.6	7.2	6.0	3.6	0.4	2.6	8.8	17.2	28.3	2.1	4.6	2.1	1.3	10.6	1.3	11.3	1.7	4.0	1.0	5.0	3.6	1.5	2.1	18.3	19.2	6.7	3.4	78.2	6.6	6.1	11.3	27.3	2.5	4.7	3.7	2.0	3.5	17.1	1.3	0.7	17.7	12.4	6.9	8.3	7.6	0.0	0.2	23.5	1.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.2	0.0	9.6	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.2	0.7	0.0	11.8	0.1	10.7	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	30.0	0.0	3.4	1.4	0.0	0.0	0.0	0.0	0.1	11.6	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	3.2	0.1	0.0	1.3	0.0	39.0	0.6	7.6	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	1.1	2.6	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	23.5	0.0	0.1	0.0	0.0	0.1	0.6	1.8	0.4	1.3	2.1	1.3	4.0	1.0	19.2	1.3	0.0	1.0	0.5	34.2	29.2	6.0	4.8	5.1	9.4	6.8	0.0	25.5	7.7	0.0	0.1	447.7	3.1	1.3	0.0	0.0	15.3	3.4	4.5	1.1	0.8	2.8	0.0	0.0	9.2	5.6	1248.1	6.9	2.4	62.4	1.0	3.4	71.0	0.1	0.0	6.7	0.3	74.9	19.4	3.1	8.4	4.4	26.5	8.8	2.2	1.5	31.0
ST6GALNAC3	SIAT7C	ENSG00000184005	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3"	Q8NDV1	1	76074719-76634601	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	23	"Endothelial cells: 21.6;Ito cells: 57.1;Kupffer cells: 11.7;Muller glia cells: 11.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 18.6;HUVEC TERT2: 23.6;SK-MEL-30: 32.2;TIME: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054566, HPA055399"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA054566: AB_2682526, HPA055399: AB_2682806"	"unprognostic (7.85e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.70e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.55e-3)"	"unprognostic (7.31e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.97e-4)"	"unprognostic (3.33e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.44e-4)"	20.7	2.9	7.0	3.6	13.0	5.3	13.9	3.8	9.7	4.3	4.0	13.4	2.0	1.8	10.7	2.1	3.8	4.2	4.7	7.8	8.8	6.0	14.9	3.9	7.5	5.1	16.3	3.6	4.7	2.2	12.6	4.3	5.7	12.9	2.5	4.7	2.8	2.3	3.5	3.3	1.9	2.7	8.3	19.0	3.0	3.0	1.2	12.5	0.0	23.2	1.5	1.7	5.5	5.2	5.9	3.0	5.2	8.3	0.4	1.9	2.6	0.1	0.0	18.6	0.0	0.3	0.0	0.0	0.0	2.2	0.3	0.2	6.0	0.0	0.3	1.2	0.1	1.2	0.0	0.0	0.2	0.1	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.5	23.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	1.4	0.0	0.9	0.8	0.0	0.0	0.0	1.4	4.6	0.0	0.0	32.2	4.5	0.0	0.1	10.4	0.1	1.5	0.0	1.7	0.0	0.0	0.0	0.0	4.2	2.8	0.0	8.3	3.7	0.0	2.9	0.0	3.3	0.5	0.8	3.0	5.9	1.9	1.9	5.2	0.4	5.3	0.0	0.0	2.6	7.0	13.0	3.8	9.7	8.8	6.0	16.3	3.6	12.9	12.5	3.0	1.0	1.3	0.1	0.2	3.0	1.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.4	0.8	0.0	0.0	57.1	11.7	0.4	0.0	1.5	5.0	0.0	0.3	11.0	0.2	3.2	0.0	0.0	0.5	0.0	0.3	0.2	0.4	0.4	0.1	0.0	0.0	0.1
ST6GALNAC4	"SIAT3C, SIAT7D, ST6GALNACIV"	ENSG00000136840	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4"	Q9H4F1	9	127907886-127917038	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 58.8;pancreas: 61.0"	"Cell type enhanced"	"Detected in many"	6	"Intestinal endocrine cells: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"plasmacytoid DC: 58.8"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 58.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 35.5;RPMI-8226: 50.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009042			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA009042: AB_1079963"	"unprognostic (2.05e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (8.63e-7)"	"unprognostic (1.62e-2)"	"unprognostic (4.26e-1)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (8.39e-4)"	"unprognostic (1.30e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.03e-2)"	8.0	7.8	5.6	7.9	5.6	26.2	12.1	9.8	8.5	9.2	9.3	4.8	28.9	11.7	8.7	9.6	6.9	8.7	12.2	18.4	5.2	3.4	9.4	5.0	13.5	9.7	4.2	4.7	14.9	61.0	2.4	9.4	4.3	4.8	6.1	5.4	4.8	9.3	30.0	12.6	4.0	9.7	6.1	3.9	18.2	7.2	4.3	4.7	4.7	6.3	5.9	12.5	8.9	8.3	6.7	58.8	0.8	3.2	4.3	3.4	2.4	3.2	5.5	1.4	7.0	9.9	7.6	1.0	5.6	6.2	5.7	3.3	3.1	5.9	20.5	8.5	7.0	8.1	7.9	2.9	5.9	0.9	35.5	2.4	6.5	17.6	11.6	12.1	0.5	6.8	9.2	6.3	5.1	4.6	4.6	15.2	3.9	4.6	13.7	2.7	1.5	1.2	0.7	1.6	10.5	13.6	6.2	3.7	50.3	5.8	0.1	12.0	2.7	8.1	17.6	1.0	0.5	3.6	4.2	10.8	4.7	5.4	14.6	8.7	22.4	11.5	6.4	9.4	2.9	0.6	0.8	2.1	0.0	2.9	1.9	3.3	6.7	1.8	3.4	2.8	4.9	2.3	3.1	0.2	4.3	3.2	58.8	3.3	2.4	5.6	5.6	9.8	8.5	5.2	3.4	4.2	4.7	4.8	4.7	8.9	24.5	43.4	11.9	1.9	2.4	10.3	10.2	5.3	4.5	1.8	0.0	0.9	1.7	14.0	0.1	10.8	19.6	23.3	12.5	14.4	11.9	2.0	8.1	1.5	22.1	0.0	65.1	4.9	11.4	0.0	16.1	8.5	6.8	12.6	13.1	14.1	11.9	6.5	40.3	17.3	1.7	12.9	8.9	0.2	1.3	2.8	3.8	10.2	16.4	10.0
ST6GALNAC5	"MGC3184, SIAT7E, ST6GalNAcV"	ENSG00000117069	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5"	Q9BVH7	1	76867441-77065711	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.4"	"Cell type enriched"	"Detected in some"	7	"Alveolar cells type 1: 50.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.9"	"Group enriched"	"Detected in many"	4	"amygdala: 22.1;basal ganglia: 22.3;cerebral cortex: 12.7;hippocampal formation: 29.4;olfactory region: 14.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.1;fHDF/TERT166: 10.9;HaCaT: 5.2;SH-SY5Y: 7.9;U-2 OS: 9.0;U-251 MG: 5.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA065593, HPA070354"	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA065593: AB_2685515, HPA070354: AB_2686260"	"unprognostic (1.32e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.90e-3)"	"unprognostic (9.66e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.69e-2)"	0.7	10.1	22.1	5.2	22.3	0.4	4.2	0.6	12.7	2.9	3.4	0.3	0.0	1.4	0.9	0.7	3.7	6.9	12.6	1.4	29.4	2.7	0.7	0.6	12.1	1.6	3.0	14.2	6.5	0.8	0.4	8.5	0.9	4.7	4.2	2.7	5.8	1.5	1.6	0.6	1.0	2.1	10.2	0.8	1.0	3.7	1.2	0.2	0.0	0.6	0.0	1.4	4.2	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.4	2.4	0.0	9.1	0.0	0.0	0.0	0.0	0.8	3.2	2.6	0.8	0.0	0.2	0.0	0.0	10.9	0.0	5.2	0.0	0.1	2.8	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.7	0.6	0.0	0.1	2.5	7.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	9.0	0.0	5.0	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	22.1	22.3	0.6	12.7	29.4	2.7	3.0	14.2	4.7	0.2	50.6	0.3	0.0	0.0	0.0	7.3	0.4	0.0	1.4	1.2	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.6	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.0	0.1
ST6GALNAC6	"SIAT7F, ST6GALNACVI"	ENSG00000160408	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6"	Q969X2	9	127885321-127905408	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 94.1;Mucus-secreting cells: 109.4;Paneth cells: 153.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"NK-cells: 12.7;T-cells: 16.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 52.7"									HPA018890	Approved				"Intracellular and membrane"	NA	NA					"HPA018890: AB_1857531"	"unprognostic (2.27e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.84e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.24e-3)"	"unprognostic (3.31e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.10e-2)"	"unprognostic (9.85e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.67e-2)"	39.3	12.9	45.1	9.7	40.8	7.7	59.6	23.4	37.4	17.2	44.5	8.7	18.6	5.5	14.8	27.3	21.0	31.1	17.8	22.8	38.2	17.0	13.2	18.1	23.5	13.7	18.3	28.3	39.4	19.1	12.7	7.8	10.8	13.6	12.8	72.9	9.6	14.5	22.0	18.9	9.8	9.8	21.9	9.6	18.7	12.1	6.9	15.9	2.3	9.6	9.1	11.2	16.7	29.2	3.3	1.1	2.7	2.8	12.7	16.0	6.5	3.6	3.3	6.5	11.7	52.7	28.5	2.5	9.3	21.4	13.6	11.2	5.5	3.1	3.7	4.1	21.2	9.4	6.2	8.4	6.9	6.3	17.7	4.7	3.9	5.4	5.6	13.8	1.1	6.4	28.9	8.5	9.9	4.4	19.2	13.5	3.7	3.6	4.6	17.5	3.1	2.3	6.1	2.8	3.5	5.9	7.3	8.1	4.5	10.9	0.7	4.1	6.1	6.4	2.6	2.4	4.7	3.1	7.8	8.1	8.1	4.9	8.9	5.1	5.6	3.4	6.9	7.6	1.3	2.8	2.7	0.7	0.1	16.0	1.1	11.7	3.3	10.3	11.5	1.0	2.6	6.5	8.4	0.4	12.7	2.8	1.1	15.3	6.5	45.1	40.8	23.4	37.4	38.2	17.0	18.3	28.3	13.6	15.9	3.0	7.0	15.2	14.5	20.6	18.2	7.0	7.6	4.0	2.3	0.0	5.9	3.2	0.0	0.4	1.7	22.5	94.1	23.3	0.3	6.5	34.0	11.5	6.9	24.2	10.8	23.8	37.0	35.0	6.9	4.7	61.5	5.8	23.6	2.8	109.4	31.6	0.4	153.1	57.3	0.0	6.4	84.1	72.1	1.0	4.3	23.5	3.0	29.8	56.2	15.7
ST8SIA1	"SIAT8, SIAT8A"	ENSG00000111728	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1"	Q92185	12	22063773-22437041	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.2"	"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 43.2;granulocytes: 32.4;Muller glia cells: 41.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"granulocytes: 1.2;T-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"AF22: 9.1;ASC TERT1: 6.0;hTERT-RPE1: 4.2;RPTEC TERT1: 4.6;SK-MEL-30: 8.3;WM-115: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026775	Approved					NA	NA					"HPA026775: AB_1857534"	"unprognostic (1.98e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.79e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.37e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.07e-8)"	"unprognostic (1.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.16e-2)"	1.7	7.6	7.0	5.3	6.2	2.3	5.9	20.2	13.0	3.5	5.4	2.3	2.3	0.4	4.5	1.4	3.0	2.3	2.4	4.4	7.6	8.5	1.1	0.6	3.8	8.6	7.6	6.5	2.6	1.2	7.2	0.6	0.4	9.4	6.6	3.5	1.5	3.2	4.4	1.0	4.3	2.1	6.3	10.9	2.7	2.1	1.0	4.8	0.2	1.4	0.5	9.2	6.7	3.1	0.3	0.2	1.2	0.2	0.3	3.0	0.6	0.1	0.5	9.1	0.0	1.4	6.0	0.9	0.0	0.0	0.1	0.4	0.3	0.1	1.1	0.0	0.0	0.2	0.4	0.0	0.2	0.6	0.0	0.0	1.1	0.1	0.1	0.0	0.3	0.1	0.5	0.9	0.1	0.9	4.2	0.2	0.1	0.0	0.6	0.2	0.0	1.2	0.3	2.3	3.5	0.0	0.0	0.2	0.2	4.6	0.0	0.1	0.2	0.0	0.1	8.3	0.3	0.7	0.1	0.0	0.7	0.9	0.1	1.4	0.7	0.5	0.7	1.4	0.1	9.0	1.2	0.2	0.2	0.4	0.1	0.9	0.1	2.9	2.3	0.1	0.3	0.4	1.0	0.9	0.3	0.2	0.2	3.0	0.6	7.0	6.2	20.2	13.0	7.6	8.5	7.6	6.5	9.4	4.8	0.0	2.6	0.0	0.4	3.9	7.5	3.1	0.0	8.1	2.3	0.0	43.2	3.0	1.7	0.0	5.3	0.7	0.0	0.0	0.0	10.1	3.0	3.7	32.4	0.0	0.7	4.8	0.0	0.0	0.0	3.0	0.3	0.0	11.8	0.0	0.0	41.7	0.0	0.0	0.0	0.2	2.8	0.0	1.2	3.9	5.5	2.0	3.1	4.3	0.0	0.1
ST8SIA4	"PST, PST1, SIAT8D"	ENSG00000113532	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4"	Q92187	5	100806935-100903266	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 37.1;lymphoid tissue: 34.7"	"Cell type enhanced"	"Detected in many"	11	"Kupffer cells: 79.2;Macrophages: 44.4;monocytes: 119.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 37.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 37.1"	"Cell line enhanced"	"Detected in many"		"AF22: 19.1;HDLM-2: 30.8;Karpas-707: 26.5;NB-4: 12.4;RPMI-8226: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051126, HPA053995"	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		580000	"Golgi apparatus"		"HPA051126: AB_2681352, HPA053995: AB_2682336"	"unprognostic (2.25e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (7.80e-7)"	"unprognostic (6.07e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.23e-2)"	11.7	2.7	4.3	16.7	4.3	8.2	6.5	1.3	4.2	3.4	5.3	2.6	0.3	4.0	2.3	4.2	4.3	3.5	6.5	4.7	4.0	8.0	2.6	3.3	17.5	27.9	5.1	1.7	2.5	2.1	1.5	2.4	13.7	11.6	3.4	5.6	2.7	4.0	1.3	2.0	2.1	7.7	3.6	8.0	31.6	3.7	1.6	4.3	34.7	4.9	0.8	13.8	7.4	3.5	4.7	4.9	37.1	8.9	4.0	6.9	4.4	0.0	2.8	19.1	0.0	1.2	1.8	0.4	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.4	0.0	0.0	30.8	0.0	1.1	0.2	0.0	0.0	5.7	2.3	1.5	0.0	0.0	0.0	2.5	3.5	4.6	0.0	26.5	1.1	0.2	8.1	12.4	0.1	0.0	0.1	4.6	0.3	19.7	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	5.2	1.2	0.2	0.1	0.0	0.3	8.7	8.8	1.7	0.4	7.1	2.3	18.8	7.5	8.9	5.7	8.8	4.3	4.7	3.8	4.7	4.9	3.6	2.4	4.5	37.1	4.0	8.9	1.5	6.9	4.4	4.3	4.3	1.3	4.2	4.0	8.0	5.1	1.7	11.6	4.3	6.0	13.1	25.4	0.2	7.3	0.4	2.0	0.0	26.8	15.9	0.0	0.0	7.7	1.7	0.0	0.2	16.4	0.0	0.0	0.0	31.1	6.1	0.1	23.1	0.0	20.9	0.0	0.0	7.4	79.2	0.0	0.0	44.4	13.5	119.0	0.0	3.9	0.0	0.0	0.4	0.3	0.6	12.9	5.7	0.4	0.7	4.8	16.0	28.0	0.0	0.4
ST8SIA5	SIAT8E	ENSG00000101638	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5"	O15466	18	46667821-46759257	"Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 12.8;brain: 36.4"	"Cell type enhanced"	"Detected in some"	16	"Cardiomyocytes: 6.9;Collecting duct cells: 1.8;Early spermatids: 2.7;Late spermatids: 5.2"	"Cancer enriched"	"Detected in single"	8	"glioma: 2.6"	"Region enhanced"	"Detected in many"		"cerebellum: 36.4"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"WM-115: 52.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043813, HPA046771"	Approved		Approved	"Plasma membrane,Midbody"		NA	NA			"Plasma membrane, Midbody"		"HPA043813: AB_2678683, HPA046771: AB_2679798"	"unprognostic (3.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.33e-4)"	"unprognostic (2.99e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.55e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-2)"	0.6	12.8	3.6	0.6	7.8	0.9	0.5	36.4	16.1	0.5	0.5	1.0	0.0	0.7	0.5	0.9	0.4	0.7	0.6	7.2	4.0	1.8	1.5	0.4	0.5	0.5	2.0	6.9	0.7	0.4	4.9	0.7	0.4	4.1	0.6	0.5	0.0	0.4	0.5	8.2	0.7	0.5	0.5	2.5	0.5	0.7	0.9	0.7	0.0	0.6	0.0	0.5	0.5	0.1	0.8	0.4	1.5	0.4	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.1	0.1	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	52.9	1.0	0.4	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.0	0.8	0.3	0.3	1.5	0.5	0.2	0.4	0.1	0.0	3.6	7.8	36.4	16.1	4.0	1.8	2.0	6.9	4.1	0.7	0.0	0.0	0.0	0.0	0.0	1.0	6.9	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.4	0.0	0.7	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0
STT3A	"ITM1, MGC9042, STT3-A, TMC"	ENSG00000134910	"STT3A, catalytic subunit of the oligosaccharyltransferase complex"	P46977	11	125591712-125625215	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 202.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030735	Approved		Uncertain	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Vesicles	"HPA030735: AB_10603342"	"unprognostic (8.25e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.02e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (3.57e-4)"	"unprognostic (8.40e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.82e-2)"	20.6	20.5	8.3	13.1	11.7	8.3	16.9	10.7	13.9	27.8	19.3	17.7	39.6	12.0	30.5	41.4	19.6	20.8	15.1	19.5	8.3	9.1	26.2	67.1	18.7	14.9	9.3	7.7	30.1	59.0	202.3	27.5	35.9	11.6	22.2	17.4	20.8	50.7	41.4	9.5	12.9	19.8	17.1	12.3	21.8	17.7	17.1	6.7	19.2	38.6	13.6	20.8	19.5	18.0	15.0	53.2	27.0	15.5	17.2	27.5	13.4	21.0	19.2	24.5	33.6	46.2	35.8	26.3	38.5	46.0	31.3	39.2	58.2	56.9	27.4	46.7	56.6	44.4	38.9	33.9	33.7	41.7	21.3	18.0	64.5	13.2	40.2	51.1	38.6	30.3	27.6	24.5	43.4	84.8	36.9	34.9	12.3	27.1	41.1	39.5	15.5	15.5	12.3	15.7	42.1	20.9	18.4	20.9	41.2	34.2	32.7	15.2	13.2	27.2	44.5	13.7	30.0	52.2	27.8	31.2	45.2	16.3	19.0	30.2	12.9	15.1	21.1	17.4	39.1	35.8	27.0	15.5	11.6	19.7	14.8	27.5	15.0	19.1	18.2	21.6	11.6	13.8	16.0	5.4	17.2	13.0	53.2	14.1	13.4	8.3	11.7	10.7	13.9	8.3	9.1	9.3	7.7	11.6	6.7	26.8	23.5	18.2	11.3	14.3	10.2	18.6	12.7	14.7	14.8	15.7	19.6	40.7	1.7	26.7	7.6	11.9	13.5	23.3	23.5	56.2	25.7	16.7	16.2	32.7	27.0	1.6	15.0	33.2	22.3	2.6	19.8	13.2	23.6	8.2	32.3	15.2	29.5	14.0	17.7	11.9	13.8	19.4	10.3	29.9	10.9	12.9	38.1	13.3	22.9	12.9
STT3B	"FLJ90106, SIMP, STT3-B"	ENSG00000163527	"STT3B, catalytic subunit of the oligosaccharyltransferase complex"	Q8TCJ2	3	31532638-31637622	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036448, HPA036646"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		9300	"Endoplasmic reticulum"		"HPA036448: AB_2675129, HPA036646: AB_10673472"	"unprognostic (2.17e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (7.91e-5)"	"unprognostic (1.60e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.86e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.02e-1)"	23.0	30.3	16.0	27.5	16.7	21.7	27.4	15.4	19.4	28.4	25.0	16.9	37.0	18.6	28.4	37.9	28.8	22.4	29.0	27.5	15.1	15.6	28.2	64.1	30.1	36.9	16.5	15.5	62.3	39.4	36.2	20.3	85.9	16.5	26.3	25.1	22.3	25.2	26.3	31.2	19.2	29.2	23.2	19.7	29.4	22.9	36.7	13.6	60.2	44.3	23.4	30.3	27.5	27.7	3.6	7.7	8.4	5.3	8.4	8.5	3.0	16.6	28.0	25.8	27.0	32.5	32.8	56.4	31.3	27.5	23.4	27.2	25.5	36.2	29.0	15.4	28.3	19.3	14.1	23.8	27.1	30.8	81.6	15.7	24.8	28.5	27.1	25.1	53.5	29.7	25.1	29.1	33.3	42.2	36.2	23.6	37.2	13.3	46.5	31.8	9.4	52.3	33.1	20.8	27.9	15.8	54.7	14.0	42.0	27.2	24.1	11.0	13.4	31.0	46.1	18.1	23.0	20.7	28.6	45.9	31.7	20.3	31.3	27.5	29.3	35.1	24.3	28.7	36.8	26.0	2.3	4.6	8.4	4.7	5.3	7.5	3.4	8.5	6.5	4.0	3.6	8.2	6.5	1.7	8.4	3.7	7.7	4.1	3.0	16.0	16.7	15.4	19.4	15.1	15.6	16.5	15.5	16.5	13.6	80.4	51.9	42.7	51.5	60.6	48.3	64.1	56.0	40.2	88.7	41.8	64.8	58.7	11.6	32.8	125.1	35.0	40.6	0.0	38.9	84.1	47.2	61.2	31.1	58.2	50.2	42.9	43.4	38.6	46.8	186.1	33.6	58.1	49.0	9.0	50.8	36.3	38.5	49.1	30.8	26.4	33.6	25.8	38.9	61.2	52.7	54.1	79.8	62.1	51.2	55.9
TMPPE	FLJ45032	ENSG00000188167	"Transmembrane protein with metallophosphoesterase domain"	Q6ZT21	3	33090421-33096801	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	5	"Alveolar cells type 2: 2.2;Rod photoreceptor cells: 2.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	6	"BEWO: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027019	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			"Nucleoplasm, Mitochondria"		"HPA027019: AB_1848942"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.34e-3)"	"unprognostic (8.14e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-7)"	"unprognostic (1.61e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.33e-2)"	6.3	5.4	3.7	6.8	5.2	20.3	6.8	5.3	7.4	4.5	6.9	4.1	7.4	6.4	6.5	12.0	7.0	5.4	9.9	4.4	3.6	3.7	13.9	13.1	9.3	9.6	3.5	3.0	5.7	9.7	12.1	5.2	8.4	4.9	4.6	6.5	9.0	7.7	6.5	3.8	10.3	11.0	4.6	3.8	7.2	6.8	3.2	2.3	2.4	9.5	2.2	7.2	5.3	5.0	0.8	2.2	4.2	5.5	0.1	1.4	0.9	1.3	1.7	1.0	1.6	1.2	1.0	25.5	0.6	0.9	1.5	0.9	2.5	3.5	0.7	1.1	1.6	0.8	1.4	1.6	1.4	2.5	3.8	0.6	3.1	1.7	1.9	0.8	2.6	4.5	1.1	1.2	1.9	1.3	0.7	1.8	1.6	2.3	2.7	1.1	1.2	1.1	1.2	1.0	0.3	1.0	1.3	0.5	1.7	1.4	1.7	0.2	0.6	0.8	2.4	0.6	1.3	1.3	3.8	2.5	2.3	2.9	1.2	2.4	2.2	1.4	0.4	2.9	2.0	1.5	0.0	2.3	0.7	0.4	5.5	1.4	0.8	0.5	0.1	2.2	0.3	0.0	0.0	4.2	0.1	2.3	0.4	0.5	0.9	3.7	5.2	5.3	7.4	3.6	3.7	3.5	3.0	4.9	2.3	0.0	2.2	0.0	0.0	0.7	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.1	1.3	0.0	0.7	1.2	0.3	0.2	0.0	0.2	0.8	1.6	0.0	0.6	1.2	0.0	0.0	0.5	0.0	0.0	0.2	0.4	0.4	0.9	0.4	0.3	2.1	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.6	0.1
UGCG	GCS	ENSG00000148154	"UDP-glucose ceramide glucosyltransferase"	Q16739	9	111896766-111935369	"Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Urothelial cells: 446.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	19	"plasmacytoid DC: 39.7"	"Lineage enriched"	"Detected in many"	19	"dendritic cells: 39.7"	"Cell line enhanced"	"Detected in all"		"LHCN-M2: 50.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024124	Approved					NA	NA					"HPA024124: AB_1858595"	"unprognostic (1.22e-2)"	"prognostic favorable (6.62e-4)"	"unprognostic (5.39e-2)"	"prognostic favorable (4.44e-5)"	"unprognostic (1.53e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.84e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.77e-2)"	33.7	37.7	5.9	21.4	7.8	55.2	20.5	9.5	11.2	14.6	19.6	5.0	3.3	13.3	10.6	8.6	34.0	11.1	24.5	17.5	8.6	9.0	23.8	18.4	28.1	35.4	7.1	5.8	15.9	11.4	3.5	11.9	15.3	6.8	12.4	10.5	11.9	10.8	5.4	14.0	21.7	25.5	12.4	12.9	33.1	26.1	11.7	6.2	17.9	8.5	16.9	27.7	34.2	25.9	2.0	39.7	0.4	0.3	0.5	1.2	0.5	23.1	2.4	4.0	2.7	8.8	10.6	2.1	14.5	15.3	17.0	23.1	4.9	17.8	5.5	11.5	9.6	37.3	11.9	4.7	6.3	18.3	2.2	2.7	2.2	3.7	2.4	6.3	2.4	3.6	10.5	4.9	16.2	23.4	39.5	5.2	2.7	12.1	10.7	50.2	3.9	2.6	2.7	4.6	7.8	2.6	3.0	28.9	1.7	39.1	8.8	1.9	3.1	6.4	5.4	15.9	25.1	29.2	2.5	24.4	7.8	4.0	21.9	10.3	2.0	7.3	2.5	9.7	1.5	10.6	0.0	0.1	0.0	0.4	0.2	0.7	1.6	0.8	0.6	0.6	2.0	0.7	0.7	0.4	0.5	0.3	39.7	1.2	0.5	5.9	7.8	9.5	11.2	8.6	9.0	7.1	5.8	6.8	6.2	38.7	48.5	29.9	123.9	67.2	26.0	9.2	30.6	115.1	113.7	27.9	58.9	5.7	14.9	98.3	14.5	72.6	52.6	0.0	43.7	10.2	46.0	156.5	10.4	15.5	19.6	17.5	17.7	92.7	30.2	3.6	45.5	30.8	55.6	69.5	41.5	7.8	67.4	21.0	36.0	56.0	14.2	12.9	60.8	1.6	1.5	106.9	2.9	26.6	12.8	446.9
UGGT1	"HUGT1, UGCGL1"	ENSG00000136731	"UDP-glucose glycoprotein glucosyltransferase 1"	Q9NYU2	2	128091200-128195677	"Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012761, HPA015127"	Enhanced		Uncertain	Cytosol		NA	NA		3800000	Cytosol		"HPA012761: AB_1858597, HPA015127: AB_1858596"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.45e-2)"	"unprognostic (7.03e-3)"	"unprognostic (3.13e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.09e-3)"	"unprognostic (7.05e-2)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (3.86e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.38e-3)"	13.7	14.7	7.6	16.4	10.2	23.8	11.3	10.7	10.8	12.7	15.2	10.0	21.1	11.4	12.3	26.3	13.1	10.6	11.3	13.0	7.7	7.9	13.7	33.4	13.9	14.6	11.0	5.7	10.4	44.1	13.4	11.2	22.1	9.1	11.7	13.5	9.7	15.5	20.5	19.3	11.1	17.4	8.9	9.0	16.1	13.0	9.9	9.5	24.3	13.8	6.4	15.7	11.4	11.0	6.3	7.4	8.8	6.2	4.7	5.9	2.8	16.5	5.8	11.1	23.8	14.6	11.7	16.9	19.1	8.4	6.4	5.8	12.8	12.3	23.5	7.7	14.0	5.8	12.3	8.4	8.3	13.1	14.9	4.0	20.6	7.6	39.1	14.5	27.5	13.0	8.5	6.6	12.9	11.8	12.8	14.9	9.8	13.2	12.8	13.5	11.6	11.1	15.8	19.6	11.7	6.0	9.1	10.6	10.0	11.8	12.3	5.8	8.8	13.2	18.1	11.2	11.9	7.1	19.5	20.5	17.7	12.1	10.1	13.6	13.4	18.6	10.8	15.0	15.1	16.3	7.1	6.2	5.4	5.9	6.0	5.8	4.0	4.8	5.3	4.5	6.3	4.1	5.9	8.8	4.7	5.7	7.4	3.8	2.8	7.6	10.2	10.7	10.8	7.7	7.9	11.0	5.7	9.1	9.5	32.8	24.8	6.7	4.9	7.2	20.0	14.1	17.8	6.7	25.0	3.5	21.6	9.5	1.7	12.2	7.0	11.3	19.4	0.0	16.8	15.8	10.8	11.7	10.5	33.0	14.7	19.1	21.9	19.6	23.0	1.8	13.8	15.5	13.5	12.6	20.8	9.7	18.4	10.5	12.7	8.7	18.9	6.5	11.1	8.9	8.1	9.4	9.0	13.8	17.5	9.8
UGGT2	"FLJ10873, FLJ11485, HUGT2, MGC117360, MGC150689, MGC87276, UGCGL2"	ENSG00000102595	"UDP-glucose glycoprotein glucosyltransferase 2"	Q9NYU1	13	95801580-96053482	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA047955	Uncertain				"Intracellular and membrane"	NA	NA					"HPA047955: AB_2680222"	"unprognostic (5.32e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.33e-2)"	"unprognostic (8.70e-2)"	"prognostic unfavorable (9.99e-4)"	"prognostic unfavorable (5.47e-4)"	"unprognostic (1.55e-1)"	"unprognostic (9.21e-2)"	"unprognostic (7.75e-3)"	"unprognostic (6.27e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.61e-2)"	19.7	11.5	9.7	8.0	12.0	5.4	16.3	2.8	13.6	14.2	11.2	11.2	10.2	8.9	17.8	26.6	8.1	13.5	10.1	16.6	11.2	10.9	12.9	13.4	11.8	6.7	10.4	8.9	15.1	16.9	11.7	26.4	17.6	14.3	12.8	10.4	12.4	12.6	15.2	15.4	8.7	8.4	16.1	17.4	8.7	12.8	18.3	11.2	0.0	18.4	5.0	4.8	15.3	14.8	1.5	4.5	3.0	7.7	1.2	0.2	2.2	11.2	5.4	11.3	5.9	19.0	20.4	9.4	19.3	14.4	9.1	15.6	8.2	9.8	3.9	7.2	12.2	6.6	7.1	3.9	4.0	13.2	0.1	5.3	5.0	11.7	5.5	11.1	13.7	12.4	12.0	4.3	3.5	10.7	16.6	8.0	0.1	3.2	6.5	12.5	3.7	0.1	6.1	4.8	8.3	3.2	0.0	8.2	5.7	7.8	11.5	2.3	9.3	10.4	10.5	7.9	16.1	9.2	6.6	14.1	9.0	6.0	10.2	9.8	9.2	4.7	4.9	24.0	7.4	12.1	0.3	7.5	3.0	0.2	7.7	0.1	1.5	0.1	0.1	4.5	0.6	0.1	0.1	0.5	1.2	6.9	0.3	0.0	2.2	9.7	12.0	2.8	13.6	11.2	10.9	10.4	8.9	14.3	11.2	14.9	14.5	2.2	7.6	3.5	20.2	12.2	7.6	20.1	19.4	14.0	29.5	16.3	0.0	11.1	44.1	13.4	3.3	0.0	16.4	14.5	19.4	8.8	17.4	7.2	6.8	17.5	4.6	16.5	5.9	12.4	20.4	10.0	3.3	3.6	5.8	12.6	14.8	3.5	15.6	5.6	17.6	32.3	16.9	36.8	23.8	2.8	11.6	0.0	6.8	6.2
